% -------------------------------------------------------------------------
% This BibTex file was generated by Qiqqa (http://www.qiqqa.com/?ref=EXPBIB)
% Wednesday, November 2, 2022 11:26:15 PM
% Version 3
% -------------------------------------------------------------------------

@article{cordonnier2009randomized,
  title={Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation},
  author={Cordonnier, C. and Labopin, M. and Chesnel, V. and Ribaud, P. and De La Camara, R. and Martino, R. and Ullmann, A.J. and Parkkali, T. and Locasciulli, A. and Yakouben, K. and others},
  journal={Clinical Infectious Diseases},
  volume={48},
  number={10},
  pages={1392--1401},
  year={2009},
  publisher={Oxford University Press}
}

@article{gold2008human,
  title={Human Innate Mycobacterium tuberculosis--Reactive $\alpha$$\beta$TCR+ Thymocytes},
  author={Gold, M.C. and Ehlinger, H.D. and Cook, M.S. and Smyk-Pearson, S.K. and Wille, P.T. and Ungerleider, R.M. and Lewinsohn, D.A. and Lewinsohn, D.M.},
  journal={PLoS pathogens},
  volume={4},
  number={2},
  pages={e39},
  year={2008},
  publisher={Public Library of Science}
}

@article{adibi2012reduction,
  title={Reduction in Hospital Admission Rates Due to Post-Prostate Biopsy Infections After Augmenting Standard Antibiotic Prophylaxis.},
  author={Adibi, M. and Hornberger, B. and Bhat, D. and Raj, G. and Roehrborn, CG and Lotan, Y.},
  journal={The Journal of urology},
  year={2012}
}

@article{roach1991ciprofloxacin,
  title={Ciprofloxacin versus gentamicin in prophylaxis against bacteremia in transrectal prostate needle biopsy},
  author={Roach, M.B. and George, W.J. and Figueroa, T.E. and Neal, D.E. and McBride, D.},
  journal={Urology},
  volume={38},
  number={1},
  pages={84--87},
  year={1991},
  publisher={Elsevier}
}

@article{kapoor1998single,
  title={Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy.},
  author={Kapoor, D.A. and Klimberg, I.W. and Malek, G.H. and Wegenke, J.D. and Cox, C.E. and Patterson, A.L. and Graham, E. and Echols, R.M. and Whalen, E. and Kowalsky, S.F. and others},
  journal={Urology},
  volume={52},
  number={4},
  pages={552},
  year={1998}
}

@article{aron2001antibiotic,
  title={Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study},
  author={Aron, M. and Rajeev, TP and Gupta, NP},
  journal={BJU international},
  volume={85},
  number={6},
  pages={682--685},
  year={2001},
  publisher={Wiley Online Library}
}

@article{ho2009intramuscular,
  title={Intramuscular gentamicin improves the efficacy of ciprofloxacin as an antibiotic prophylaxis for transrectal prostate biopsy},
  author={Ho, H.S.S. and Ng, L.G. and Tan, Y.H. and Yeo, M. and Cheng, C.W.S.},
  journal={Annals Academy of Medicine Singapore},
  volume={38},
  number={3},
  pages={212},
  year={2009}
}

@article{junghanss2002incidence,
  title={Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study},
  author={Junghanss, Christian and Marr, Kieren A and Carter, Rachel A and Sandmaier, Brenda M and Maris, Michael B and Maloney, David G and Chauncey, Thomas and McSweeney, Peter A and Storb, Rainer and others},
  journal={Biology of Blood and Marrow Transplantation},
  volume={8},
  number={9},
  pages={512--520},
  year={2002},
  publisher={Elsevier Science}
}

@article{ley1998detection,
  title={Detection of bacteraemia in patients with fever and neutropenia using 16S rRNA gene amplification by polymerase chain reaction},
  author={Ley, BE and Linton, CJ and Bennett, DMC and Jalal, H and Foot, ABM and Millar, MR},
  journal={European Journal of Clinical Microbiology \& Infectious Diseases},
  volume={17},
  number={4},
  pages={247--253},
  year={1998},
  publisher={Springer}
}

@article{castagnola2009management,
  title={Management of bacteremia in patients undergoing hematopoietic stem cell transplantation},
  author={Castagnola, Elio and Faraci, Maura},
  journal={Expert review of anti-infective therapy},
  volume={7},
  number={5},
  pages={607--621},
  year={2009}
}

@article{winston1990ofloxacin,
  title={Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients},
  author={Winston, Drew J and Ho, Winston G and Bruckner, David A and Gale, Robert P and Champlin, Richard E},
  journal={The American journal of medicine},
  volume={88},
  number={1},
  pages={36--42},
  year={1990},
  publisher={Elsevier}
}

@article{van2009chemotherapy,
  title={Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut},
  author={van Vliet, Michel J and Tissing, Wim JE and Dun, Catharina AJ and Meessen, Nico EL and Kamps, Willem A and de Bont, Eveline SJM and Harmsen, Hermie JM},
  journal={Clinical infectious diseases},
  volume={49},
  number={2},
  pages={262--270},
  year={2009},
  publisher={Oxford University Press}
}

@article{diekema2001antimicrobial,
  title={Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America},
  author={Diekema, DJ and Beach, ML and Pfaller, MA and Jones, RN},
  journal={Clinical microbiology and infection},
  volume={7},
  number={3},
  pages={152--157},
  year={2001},
  publisher={Wiley Online Library}
}

@article{yan2007soluble,
  title={Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth},
  author={Yan, Fang and Cao, Hanwei and Cover, Timothy L and Whitehead, Robert and Washington, M Kay and Polk, D Brent},
  journal={Gastroenterology},
  volume={132},
  number={2},
  pages={562--575},
  year={2007},
  publisher={Elsevier}
}

@article{ewaschuk2008secreted,
  title={Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function},
  author={Ewaschuk, Julia B and Diaz, Hugo and Meddings, Liisa and Diederichs, Brendan and Dmytrash, Andrea and Backer, Jody and Looijer-van Langen, Mirjam and Madsen, Karen L},
  journal={American Journal of Physiology-Gastrointestinal and Liver Physiology},
  volume={295},
  number={5},
  pages={G1025--G1034},
  year={2008},
  publisher={Am Physiological Soc}
}

@article{marron2000serious,
  title={Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer},
  author={Marron, Anna and Carratal{\`a}, Jordi and Gonz{\'a}lez-Barca, Eva and Fern{\'a}ndez-Sevilla, Alberto and Alcaide, Fernando and Gudiol, Francesc},
  journal={Clinical infectious diseases},
  volume={31},
  number={5},
  pages={1126--1130},
  year={2000},
  publisher={Oxford University Press}
}

@article{miller1954effect,
  title={The effect of antibiotic therapy on susceptibility to an experimental enteric infection.},
  author={Miller, CP and Bohnhoff, M and Drake, BL and others},
  journal={Transactions of the Association of American Physicians},
  volume={67},
  pages={156},
  year={1954}
}

@article{moorthy2009lactobacilli,
  title={Lactobacilli facilitate maintenance of intestinal membrane integrity during< i> Shigella dysenteriae</i> 1 infection in rats},
  author={Moorthy, Guhapriya and Murali, Malliga Raman and Devaraj, S Niranjali},
  journal={Nutrition},
  volume={25},
  number={3},
  pages={350--358},
  year={2009},
  publisher={Elsevier}
}

@article{landes2008prevention,
  title={Prevention of surgical site infection and appropriateness of antibiotic prescribing habits in plastic surgery.},
  author={Landes, Genevieve and Harris, Patrick G and Lemaine, Valerie and Perreault, Isabelle and Sampalis, John S and Brutus, Jean-Paul and Lessard, Lucie and Dionyssopoulos, Alexandre and Nikolis, Andreas and others},
  journal={Journal of plastic, reconstructive \& aesthetic surgery: JPRAS},
  volume={61},
  number={11},
  pages={1347},
  year={2008}
}

@article{zani2011antibiotic,
  title={Antibiotic prophylaxis for transrectal prostate biopsy},
  author={Zani, E.L. and Clark, OA and Rodrigues Netto Jr, N.},
  journal={Cochrane Database Syst Rev},
  volume={5},
  year={2011},
  publisher={Wiley Online Library}
}

@article{worth2007vancomycin,
  title={Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk},
  author={Worth, Leon J and Thursky, Karin A and Seymour, John F and Slavin, Monica A},
  journal={European journal of haematology},
  volume={79},
  number={3},
  pages={226--233},
  year={2007},
  publisher={Wiley Online Library}
}

@article{kamboj2010changing,
  title={The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients},
  author={Kamboj, Mini and Chung, Dick and Seo, Susan K and Pamer, Eric G and Sepkowitz, Kent A and Jakubowski, Ann A and Papanicolaou, Genovefa},
  journal={Biology of Blood and Marrow Transplantation},
  volume={16},
  number={11},
  pages={1576--1581},
  year={2010},
  publisher={Elsevier}
}

@article{avery2005early,
  title={Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course},
  author={Avery, R and Kalaycio, M and Pohlman, B and Sobecks, R and Kuczkowski, E and Andresen, S and Mossad, S and Shamp, J and Curtis, J and Kosar, J and others},
  journal={Bone marrow transplantation},
  volume={35},
  number={5},
  pages={497--499},
  year={2005},
  publisher={Nature Publishing Group}
}

@article{tsiatis2004incidence,
  title={Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients},
  author={Tsiatis, AC and Manes, B and Calder, C and Billheimer, D and Wilkerson, KS and Frangoul, H},
  journal={Bone marrow transplantation},
  volume={33},
  number={9},
  pages={937--941},
  year={2004},
  publisher={Nature Publishing Group}
}

@article{hohl2007aspergillus,
  title={Aspergillus fumigatus: principles of pathogenesis and host defense},
  author={Hohl, Tobias M and Feldmesser, Marta},
  journal={Eukaryotic cell},
  volume={6},
  number={11},
  pages={1953--1963},
  year={2007},
  publisher={Am Soc Microbiol}
}

@article{hohl2005aspergillus
,	title	= {Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display}
,	author	= {Hohl, Tobias M and Van Epps, Heather L and Rivera, Amariliz and Morgan, Laura A and Chen, Patrick L and Feldmesser, Marta and Pamer, Eric G}
,	journal	= {PLoS Pathogens}
,	volume	= {1}
,	number	= {3}
,	pages	= {e30}
,	year	= {2005}
,	publisher	= {Public Library of Science}
}

@article{taur2005cardiac,
  title={The cardiac ryanodine receptor (RyR2) and its role in heart disease},
  author={Taur, Ying and Frishman, William H},
  journal={Cardiology in review},
  volume={13},
  number={3},
  pages={142--146},
  year={2005},
  publisher={LWW}
}

@article{mahler2012safety,
  title={Safety and immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic hematopoietic stem cell transplantation},
  author={Mahler, Michelle B and Taur, Ying and Jean, Raymond and Kernan, Nancy A and Prockop, Susan E and Small, Trudy N},
  journal={Biology of Blood and Marrow Transplantation},
  volume={18},
  number={1},
  pages={145--149},
  year={2012},
  publisher={Elsevier}
}

@article{leventakos2010fungal,
  title={Fungal infections in leukemia patients: how do we prevent and treat them?},
  author={Leventakos, Konstantinos and Lewis, Russell E and Kontoyiannis, Dimitrios P},
  journal={Clinical infectious diseases},
  volume={50},
  number={3},
  pages={405--415},
  year={2010},
  publisher={Oxford University Press}
}

@article{dubos1965indigenous,
  title={Indigenous, normal, and autochthonous flora of the gastrointestinal tract},
  author={Dubos, Ren{\'e} and Schaedler, Russell W and Costello, Richard and Hoet, Philippe},
  journal={The Journal of experimental medicine},
  volume={122},
  number={1},
  pages={67--76},
  year={1965},
  publisher={Rockefeller Univ Press}
}

@article{sekirov2010salmonella,
  title={Salmonella SPI-1-mediated neutrophil recruitment during enteric colitis is associated with reduction and alteration in intestinal microbiota},
  author={Sekirov, Inna and Gill, Navkiran and Jogova, Maria and Tam, Nicola and Robertson, Marilyn and de Llanos, Rosa and Li, Yuling and Finlay, Brett B},
  journal={Gut Microbes},
  volume={1},
  number={1},
  pages={30},
  year={2010},
  publisher={Landes Bioscience}
}

@article{chapman2006diagnosis,
  title={Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals.},
  author={Chapman, Alice S and Bakken, Johan S and Folk, SM and Paddock, CD and Bloch, KC and Krusell, A and Sexton, DJ and Buckingham, SC and Marshall, Gary S and Storch, GA and others},
  journal={MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control},
  volume={55},
  number={RR-4},
  pages={1},
  year={2006}
}

@article{rubenstein2004clinical,
  title={Clinical practice guidelines for the prevention and treatment of cancer therapy--induced oral and gastrointestinal mucositis},
  author={Rubenstein, Edward B and Peterson, Douglas E and Schubert, Mark and Keefe, Dorothy and McGuire, Deborah and Epstein, Joel and Elting, Linda S and Fox, Philip C and Cooksley, Catherine and Sonis, Stephen T},
  journal={Cancer},
  volume={100},
  number={S9},
  pages={2026--2046},
  year={2004},
  publisher={Wiley Online Library}
}

@article{waters2005quorum,
  title={Quorum sensing: cell-to-cell communication in bacteria},
  author={Waters, Christopher M and Bassler, Bonnie L},
  journal={Annu. Rev. Cell Dev. Biol.},
  volume={21},
  pages={319--346},
  year={2005},
  publisher={Annual Reviews}
}

@article{warren1990prevention,
  title={Prevention of infection by ciprofloxacin in neutropenia},
  author={Warren, RE and Wimperis, JZ and Baglin, TP and Constantine, CE and Marcus, R},
  journal={Journal of Antimicrobial Chemotherapy},
  volume={26},
  number={suppl F},
  pages={109},
  year={1990},
  publisher={Br Soc Antimicrob Chemo}
}

@article{cruciani2003reappraisal,
  title={Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients},
  author={Cruciani, Mario and Malena, Marina and Bosco, Oliviero and Nardi, Stefano and Serpelloni, Giovanni and Mengoli, Carlo},
  journal={Journal of clinical oncology},
  volume={21},
  number={22},
  pages={4127--4137},
  year={2003},
  publisher={American Society of Clinical Oncology}
}

@article{rolston2005challenges,
  title={Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia},
  author={Rolston, Kenneth VI},
  journal={Clinical infectious diseases},
  volume={40},
  number={Supplement 4},
  pages={S246--S252},
  year={2005},
  publisher={Oxford University Press}
}

@article{zinner1999changing,
  title={Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria},
  author={Zinner, Stephen H},
  journal={Clinical infectious diseases},
  volume={29},
  number={3},
  pages={490--494},
  year={1999},
  publisher={Oxford University Press}
}

@article{bochud1994bacteremia,
  title={Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors},
  author={Bochud, P-Y and Eggiman, PH and Calandra, TH and Van Melle, G and Saghafi, L and Francioli, P},
  journal={Clinical infectious diseases},
  volume={18},
  number={1},
  pages={25--31},
  year={1994},
  publisher={Oxford University Press}
}

@article{cometta1994escherichia,
  title={Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia},
  author={Cometta, Alain and Calandra, Thierry and Bille, Jacques and Glauser, Michel Pierre},
  journal={New England Journal of Medicine},
  volume={330},
  number={17},
  pages={1240--1241},
  year={1994},
  publisher={Mass Medical Soc}
}

@article{markle2013sex,
  title={Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity},
  author={Markle, Janet GM and Frank, Daniel N and Mortin-Toth, Steven and Robertson, Charles E and Feazel, Leah M and Rolle-Kampczyk, Ulrike and von Bergen, Martin and McCoy, Kathy D and Macpherson, Andrew J and Danska, Jayne S},
  journal={Science},
  volume={339},
  number={6123},
  pages={1084--1088},
  year={2013},
  publisher={American Association for the Advancement of Science}
}

@article{bochud1994bacteremia_review
,	author	= {Bochud, Pierre-Yves and Calandra, Thierry and Francioli, Patrick}
,	title	= {Bacteremia due to viridans streptococci in neutropenic patients: a review}
,	journal	= {The American journal of medicine}
,	year	= {1994}
,	volume	= {97}
,	number	= {3}
,	pages	= {256--264}
,	publisher	= {Elsevier}
}

@article{jarchum2012critical,
  title={Critical Role for MyD88-Mediated Neutrophil Recruitment during Clostridium difficile Colitis},
  author={Jarchum, Irene and Liu, Mingyu and Shi, Chao and Equinda, Michele and Pamer, Eric G},
  journal={Infection and Immunity},
  volume={80},
  number={9},
  pages={2989--2996},
  year={2012},
  publisher={Am Soc Microbiol}
}

@article{hasegawa2011nucleotide,
  title={Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen},
  author={Hasegawa, Mizuho and Yamazaki, Takashi and Kamada, Nobuhiko and Tawaratsumida, Kazuki and Kim, Yun-Gi and N{\'u}{\~n}ez, Gabriel and Inohara, Naohiro},
  journal={The Journal of Immunology},
  volume={186},
  number={8},
  pages={4872--4880},
  year={2011},
  publisher={Am Assoc Immnol}
}

@article{freifeld2006conundrum,
  title={The conundrum of fluoroquinolone prophylaxis},
  author={Freifeld, Alison and Sepkowitz, Kent},
  journal={Nature Clinical Practice Oncology},
  volume={3},
  number={10},
  pages={524--525},
  year={2006},
  publisher={Nature Publishing Group}
}

@article{gafter2012antibiotic,
  title={Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy (Review)},
  author={Gafter-Gvili, A and Fraser, A and Paul, M and Vidal, L and Lawrie, TA and van de Wetering, MD and Kremer, LCM and Leibovici, L},
  year={2012},
  publisher={Wiley Online Library}
}

@article{leibovici2006antibiotic,
  title={Antibiotic prophylaxis in neutropenic patients},
  author={Leibovici, Leonard and Paul, Mical and Cullen, Michael and Bucaneve, Giampaolo and Gafter-Gvili, Anat and Fraser, Abigail and Kern, Winfried V},
  journal={Cancer},
  volume={107},
  number={8},
  pages={1743--1751},
  year={2006},
  publisher={Wiley Online Library}
}

@article{morotomi2008dialister,
  title={Dialister succinatiphilus sp. nov. and Barnesiella intestinihominis sp. nov., isolated from human faeces},
  author={Morotomi, Masami and Nagai, Fumiko and Sakon, Hiroshi and Tanaka, Ryuichiro},
  journal={International journal of systematic and evolutionary microbiology},
  volume={58},
  number={12},
  pages={2716--2720},
  year={2008},
  publisher={Soc General Microbiol}
}

@article{richard1995viridans,
  title={Viridans streptococcal bacteraemia in patients with neutropenia},
  author={Richard, P and Felice, MP and Daeschler, T and Richet, H and Amador Del Valle, G and Moreau, P and Milpied, N and Harousseau, JL},
  journal={The Lancet},
  volume={345},
  number={8965},
  pages={1607--1609},
  year={1995},
  publisher={Elsevier}
}

@article{hasegawa2012protective,
  title={Protective Role of Commensals against Clostridium difficile Infection via an IL-1$\beta$--Mediated Positive-Feedback Loop},
  author={Hasegawa, Mizuho and Kamada, Nobuhiko and Jiao, Yizu and Liu, Meng Zhen and N{\'u}{\~n}ez, Gabriel and Inohara, Naohiro},
  journal={The Journal of Immunology},
  volume={189},
  number={6},
  pages={3085--3091},
  year={2012},
  publisher={Am Assoc Immnol}
}

@article{bhasin2010testosterone,
  title={Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline},
  author={Bhasin, Shalender and Cunningham, Glenn R and Hayes, Frances J and Matsumoto, Alvin M and Snyder, Peter J and Swerdloff, Ronald S and Montori, Victor M},
  journal={Journal of Clinical Endocrinology \& Metabolism},
  volume={95},
  number={6},
  pages={2536--2559},
  year={2010},
  publisher={Endocrine Soc}
}

@article{harris2013diagnostic,
  title={Diagnostic Bronchoscopy in Solid-Organ and Hematopoietic Stem Cell Transplantation},
  author={Harris, Bianca and Lowy, Franklin David and Stover, Diane Elizabeth and Arcasoy, Selim Mehmet},
  journal={Annals of the American Thoracic Society},
  volume={10},
  number={1},
  pages={39--49},
  year={2013},
  publisher={Am Thoracic Soc}
}

@article{varma2004signs,
  title={Signs and symptoms predictive of death in patients with foodborne botulism—Republic of Georgia, 1980--2002},
  author={Varma, Jay K and Katsitadze, Guram and Moiscrafishvili, Maia and Zardiashvili, Tamar and Chokheli, Maia and Tarkhashvili, Natalia and Jhorjholiani, Ekaterina and Chubinidze, Maia and Kukhalashvili, Teimuraz and Khmaladze, Irakli and others},
  journal={Clinical infectious diseases},
  volume={39},
  number={3},
  pages={357--362},
  year={2004},
  publisher={Oxford University Press}
}

@article{horowitz2005botulinum,
  title={Botulinum toxin.},
  author={Horowitz, B Zane and others},
  journal={Critical care clinics},
  volume={21},
  number={4},
  pages={825},
  year={2005}
}

@article{tunkel2002infections,
  title={Infections caused by viridans streptococci in patients with neutropenia},
  author={Tunkel, Allan R and Sepkowitz, Kent A},
  journal={Clinical infectious diseases},
  volume={34},
  number={11},
  pages={1524--1529},
  year={2002},
  publisher={Oxford University Press}
}

@article{peck2009biology,
  title={Biology and Genomic Analysis of< i> Clostridium botulinum</i>},
  author={Peck, Michael W},
  journal={Advances in microbial physiology},
  volume={55},
  pages={183--320},
  year={2009},
  publisher={Elsevier}
}

@article{cherington1998clinical,
  title={Clinical spectrum of botulism},
  author={Cherington, Michael},
  journal={Muscle \& nerve},
  volume={21},
  number={6},
  pages={701--710},
  year={1998},
  publisher={Wiley Online Library}
}

@article{altschul1990basic
,	author	= {Altschul, S F and Gish, W and Miller, W and Myers, E W and Lipman, D J}
,	title	= {Basic local alignment search tool.}
,	journal	= {Journal of molecular biology}
,	year	= {1990}
,	volume	= {215}
,	number	= {3}
,	pages	= {403--10}
,	month	= {Oct}
,	journal-iso	= {J. Mol. Biol.}
,	pmid	= {2231712}
,	abstract	= {A new approach to rapid sequence comparison, basic local alignment search tool (BLAST), directly approximates alignments that optimize a measure of local similarity, the maximal segment pair (MSP) score. Recent mathematical results on the stochastic properties of MSP scores allow an analysis of the performance of this method as well as the statistical significance of alignments it generates. The basic algorithm is simple and robust; it can be implemented in a number of ways and applied in a variety of contexts including straightforward DNA and protein sequence database searches, motif searches, gene identification searches, and in the analysis of multiple regions of similarity in long DNA sequences. In addition to its flexibility and tractability to mathematical analysis, BLAST is an order of magnitude faster than existing sequence comparison tools of comparable sensitivity.}
}

@inproceedings{simon2012therapeutic,
  title={Therapeutic Approaches to Patients With Hypereosinophilic Syndromes},
  author={Simon, Hans-Uwe and Klion, Amy},
  booktitle={Seminars in hematology},
  volume={49},
  number={2},
  pages={160--170},
  year={2012},
  organization={Elsevier}
}

@inproceedings{mejia2012evaluation,
  title={Evaluation and Differential Diagnosis of Marked, Persistent Eosinophilia},
  author={Mejia, Rojelio and Nutman, Thomas B},
  booktitle={Seminars in hematology},
  volume={49},
  number={2},
  pages={149--159},
  year={2012},
  organization={Elsevier}
}

@article{pmid:23399072,
  title={Acute myeloid leukaemia in adults.},
  author={Ferrara, Felicetto and Schiffer, Charles A},
  journal={Lancet},
  journal-iso={Lancet},
  volume={381},
  number={9865},
  year={2013},
  month={Feb},
  pages={484--95},
  doi={10.1016/S0140-6736(12)61727-9},
  pmid={23399072},
  abstract={The outlook for patients with acute myeloid leukaemia has improved in the past 30 years. Unlike other cancers, much of this progress is attributable to refinement of supportive treatment, rather than the introduction of new drugs. New antibacterial and antifungal agents, antiemetics, and improved transfusion support have decreased the rate of early death, and morbidity and mortality from allogeneic stem cell transplantation has been substantially reduced. However, more than half of young adult patients and about 90% of older patients still die from their disease. Refractoriness to initial induction treatment and, more frequently, relapse after complete remission, are still the main obstacles to cure. Accordingly, new treatment approaches with mechanisms of action different from those of conventional chemotherapy are needed. Our knowledge of the various chromosomal and molecular abnormalities implicated in the pathogenesis of the many subtypes of the disease has greatly expanded; as a result, clinical research is moving towards the investigation of new non-cytotoxic agents in combination with chemotherapy. The goal is to target the molecular abnormalities identified at diagnosis; however, several aberrations can coexist in subclones of acute myeloid leukaemia, making the disease less likely to be inhibited by a single agent.Copyright © 2013 Elsevier Ltd. All rights reserved.}
}


% BEGIN:Original PubMed XML
%  <PubmedArticle>
%    <MedlineCitation Owner="NLM" Status="MEDLINE">
%      <PMID Version="1">23399072</PMID>
%      <DateCreated>
%        <Year>2013</Year>
%        <Month>02</Month>
%        <Day>12</Day>
%      </DateCreated>
%      <DateCompleted>
%        <Year>2013</Year>
%        <Month>03</Month>
%        <Day>05</Day>
%      </DateCompleted>
%      <Article PubModel="Print">
%        <Journal>
%          <ISSN IssnType="Electronic">1474-547X</ISSN>
%          <JournalIssue CitedMedium="Internet">
%            <Volume>381</Volume>
%            <Issue>9865</Issue>
%            <PubDate>
%              <Year>2013</Year>
%              <Month>Feb</Month>
%              <Day>9</Day>
%            </PubDate>
%          </JournalIssue>
%          <Title>Lancet</Title>
%          <ISOAbbreviation>Lancet</ISOAbbreviation>
%        </Journal>
%        <ArticleTitle>Acute myeloid leukaemia in adults.</ArticleTitle>
%        <Pagination>
%          <MedlinePgn>484-95</MedlinePgn>
%        </Pagination>
%        <ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(12)61727-9</ELocationID>
%        <ELocationID EIdType="pii" ValidYN="Y">S0140-6736(12)61727-9</ELocationID>
%        <Abstract>
%          <AbstractText>The outlook for patients with acute myeloid leukaemia has improved in the past 30 years. Unlike other cancers, much of this progress is attributable to refinement of supportive treatment, rather than the introduction of new drugs. New antibacterial and antifungal agents, antiemetics, and improved transfusion support have decreased the rate of early death, and morbidity and mortality from allogeneic stem cell transplantation has been substantially reduced. However, more than half of young adult patients and about 90% of older patients still die from their disease. Refractoriness to initial induction treatment and, more frequently, relapse after complete remission, are still the main obstacles to cure. Accordingly, new treatment approaches with mechanisms of action different from those of conventional chemotherapy are needed. Our knowledge of the various chromosomal and molecular abnormalities implicated in the pathogenesis of the many subtypes of the disease has greatly expanded; as a result, clinical research is moving towards the investigation of new non-cytotoxic agents in combination with chemotherapy. The goal is to target the molecular abnormalities identified at diagnosis; however, several aberrations can coexist in subclones of acute myeloid leukaemia, making the disease less likely to be inhibited by a single agent.</AbstractText>
%          <CopyrightInformation>Copyright © 2013 Elsevier Ltd. All rights reserved.</CopyrightInformation>
%        </Abstract>
%        <Affiliation>Division of Haematology and Stem Cell Transplantation Unit, Naples, Italy. felicettoferrara@katamail.com</Affiliation>
%        <AuthorList CompleteYN="Y">
%          <Author ValidYN="Y">
%            <LastName>Ferrara</LastName>
%            <ForeName>Felicetto</ForeName>
%            <Initials>F</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Schiffer</LastName>
%            <ForeName>Charles A</ForeName>
%            <Initials>CA</Initials>
%          </Author>
%        </AuthorList>
%        <Language>eng</Language>
%        <PublicationTypeList>
%          <PublicationType>Journal Article</PublicationType>
%          <PublicationType>Review</PublicationType>
%        </PublicationTypeList>
%      </Article>
%      <MedlineJournalInfo>
%        <Country>England</Country>
%        <MedlineTA>Lancet</MedlineTA>
%        <NlmUniqueID>2985213R</NlmUniqueID>
%        <ISSNLinking>0140-6736</ISSNLinking>
%      </MedlineJournalInfo>
%      <CitationSubset>AIM</CitationSubset>
%      <CitationSubset>IM</CitationSubset>
%      <MeshHeadingList>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Adult</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Age Factors</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Age of Onset</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
%          <QualifierName MajorTopicYN="Y">administration &amp; dosage</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Bone Marrow Transplantation</DescriptorName>
%          <QualifierName MajorTopicYN="N">methods</QualifierName>
%          <QualifierName MajorTopicYN="N">mortality</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Disease-Free Survival</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Female</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Hematopoietic Stem Cell Transplantation</DescriptorName>
%          <QualifierName MajorTopicYN="Y">methods</QualifierName>
%          <QualifierName MajorTopicYN="N">mortality</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Humans</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Leukemia, Myeloid, Acute</DescriptorName>
%          <QualifierName MajorTopicYN="N">diagnosis</QualifierName>
%          <QualifierName MajorTopicYN="Y">epidemiology</QualifierName>
%          <QualifierName MajorTopicYN="Y">therapy</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Male</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>
%          <QualifierName MajorTopicYN="N">mortality</QualifierName>
%          <QualifierName MajorTopicYN="Y">therapy</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Prognosis</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Risk Assessment</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Severity of Illness Index</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Sex Factors</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Survival Analysis</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Transplantation, Autologous</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Transplantation, Homologous</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Treatment Outcome</DescriptorName>
%        </MeshHeading>
%      </MeshHeadingList>
%    </MedlineCitation>
%    <PubmedData>
%      <History>
%        <PubMedPubDate PubStatus="entrez">
%          <Year>2013</Year>
%          <Month>2</Month>
%          <Day>13</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="pubmed">
%          <Year>2013</Year>
%          <Month>2</Month>
%          <Day>13</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="medline">
%          <Year>2013</Year>
%          <Month>3</Month>
%          <Day>6</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%      </History>
%      <PublicationStatus>ppublish</PublicationStatus>
%      <ArticleIdList>
%        <ArticleId IdType="pii">S0140-6736(12)61727-9</ArticleId>
%        <ArticleId IdType="doi">10.1016/S0140-6736(12)61727-9</ArticleId>
%        <ArticleId IdType="pubmed">23399072</ArticleId>
%      </ArticleIdList>
%    </PubmedData>
%  </PubmedArticle>
% END:Original PubMed XML


@article{miller2001quorum,
  title={Quorum sensing in bacteria},
  author={Miller, Melissa B and Bassler, Bonnie L},
  journal={Annual Reviews in Microbiology},
  volume={55},
  number={1},
  pages={165--199},
  year={2001},
  publisher={Annual Reviews 4139 El Camino Way, PO Box 10139, Palo Alto, CA 94303-0139, USA}
}

@article{gorschluter2001clostridium,
  title={Clostridium difficile infection in patients with neutropenia},
  author={Gorschl{\"u}ter, Marcus and Glasmacher, Axel and Hahn, Corinna and Schakowski, Frank and Ziske, Carsten and Molitor, Ernst and Marklein, G{\"u}nter and Sauerbruch, Tilman and Schmidt-Wolf, Ingo GH},
  journal={Clinical infectious diseases},
  volume={33},
  number={6},
  pages={786--791},
  year={2001},
  publisher={Oxford University Press}
}

@article{brandl2008vancomycin,
  title={Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits},
  author={Brandl, Katharina and Plitas, George and Mihu, Coralia N and Ubeda, Carles and Jia, Ting and Fleisher, Martin and Schnabl, Bernd and DeMatteo, Ronald P and Pamer, Eric G},
  journal={Nature},
  volume={455},
  number={7214},
  pages={804--807},
  year={2008},
  publisher={Nature Publishing Group}
}

@article{sekirov2009role,
  title={The role of the intestinal microbiota in enteric infection},
  author={Sekirov, Inna and Finlay, B Brett},
  journal={The Journal of physiology},
  volume={587},
  number={17},
  pages={4159--4167},
  year={2009},
  publisher={Wiley Online Library}
}

@article{ubeda2010vancomycin
,	author	= {Ubeda, Carles and Taur, Ying and Jenq, Robert R and Equinda, Michele J and Son, Tammy and Samstein, Miriam and Viale, Agnes and Socci, Nicholas D and van den Brink, Marcel R M and Kamboj, Mini and Pamer, Eric G}
,	title	= {Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.}
,	journal	= {The Journal of clinical investigation}
,	year	= {2010}
,	volume	= {120}
,	number	= {12}
,	pages	= {4332--41}
,	month	= {Dec}
,	journal-iso	= {J. Clin. Invest.}
,	doi	= {10.1172/JCI43918}
,	pmid	= {21099116}
,	abstract	= {Bloodstream infection by highly antibiotic-resistant bacteria, such as vancomycin-resistant Enterococcus (VRE), is a growing clinical problem that increasingly defies medical intervention. Identifying patients at high risk for bacterial sepsis remains an important clinical challenge. Recent studies have shown that antibiotics can alter microbial diversity in the intestine. Here, we characterized these effects using 16s rDNA pyrosequencing and demonstrated that antibiotic treatment of mice enabled exogenously administered VRE to efficiently and nearly completely displace the normal microbiota of the small and large intestine. In the clinical setting, we found that intestinal domination by VRE preceded bloodstream infection in patients undergoing allogeneic hematopoietic stem cell transplantation. Our results demonstrate that antibiotics perturb the normal commensal microbiota and set the stage for intestinal domination by bacteria associated with hospital-acquired infections. Thus, high-throughput DNA sequencing of the intestinal microbiota could identify patients at high risk of developing bacterial sepsis.}
}

@article{treiner2003selection,
  title={Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1},
  author={Treiner, Emmanuel and Duban, Livine and Bahram, Seiamak and Radosavljevic, Mirjana and Wanner, Valerie and Tilloy, Florence and Affaticati, Pierre and Gilfillan, Susan and Lantz, Olivier},
  journal={Nature},
  volume={422},
  number={6928},
  pages={164--169},
  year={2003},
  publisher={Nature Publishing Group}
}

@article{gold2012co,
  title={Co-dependents: MR1-restricted MAIT cells and their antimicrobial function},
  author={Gold, M.C. and Lewinsohn, D.M.},
  journal={Nature Reviews Microbiology},
  volume={11},
  number={1},
  pages={14--19},
  year={2012},
  publisher={Nature Publishing Group}
}

@article{ochoa2009role,
  title={Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis},
  author={Ochoa-Rep{\'a}raz, Javier and Mielcarz, Daniel W and Ditrio, Lauren E and Burroughs, Ashley R and Foureau, David M and Haque-Begum, Sakhina and Kasper, Lloyd H},
  journal={The Journal of Immunology},
  volume={183},
  number={10},
  pages={6041--6050},
  year={2009},
  publisher={Am Assoc Immnol}
}

@article{atarashi2011induction,
  title={Induction of colonic regulatory T cells by indigenous Clostridium species},
  author={Atarashi, Koji and Tanoue, Takeshi and Shima, Tatsuichiro and Imaoka, Akemi and Kuwahara, Tomomi and Momose, Yoshika and Cheng, Genhong and Yamasaki, Sho and Saito, Takashi and Ohba, Yusuke and others},
  journal={Science Signaling},
  volume={331},
  number={6015},
  pages={337},
  year={2011},
  publisher={AAAS}
}

@article{caporaso2012ultra
,	author	= {Caporaso, J Gregory and Lauber, Christian L and Walters, William A and Berg-Lyons, Donna and Huntley, James and Fierer, Noah and Owens, Sarah M and Betley, Jason and Fraser, Louise and Bauer, Markus and Gormley, Niall and Gilbert, Jack A and Smith, Geoff and Knight, Rob}
,	title	= {Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms.}
,	journal	= {The ISME journal}
,	year	= {2012}
,	volume	= {6}
,	number	= {8}
,	pages	= {1621--4}
,	month	= {Aug}
,	journal-iso	= {ISME J}
,	doi	= {10.1038/ismej.2012.8}
,	pmid	= {22402401}
,	abstract	= {DNA sequencing continues to decrease in cost with the Illumina HiSeq2000 generating up to 600 Gb of paired-end 100 base reads in a ten-day run. Here we present a protocol for community amplicon sequencing on the HiSeq2000 and MiSeq Illumina platforms, and apply that protocol to sequence 24 microbial communities from host-associated and free-living environments. A critical question as more sequencing platforms become available is whether biological conclusions derived on one platform are consistent with what would be derived on a different platform. We show that the protocol developed for these instruments successfully recaptures known biological results, and additionally that biological conclusions are consistent across sequencing platforms (the HiSeq2000 versus the MiSeq) and across the sequenced regions of amplicons.}
}

@article{randles1979introduction,
  title={Introduction to the theory of nonparametric statistics},
  author={Randles, Ronald H and Wolfe, Douglas A},
  journal={Introduction to the theory of nonparametric statistics, by Randles, Ronald H.; Wolfe, Douglas A. New York: Wiley, c1979. Wiley series in probability and mathematical statistics},
  volume={1},
  year={1979}
}

@article{giordano2007skin,
  title={Skin and skin structure infections: treatment with newer generation fluoroquinolones},
  author={Giordano, Philip and Weber, Kurt and Gesin, Gail and Kubert, Jason},
  journal={Therapeutics and clinical risk management},
  volume={3},
  number={2},
  pages={309},
  year={2007},
  publisher={Dove Press}
}

@article{weller2002vitro,
  title={The in vitro activity of BMS-284756, a new des-fluorinated quinolone},
  author={Weller, TMA and Andrews, JM and Jevons, G and Wise, R},
  journal={Journal of Antimicrobial Chemotherapy},
  volume={49},
  number={1},
  pages={177--184},
  year={2002},
  publisher={Br Soc Antimicrob Chemo}
}

@article{naiman2003intralesional,
  title={Intralesional cidofovir and surgical excision for laryngeal papillomatosis},
  author={Naiman, Ana Nusa and Ceruse, Philip and Coulombeau, Bruno and Froehlich, Patrick},
  journal={The Laryngoscope},
  volume={113},
  number={12},
  pages={2174--2181},
  year={2003},
  publisher={Wiley Online Library}
}

@article{milczukm2003intralesional,
  title={Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children},
  author={Milczukm, Henry A},
  journal={Otolaryngology--Head and Neck Surgery},
  volume={128},
  number={6},
  pages={788--794},
  year={2003},
  publisher={SAGE Publications}
}

@article{akst2003stepped,
  title={Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children},
  author={Akst, Lee M and Lee, Walter and Discolo, Christopher and Knott, Daniel and Younes, Abbas and Koltai, Peter J},
  journal={Archives of Otolaryngology—Head \& Neck Surgery},
  volume={129},
  number={8},
  pages={841},
  year={2003},
  publisher={Am Med Assoc}
}

@article{venkatesan2012recurrent,
  title={Recurrent respiratory papillomatosis.},
  author={Venkatesan, N.N. and Pine, H.S. and Underbrink, M.P.},
  journal={Otolaryngologic Clinics of North America},
  volume={45},
  number={3},
  pages={671},
  year={2012}
}

@article{ayres2012lethal,
  title={Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota},
  author={Ayres, Janelle S and Trinidad, Norver J and Vance, Russell E},
  journal={Nature medicine},
  volume={18},
  number={5},
  pages={799--806},
  year={2012},
  publisher={Nature Publishing Group}
}

@article{pmid:19191635,
  title={Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.},
  author={Pappas, Peter G and Kauffman, Carol A and Andes, David and Benjamin, Daniel K and Calandra, Thierry F and Edwards, John E and Filler, Scott G and Fisher, John F and Kullberg, Bart-Jan and Ostrosky-Zeichner, Luis and Reboli, Annette C and Rex, John H and Walsh, Thomas J and Sobel, Jack D},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  journal-iso={Clin. Infect. Dis.},
  volume={48},
  number={5},
  year={2009},
  month={Mar},
  pages={503--35},
  doi={10.1086/596757},
  pmid={19191635},
  abstract={Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous guidelines published in the 15 January 2004 issue of Clinical Infectious Diseases and are intended for use by health care providers who care for patients who either have or are at risk of these infections. Since 2004, several new antifungal agents have become available, and several new studies have been published relating to the treatment of candidemia, other forms of invasive candidiasis, and mucosal disease, including oropharyngeal and esophageal candidiasis. There are also recent prospective data on the prevention of invasive candidiasis in high-risk neonates and adults and on the empiric treatment of suspected invasive candidiasis in adults. This new information is incorporated into this revised document.}
}


% BEGIN:Original PubMed XML
%  <PubmedArticle>
%    <MedlineCitation Owner="NLM" Status="MEDLINE">
%      <PMID Version="1">19191635</PMID>
%      <DateCreated>
%        <Year>2009</Year>
%        <Month>02</Month>
%        <Day>04</Day>
%      </DateCreated>
%      <DateCompleted>
%        <Year>2009</Year>
%        <Month>02</Month>
%        <Day>23</Day>
%      </DateCompleted>
%      <DateRevised>
%        <Year>2009</Year>
%        <Month>07</Month>
%        <Day>22</Day>
%      </DateRevised>
%      <Article PubModel="Print">
%        <Journal>
%          <ISSN IssnType="Electronic">1537-6591</ISSN>
%          <JournalIssue CitedMedium="Internet">
%            <Volume>48</Volume>
%            <Issue>5</Issue>
%            <PubDate>
%              <Year>2009</Year>
%              <Month>Mar</Month>
%              <Day>1</Day>
%            </PubDate>
%          </JournalIssue>
%          <Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title>
%          <ISOAbbreviation>Clin. Infect. Dis.</ISOAbbreviation>
%        </Journal>
%        <ArticleTitle>Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.</ArticleTitle>
%        <Pagination>
%          <MedlinePgn>503-35</MedlinePgn>
%        </Pagination>
%        <ELocationID EIdType="doi" ValidYN="Y">10.1086/596757</ELocationID>
%        <Abstract>
%          <AbstractText>Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous guidelines published in the 15 January 2004 issue of Clinical Infectious Diseases and are intended for use by health care providers who care for patients who either have or are at risk of these infections. Since 2004, several new antifungal agents have become available, and several new studies have been published relating to the treatment of candidemia, other forms of invasive candidiasis, and mucosal disease, including oropharyngeal and esophageal candidiasis. There are also recent prospective data on the prevention of invasive candidiasis in high-risk neonates and adults and on the empiric treatment of suspected invasive candidiasis in adults. This new information is incorporated into this revised document.</AbstractText>
%        </Abstract>
%        <Affiliation>Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama 35294-0006, USA. pappas@uab.edu</Affiliation>
%        <AuthorList CompleteYN="Y">
%          <Author ValidYN="Y">
%            <LastName>Pappas</LastName>
%            <ForeName>Peter G</ForeName>
%            <Initials>PG</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Kauffman</LastName>
%            <ForeName>Carol A</ForeName>
%            <Initials>CA</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Andes</LastName>
%            <ForeName>David</ForeName>
%            <Initials>D</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Benjamin</LastName>
%            <ForeName>Daniel K</ForeName>
%            <Initials>DK</Initials>
%            <Suffix>Jr</Suffix>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Calandra</LastName>
%            <ForeName>Thierry F</ForeName>
%            <Initials>TF</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Edwards</LastName>
%            <ForeName>John E</ForeName>
%            <Initials>JE</Initials>
%            <Suffix>Jr</Suffix>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Filler</LastName>
%            <ForeName>Scott G</ForeName>
%            <Initials>SG</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Fisher</LastName>
%            <ForeName>John F</ForeName>
%            <Initials>JF</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Kullberg</LastName>
%            <ForeName>Bart-Jan</ForeName>
%            <Initials>BJ</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Ostrosky-Zeichner</LastName>
%            <ForeName>Luis</ForeName>
%            <Initials>L</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Reboli</LastName>
%            <ForeName>Annette C</ForeName>
%            <Initials>AC</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Rex</LastName>
%            <ForeName>John H</ForeName>
%            <Initials>JH</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Walsh</LastName>
%            <ForeName>Thomas J</ForeName>
%            <Initials>TJ</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Sobel</LastName>
%            <ForeName>Jack D</ForeName>
%            <Initials>JD</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <CollectiveName>Infectious Diseases Society of America</CollectiveName>
%          </Author>
%        </AuthorList>
%        <Language>eng</Language>
%        <PublicationTypeList>
%          <PublicationType>Journal Article</PublicationType>
%          <PublicationType>Practice Guideline</PublicationType>
%          <PublicationType>Research Support, Non-U.S. Gov't</PublicationType>
%        </PublicationTypeList>
%      </Article>
%      <MedlineJournalInfo>
%        <Country>United States</Country>
%        <MedlineTA>Clin Infect Dis</MedlineTA>
%        <NlmUniqueID>9203213</NlmUniqueID>
%        <ISSNLinking>1058-4838</ISSNLinking>
%      </MedlineJournalInfo>
%      <ChemicalList>
%        <Chemical>
%          <RegistryNumber>0</RegistryNumber>
%          <NameOfSubstance>Antifungal Agents</NameOfSubstance>
%        </Chemical>
%      </ChemicalList>
%      <CitationSubset>IM</CitationSubset>
%      <CommentsCorrectionsList>
%        <CommentsCorrections RefType="CommentIn">
%          <RefSource>Clin Infect Dis. 2009 Aug 15;49(4):638-9; author reply 639-40</RefSource>
%          <PMID Version="1">19619044</PMID>
%        </CommentsCorrections>
%      </CommentsCorrectionsList>
%      <MeshHeadingList>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Antifungal Agents</DescriptorName>
%          <QualifierName MajorTopicYN="Y">therapeutic use</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Candidiasis</DescriptorName>
%          <QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
%          <QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
%          <QualifierName MajorTopicYN="N">prevention &amp; control</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Humans</DescriptorName>
%        </MeshHeading>
%      </MeshHeadingList>
%    </MedlineCitation>
%    <PubmedData>
%      <History>
%        <PubMedPubDate PubStatus="entrez">
%          <Year>2009</Year>
%          <Month>2</Month>
%          <Day>5</Day>
%          <Hour>9</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="pubmed">
%          <Year>2009</Year>
%          <Month>2</Month>
%          <Day>5</Day>
%          <Hour>9</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="medline">
%          <Year>2009</Year>
%          <Month>2</Month>
%          <Day>24</Day>
%          <Hour>9</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%      </History>
%      <PublicationStatus>ppublish</PublicationStatus>
%      <ArticleIdList>
%        <ArticleId IdType="doi">10.1086/596757</ArticleId>
%        <ArticleId IdType="pii">10.1086/596757</ArticleId>
%        <ArticleId IdType="pubmed">19191635</ArticleId>
%      </ArticleIdList>
%    </PubmedData>
%  </PubmedArticle>
% END:Original PubMed XML


@article{hyperbilirubinemia2004management
,	author	= {Subcommittee On Hyperbilirubinemia }
,	title	= {Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation}
,	journal	= {Pediatrics}
,	year	= {2004}
,	volume	= {114}
,	number	= {1}
,	pages	= {297--316}
}

@article{diekema1999comparison,
  title={Comparison of activities of broad-spectrum $\beta$-lactam compounds against 1,128 Gram-positive cocci recently isolated in cancer treatment centers},
  author={Diekema, Daniel J and Coffman, Stacy L and Marshall, Steven A and Beach, Mondell L and Rolston, Kenneth VI and Jones, Ronald N},
  journal={Antimicrobial agents and chemotherapy},
  volume={43},
  number={4},
  pages={940--943},
  year={1999},
  publisher={Am Soc Microbiol}
}

@inproceedings{bohnhoff1954effect,
  title={Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection.},
  author={Bohnhoff, Marjorie and Drake, Barbara L and Miller, C Phillip},
  booktitle={Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, NY)},
  volume={86},
  number={1},
  pages={132--137},
  year={1954},
  organization={Royal Society of Medicine}
}

@article{sekirov2008antibiotic,
  title={Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection},
  author={Sekirov, Inna and Tam, Nicola M and Jogova, Maria and Robertson, Marilyn L and Li, Yuling and Lupp, Claudia and Finlay, B Brett},
  journal={Infection and immunity},
  volume={76},
  number={10},
  pages={4726--4736},
  year={2008},
  publisher={Am Soc Microbiol}
}

@article{vollaard1987influence,
  title={Influence of amoxycillin, erythromycin and roxithromycin on colonization resistance and on appearance of secondary colonization in healthy volunteers.},
  author={Vollaard, EJ and Clasener, HA and van Griethuysen, AJ and Janssen, AJ and Sanders-Reijmers, AJ and others},
  journal={The Journal of antimicrobial chemotherapy},
  volume={20},
  pages={131},
  year={1987}
}

@article{vollaard1990cefotaxime
,	author	= {Vollaard, EJ and Clasener, HAL and Janssen, AJHM and Wynne, HJA}
,	title	= {Influence of cefotaxime on microbial colonization resistance in healthy volunteers}
,	journal	= {Journal of Antimicrobial Chemotherapy}
,	year	= {1990}
,	volume	= {26}
,	number	= {1}
,	pages	= {117--123}
,	publisher	= {Br Soc Antimicrob Chemo}
}

@article{spanik1997viridans,
  title={Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis},
  author={Spanik, Stanislav and Trupl, Jan and Kunova, Alena and Botek, Rudolf and Sorkovska, Dagmar and Grey, Eva and Studena, Mariana and Lacka, Jozef and Oravcova, Eva and Krchnakova, Adriana and others},
  journal={Scandinavian journal of infectious diseases},
  volume={29},
  number={3},
  pages={245--249},
  year={1997},
  publisher={Informa UK Ltd UK}
}

@article{brandl2007myd88,
  title={MyD88-mediated signals induce the bactericidal lectin RegIII$\gamma$ and protect mice against intestinal Listeria monocytogenes infection},
  author={Brandl, Katharina and Plitas, George and Schnabl, Bernd and DeMatteo, Ronald P and Pamer, Eric G},
  journal={The Journal of experimental medicine},
  volume={204},
  number={8},
  pages={1891--1900},
  year={2007},
  publisher={Rockefeller Univ Press}
}

@article{winter2013host,
  title={Host-Derived Nitrate Boosts Growth of E. coli in the Inflamed Gut},
  author={Winter, Sebastian E and Winter, Maria G and Xavier, Mariana N and Thiennimitr, Parameth and Poon, Victor and Keestra, A Marijke and Laughlin, Richard C and Gomez, Gabriel and Wu, Jing and Lawhon, Sara D and others},
  journal={science},
  volume={339},
  number={6120},
  pages={708--711},
  year={2013},
  publisher={American Association for the Advancement of Science}
}

@article{stecher2007salmonella,
  title={Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota},
  author={Stecher, B{\"a}rbel and Robbiani, Riccardo and Walker, Alan W and Westendorf, Astrid M and Barthel, Manja and Kremer, Marcus and Chaffron, Samuel and Macpherson, Andrew J and Buer, Jan and Parkhill, Julian and others},
  journal={PLoS biology},
  volume={5},
  number={10},
  pages={e244},
  year={2007},
  publisher={Public Library of Science}
}

@article{paganini2003viridans,
  title={< i> Viridans streptococci</i> bacteraemia in children with fever and neutropenia: a case--control study of predisposing factors},
  author={Paganini, H and Staffolani, V and Zubizarreta, P and Casimir, L and Lopardo, H and Luppino, V},
  journal={European Journal of Cancer},
  volume={39},
  number={9},
  pages={1284--1289},
  year={2003},
  publisher={Elsevier}
}

@article{berg2006rapid,
  title={Rapid diagnosis of toxinogenic Clostridium difficile in faecal samples with internally controlled real-time PCR},
  author={Berg, RJ and Kuijper, EJ and Coppenraet, LES and Claas, ECJ},
  journal={Clinical microbiology and infection},
  volume={12},
  number={2},
  pages={184--186},
  year={2006},
  publisher={Wiley Online Library}
}

@article{van2007evaluation,
  title={Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study},
  author={van den Berg, Renate J and Vaessen, Norbert and Endtz, Hubert P and Sch{\"u}lin, Tanja and van der Vorm, Eric R and Kuijper, Ed J},
  journal={Journal of medical microbiology},
  volume={56},
  number={1},
  pages={36--42},
  year={2007},
  publisher={Soc General Microbiol}
}

@article{vollaard1990influence,
  title={Influence of amoxycillin on microbial colonization resistance in healthy volunteers. A methodological study},
  author={Vollaard, EJ and Clasener, HAL and Janssen, AJHM and Wynne, HJA},
  journal={Journal of Antimicrobial Chemotherapy},
  volume={25},
  number={5},
  pages={861--871},
  year={1990},
  publisher={Br Soc Antimicrob Chemo}
}

@article{viscidi1981isolation,
  title={Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.},
  author={Viscidi, R and Willey, S and Bartlett, JG},
  journal={Gastroenterology},
  volume={81},
  number={1},
  pages={5},
  year={1981}
}

@article{rupnik2009clostridium,
  title={Clostridium difficile infection: new developments in epidemiology and pathogenesis},
  author={Rupnik, Maja and Wilcox, Mark H and Gerding, Dale N},
  journal={Nature Reviews Microbiology},
  volume={7},
  number={7},
  pages={526--536},
  year={2009},
  publisher={Nature Publishing Group}
}

@article{clabots1992acquisition,
  title={Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection},
  author={Clabots, Connie R and Johnson, Stuart and Olson, Mary M and Peterson, Lance R and Gerding, Dale N},
  journal={Journal of Infectious Diseases},
  volume={166},
  number={3},
  pages={561--567},
  year={1992},
  publisher={Oxford University Press}
}

@article{knetsch2011comparison,
  title={Comparison of real-time PCR techniques to cytotoxigenic culture methods for diagnosing Clostridium difficile infection},
  author={Knetsch, CW and Bakker, D and De Boer, RF and Sanders, I and Hofs, S and Kooistra-Smid, AMD and Corver, J and Eastwood, K and Wilcox, MH and Kuijper, EJ},
  journal={Journal of clinical microbiology},
  volume={49},
  number={1},
  pages={227--231},
  year={2011},
  publisher={Am Soc Microbiol}
}

@article{zhao2008sample
,	author	= {Zhao, Yan D and Rahardja, Dewi and Qu, Yongming}
,	title	= {Sample size calculation for the Wilcoxon--Mann--Whitney test adjusting for ties}
,	journal	= {Statistics in medicine}
,	year	= {2008}
,	volume	= {27}
,	number	= {3}
,	pages	= {462--468}
,	publisher	= {Wiley Online Library}
}

@article{pankla2009genomic,
  title={Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis},
  author={Pankla, Rungnapa and Buddhisa, Surachat and Berry, Matthew and Blankenship, Derek M and Bancroft, Gregory J and Banchereau, Jacques and Lertmemongkolchai, Ganjana and Chaussabel, Damien and others},
  journal={Genome Biol},
  volume={10},
  number={11},
  pages={R127},
  year={2009}
}

@article{zhang2013identification,
  title={Identification of a genetic determinant in clinical Enterococcus faecium strains which contributes to intestinal colonization during antibiotic treatment},
  author={Zhang, Xinglin and Top, Janetta and de Been, Mark and Bierschenk, Damien and Rogers, Malbert and Leendertse, Masja and Bonten, Marc JM and van der Poll, Tom and Willems, Rob JL and van Schaik, Willem},
  journal={Journal of Infectious Diseases},
  year={2013},
  publisher={Oxford University Press}
}

@article{pmid:23447697,
  title={Could a Phosphotransferase System Provide the Means to Control Outbreaks of Enterococcus faecium Infection?},
  author={Somarajan, Sudha R and Murray, Barbara E},
  journal={The Journal of infectious diseases},
  journal-iso={J. Infect. Dis.},
  volume={207},
  number={11},
  year={2013},
  month={Jun},
  pages={1633--6},
  doi={10.1093/infdis/jit080},
  pmid={23447697}
}


% BEGIN:Original PubMed XML
%  <PubmedArticle>
%    <MedlineCitation Owner="NLM" Status="In-Data-Review">
%      <PMID Version="1">23447697</PMID>
%      <DateCreated>
%        <Year>2013</Year>
%        <Month>04</Month>
%        <Day>29</Day>
%      </DateCreated>
%      <Article PubModel="Print-Electronic">
%        <Journal>
%          <ISSN IssnType="Electronic">1537-6613</ISSN>
%          <JournalIssue CitedMedium="Internet">
%            <Volume>207</Volume>
%            <Issue>11</Issue>
%            <PubDate>
%              <Year>2013</Year>
%              <Month>Jun</Month>
%            </PubDate>
%          </JournalIssue>
%          <Title>The Journal of infectious diseases</Title>
%          <ISOAbbreviation>J. Infect. Dis.</ISOAbbreviation>
%        </Journal>
%        <ArticleTitle>Could a Phosphotransferase System Provide the Means to Control Outbreaks of Enterococcus faecium Infection?</ArticleTitle>
%        <Pagination>
%          <MedlinePgn>1633-6</MedlinePgn>
%        </Pagination>
%        <ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jit080</ELocationID>
%        <Affiliation>Division of Infectious Diseases, Department of Internal Medicine.</Affiliation>
%        <AuthorList CompleteYN="Y">
%          <Author ValidYN="Y">
%            <LastName>Somarajan</LastName>
%            <ForeName>Sudha R</ForeName>
%            <Initials>SR</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Murray</LastName>
%            <ForeName>Barbara E</ForeName>
%            <Initials>BE</Initials>
%          </Author>
%        </AuthorList>
%        <Language>eng</Language>
%        <PublicationTypeList>
%          <PublicationType>Journal Article</PublicationType>
%        </PublicationTypeList>
%        <ArticleDate DateType="Electronic">
%          <Year>2013</Year>
%          <Month>02</Month>
%          <Day>27</Day>
%        </ArticleDate>
%      </Article>
%      <MedlineJournalInfo>
%        <Country>United States</Country>
%        <MedlineTA>J Infect Dis</MedlineTA>
%        <NlmUniqueID>0413675</NlmUniqueID>
%        <ISSNLinking>0022-1899</ISSNLinking>
%      </MedlineJournalInfo>
%      <CitationSubset>AIM</CitationSubset>
%      <CitationSubset>IM</CitationSubset>
%    </MedlineCitation>
%    <PubmedData>
%      <History>
%        <PubMedPubDate PubStatus="aheadofprint">
%          <Year>2013</Year>
%          <Month>2</Month>
%          <Day>27</Day>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="aheadofprint">
%          <Year>2013</Year>
%          <Month>3</Month>
%          <Day>28</Day>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="entrez">
%          <Year>2013</Year>
%          <Month>3</Month>
%          <Day>1</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="pubmed">
%          <Year>2013</Year>
%          <Month>3</Month>
%          <Day>1</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="medline">
%          <Year>2013</Year>
%          <Month>3</Month>
%          <Day>1</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%      </History>
%      <PublicationStatus>ppublish</PublicationStatus>
%      <ArticleIdList>
%        <ArticleId IdType="pii">jit080</ArticleId>
%        <ArticleId IdType="doi">10.1093/infdis/jit080</ArticleId>
%        <ArticleId IdType="pubmed">23447697</ArticleId>
%      </ArticleIdList>
%    </PubmedData>
%  </PubmedArticle>
% END:Original PubMed XML


@article{dial2005use,
  title={Use of gastric acid--suppressive agents and the risk of community-acquired Clostridium difficile--associated disease},
  author={Dial, Sandra and Delaney, JAC and Barkun, Alan N and Suissa, Samy},
  journal={JAMA: the journal of the American Medical Association},
  volume={294},
  number={23},
  pages={2989--2995},
  year={2005},
  publisher={Am Med Assoc}
}

@article{pepin2005emergence,
  title={Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile--associated diarrhea: a cohort study during an epidemic in Quebec},
  author={P{\'e}pin, Jacques and Saheb, Nathalie and Coulombe, Marie-Andr{\'e}e and Alary, Marie-Eve and Corriveau, Marie-Pier and Authier, Simon and Leblanc, Michel and Rivard, Genevieve and Bettez, Mathieu and Primeau, Val{\'e}rie and others},
  journal={Clinical Infectious Diseases},
  volume={41},
  number={9},
  pages={1254--1260},
  year={2005},
  publisher={Oxford University Press}
}

@article{mcfarland1990risk,
  title={Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients},
  author={McFarland, Lynne V and Surawicz, Christina M and Stamm, Walter E},
  journal={Journal of infectious diseases},
  volume={162},
  number={3},
  pages={678--684},
  year={1990},
  publisher={Oxford University Press}
}

@article{kelly200976,
  title={A 76-Year-Old Man With Recurrent Clostridium difficile--Associated Diarrhea},
  author={Kelly, Ciar{\'a}n P},
  journal={JAMA: The Journal of the American Medical Association},
  volume={301},
  number={9},
  pages={954--962},
  year={2009},
  publisher={Am Med Assoc}
}

@article{mcfarland1999recurrent,
  title={Recurrent Clostridium difficile disease: epidemiology and clinical characteristics},
  author={McFarland, Lynne V and Surawicz, Christina M and Rubin, Moshe and Fekety, Robert and Elmer, Gary W and Greenberg, Richard N},
  journal={Infection control and hospital epidemiology},
  volume={20},
  number={1},
  pages={43--50},
  year={1999},
  publisher={JSTOR}
}

@article{o2007emerging,
  title={The emerging infectious challenge of Clostridium difficile--associated disease in Massachusetts hospitals: clinical and economic consequences},
  author={O’Brien, Judith A and Lahue, Betsy J and J Jaime Caro, MDCM and Davidson, David M},
  journal={Infection control and hospital epidemiology},
  volume={28},
  number={11},
  pages={1219--1227},
  year={2007},
  publisher={JSTOR}
}

@article{johnson2007interruption,
  title={Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin},
  author={Johnson, Stuart and Schriever, Christopher and Galang, Minerva and Kelly, Ciar{\'a}n P and Gerding, Dale N},
  journal={Clinical infectious diseases},
  volume={44},
  number={6},
  pages={846--848},
  year={2007},
  publisher={Oxford University Press}
}

@article{wilcox2004descriptive,
  title={Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea},
  author={Wilcox, Mark H},
  journal={Journal of Antimicrobial Chemotherapy},
  volume={53},
  number={5},
  pages={882--884},
  year={2004},
  publisher={Br Soc Antimicrob Chemo}
}

@article{rolfe1980inhibitory,
  title={Inhibitory interactions between normal fecal flora and Clostridium difficile},
  author={Rolfe, Rial D and Finegold, Sydney M},
  journal={The American Journal of Clinical Nutrition},
  volume={33},
  number={11},
  pages={2539--2539},
  year={1980},
  publisher={Am Soc Nutrition}
}

@article{wilcox2012progress,
  title={Progress with a difficult infection},
  author={Wilcox, Mark H},
  journal={The Lancet Infectious Diseases},
  volume={12},
  number={4},
  pages={256--257},
  year={2012},
  publisher={Elsevier}
}

@article{bouza2012consequences,
  title={Consequences of Clostridium difficile infection: understanding the healthcare burden},
  author={Bouza, E},
  journal={Clinical Microbiology and Infection},
  volume={18},
  number={s6},
  pages={5--12},
  year={2012},
  publisher={Wiley Online Library}
}

@article{youssef1998use,
  title={Use of molecular typing to investigate bacterial translocation from the intestinal tract in malnourished children with Gram-negative bacteremia},
  author={Youssef, Mohammad and Shurman, Abdallah and Chachaty, Elisabeth and Bsoul, Abder-Rahman and Andremont, Antoine},
  journal={Clinical microbiology and infection},
  volume={4},
  number={2},
  pages={70--74},
  year={1998},
  publisher={Wiley Online Library}
}

@article{ruppe4causes,
  title={Causes, consequences and perspectives in the variations of intestinal density of colonization of multidrug resistant enterobacteria},
  author={Rupp{\'e}, Etienne and Andremont, Antoine},
  journal={Frontiers in Microbiology},
  volume={4},
  pages={129},
  publisher={Frontiers}
}

@article{stecher2013blooming,
  title={'Blooming'in the gut: how dysbiosis might contribute to pathogen evolution},
  author={Stecher, B{\"a}rbel and Maier, Lisa and Hardt, Wolf-Dietrich},
  journal={Nature Reviews Microbiology},
  volume={11},
  number={4},
  pages={277--284},
  year={2013},
  publisher={Nature Publishing Group}
}

@article{aas2003recurrent,
  title={Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube},
  author={Aas, Johannes and Gessert, Charles E and Bakken, Johan S},
  journal={Clinical infectious diseases},
  volume={36},
  number={5},
  pages={580--585},
  year={2003},
  publisher={Oxford University Press}
}

@article{yoon2010treatment,
  title={Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients},
  author={Yoon, Sonia S and Brandt, Lawrence J},
  journal={Journal of clinical gastroenterology},
  volume={44},
  number={8},
  pages={562--566},
  year={2010},
  publisher={LWW}
}

@article{rohlke2010fecal,
  title={Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology},
  author={Rohlke, Faith and Surawicz, Christina M and Stollman, Neil},
  journal={Journal of clinical gastroenterology},
  volume={44},
  number={8},
  pages={567--570},
  year={2010},
  publisher={LWW}
}

@article{bowden1981pseudomembraneous,
  title={Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis.},
  author={Bowden Jr, TA and Mansberger Jr, AR and Lykins, LE},
  journal={The American surgeon},
  volume={47},
  number={4},
  pages={178},
  year={1981}
}

@article{mazmanian2005immunomodulatory,
  title={An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system},
  author={Mazmanian, Sarkis K and Liu, Cui Hua and Tzianabos, Arthur O and Kasper, Dennis L},
  journal={Cell},
  volume={122},
  number={1},
  pages={107--118},
  year={2005},
  publisher={Elsevier}
}

@article{wilson2007prevention,
  title={Prevention of Infective Endocarditis Guidelines From the American Heart Association: A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group},
  author={Wilson, Walter and Taubert, Kathryn A and Gewitz, Michael and Lockhart, Peter B and Baddour, Larry M and Levison, Matthew and Bolger, Ann and Cabell, Christopher H and Takahashi, Masato and Baltimore, Robert S and others},
  journal={Circulation},
  volume={116},
  number={15},
  pages={1736--1754},
  year={2007},
  publisher={Am Heart Assoc}
}

@article{pruitt2012ncbi,
  title={NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy},
  author={Pruitt, Kim D and Tatusova, Tatiana and Brown, Garth R and Maglott, Donna R},
  journal={Nucleic acids research},
  volume={40},
  number={D1},
  pages={D130--D135},
  year={2012},
  publisher={Oxford Univ Press}
}

@article{cacoub2011dress,
  title={The DRESS syndrome: a literature review},
  author={Cacoub, Patrice and Musette, Philippe and Descamps, Vincent and Meyer, Olivier and Speirs, Chris and Finzi, Laetitia and Roujeau, Jean Claude},
  journal={The American journal of medicine},
  volume={124},
  number={7},
  pages={588--597},
  year={2011},
  publisher={Elsevier}
}

@article{mcfarland2005alternative,
  title={Alternative treatments for Clostridium difficile disease: what really works?},
  author={McFarland, Lynne V},
  journal={Journal of medical microbiology},
  volume={54},
  number={2},
  pages={101--111},
  year={2005},
  publisher={Soc General Microbiol}
}

@article{schwan1984relapsing,
  title={Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces},
  author={Schwan, Anna and Sjolin, Stig and Trottestam, Ulla and Aronsson, Bo},
  journal={Scandinavian journal of infectious diseases},
  volume={16},
  number={2},
  pages={211--215},
  year={1984},
  publisher={Informa UK Ltd UK}
}

@article{gustafsson1999effect,
  title={The effect of faecal enema on five microflora-associated characteristics in patients with antibiotic-associated diarrhoea},
  author={Gustafsson, A and Berstad, A and Lund-T{\o}nnesen, S and Midtvedt, T and Norin, E},
  journal={Scandinavian journal of gastroenterology},
  volume={34},
  number={6},
  pages={580--586},
  year={1999},
  publisher={Informa UK Ltd UK}
}

@article{mcdonald2006clostridium,
  title={Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996--2003},
  author={McDonald, L Clifford and Owings, Maria and Jernigan, Daniel B},
  journal={Emerging infectious diseases},
  volume={12},
  number={3},
  pages={409},
  year={2006},
  publisher={Centers for Disease Control}
}

@article{pmid:18507904,
  title={Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005.},
  author={Zilberberg, Marya D and Shorr, Andrew F and Kollef, Marin H},
  journal={Emerging infectious diseases},
  journal-iso={Emerging Infect. Dis.},
  volume={14},
  number={6},
  year={2008},
  month={Jun},
  pages={929--31},
  doi={10.3201/eid1406.071447},
  pmid={18507904},
  abstract={Virulence of and deaths from Clostridium difficile-associated disease (CDAD) are on the rise in the United States. The incidence of adult CDAD hospitalizations doubled from 5.5 cases per 10,000 population in 2000 to 11.2 in 2005, and the CDAD-related age-adjusted case-fatality rate rose from 1.2% in 2000 to 2.2% in 2004.}
}


% BEGIN:Original PubMed XML
%  <PubmedArticle>
%    <MedlineCitation Owner="NLM" Status="MEDLINE">
%      <PMID Version="1">18507904</PMID>
%      <DateCreated>
%        <Year>2008</Year>
%        <Month>05</Month>
%        <Day>29</Day>
%      </DateCreated>
%      <DateCompleted>
%        <Year>2008</Year>
%        <Month>07</Month>
%        <Day>29</Day>
%      </DateCompleted>
%      <DateRevised>
%        <Year>2009</Year>
%        <Month>11</Month>
%        <Day>18</Day>
%      </DateRevised>
%      <Article PubModel="Print">
%        <Journal>
%          <ISSN IssnType="Electronic">1080-6059</ISSN>
%          <JournalIssue CitedMedium="Internet">
%            <Volume>14</Volume>
%            <Issue>6</Issue>
%            <PubDate>
%              <Year>2008</Year>
%              <Month>Jun</Month>
%            </PubDate>
%          </JournalIssue>
%          <Title>Emerging infectious diseases</Title>
%          <ISOAbbreviation>Emerging Infect. Dis.</ISOAbbreviation>
%        </Journal>
%        <ArticleTitle>Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005.</ArticleTitle>
%        <Pagination>
%          <MedlinePgn>929-31</MedlinePgn>
%        </Pagination>
%        <ELocationID EIdType="doi" ValidYN="Y">10.3201/eid1406.071447</ELocationID>
%        <Abstract>
%          <AbstractText>Virulence of and deaths from Clostridium difficile-associated disease (CDAD) are on the rise in the United States. The incidence of adult CDAD hospitalizations doubled from 5.5 cases per 10,000 population in 2000 to 11.2 in 2005, and the CDAD-related age-adjusted case-fatality rate rose from 1.2% in 2000 to 2.2% in 2004.</AbstractText>
%        </Abstract>
%        <Affiliation>University of Massachusetts, Amherst, Massachusetts 01032, USA. marya@evimedgroup.org</Affiliation>
%        <AuthorList CompleteYN="Y">
%          <Author ValidYN="Y">
%            <LastName>Zilberberg</LastName>
%            <ForeName>Marya D</ForeName>
%            <Initials>MD</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Shorr</LastName>
%            <ForeName>Andrew F</ForeName>
%            <Initials>AF</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Kollef</LastName>
%            <ForeName>Marin H</ForeName>
%            <Initials>MH</Initials>
%          </Author>
%        </AuthorList>
%        <Language>eng</Language>
%        <PublicationTypeList>
%          <PublicationType>Journal Article</PublicationType>
%        </PublicationTypeList>
%      </Article>
%      <MedlineJournalInfo>
%        <Country>United States</Country>
%        <MedlineTA>Emerg Infect Dis</MedlineTA>
%        <NlmUniqueID>9508155</NlmUniqueID>
%        <ISSNLinking>1080-6040</ISSNLinking>
%      </MedlineJournalInfo>
%      <CitationSubset>IM</CitationSubset>
%      <CommentsCorrectionsList>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Clin Infect Dis. 2002 Feb 1;34(3):346-53</RefSource>
%          <PMID Version="1">11774082</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>CMAJ. 2004 Aug 31;171(5):466-72</RefSource>
%          <PMID Version="1">15337727</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Anaerobe. 2006 Feb;12(1):1-4</RefSource>
%          <PMID Version="1">16701605</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Emerg Infect Dis. 2006 Mar;12(3):409-15</RefSource>
%          <PMID Version="1">16704777</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Clin Microbiol Infect. 2006 Oct;12 Suppl 6:2-18</RefSource>
%          <PMID Version="1">16965399</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Infection. 2007 Oct;35(5):300-7</RefSource>
%          <PMID Version="1">17885732</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Infect Control Hosp Epidemiol. 2007 Nov;28(11):1219-27</RefSource>
%          <PMID Version="1">17926270</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Emerg Infect Dis. 2007 Sep;13(9):1417-9</RefSource>
%          <PMID Version="1">18252127</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="CommentIn">
%          <RefSource>Emerg Infect Dis. 2009 Feb;15(2):343-4</RefSource>
%          <PMID Version="1">19193291</PMID>
%        </CommentsCorrections>
%      </CommentsCorrectionsList>
%      <MeshHeadingList>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Adult</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Age Factors</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Aged</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Aged, 80 and over</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="Y">Clostridium difficile</DescriptorName>
%          <QualifierName MajorTopicYN="N">isolation &amp; purification</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Enterocolitis, Pseudomembranous</DescriptorName>
%          <QualifierName MajorTopicYN="Y">epidemiology</QualifierName>
%          <QualifierName MajorTopicYN="N">microbiology</QualifierName>
%          <QualifierName MajorTopicYN="N">mortality</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Hospital Mortality</DescriptorName>
%          <QualifierName MajorTopicYN="Y">trends</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Hospitalization</DescriptorName>
%          <QualifierName MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Humans</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Incidence</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Least-Squares Analysis</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Length of Stay</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
%          <QualifierName MajorTopicYN="N">epidemiology</QualifierName>
%        </MeshHeading>
%      </MeshHeadingList>
%      <OtherID Source="NLM">PMC2600276</OtherID>
%    </MedlineCitation>
%    <PubmedData>
%      <History>
%        <PubMedPubDate PubStatus="pubmed">
%          <Year>2008</Year>
%          <Month>5</Month>
%          <Day>30</Day>
%          <Hour>9</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="medline">
%          <Year>2008</Year>
%          <Month>7</Month>
%          <Day>30</Day>
%          <Hour>9</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="entrez">
%          <Year>2008</Year>
%          <Month>5</Month>
%          <Day>30</Day>
%          <Hour>9</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%      </History>
%      <PublicationStatus>ppublish</PublicationStatus>
%      <ArticleIdList>
%        <ArticleId IdType="pubmed">18507904</ArticleId>
%        <ArticleId IdType="pmc">PMC2600276</ArticleId>
%        <ArticleId IdType="doi">10.3201/eid1406.071447</ArticleId>
%      </ArticleIdList>
%    </PubmedData>
%  </PubmedArticle>
% END:Original PubMed XML


@article{gerding1986clostridium,
  title={Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study.},
  author={Gerding, Dale N and Olson, Mary M and Peterson, Lance R and Teasley, David G and Gebhard, Roger L and Schwartz, Michael L and Lee Jr, James T},
  journal={Archives of Internal Medicine},
  volume={146},
  number={1},
  pages={95},
  year={1986}
}

@article{mcfarland1989nosocomial,
  title={Nosocomial acquisition of Clostridium difficile infection.},
  author={McFarland, Lynne V and Mulligan, Maury E and Kwok, RY and Stamm, Walter E and others},
  journal={The New England journal of medicine},
  volume={320},
  number={4},
  pages={204},
  year={1989}
}

@article{johnson1990nosocomial,
  title={Nosocomial Clostridium difficile colonisation and disease},
  author={Johnson, S and Clabots, CR and Linn, FV and Olson, MM and Peterson, LR and Gerding, DN},
  journal={The Lancet},
  volume={336},
  number={8707},
  pages={97--100},
  year={1990},
  publisher={Elsevier}
}

@article{bilgrami1999incidence,
  title={Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation},
  author={Bilgrami, S and Feingold, JM and Dorsky, D and Edwards, RL and Bona, RD and Khan, AM and Rodriguez-Pinero, F and Clive, J and Tutschka, PJ},
  journal={Bone marrow transplantation},
  volume={23},
  number={10},
  pages={1039--1042},
  year={1999},
  publisher={Nature Publishing Group}
}

@article{sonis2004pathobiology,
  title={The pathobiology of mucositis},
  author={Sonis, Stephen T},
  journal={Nature Reviews Cancer},
  volume={4},
  number={4},
  pages={277--284},
  year={2004},
  publisher={Nature Publishing Group}
}

@article{kelly1994clostridium,
  title={Clostridium difficile colitis},
  author={Kelly, Ciaran P and Pothoulakis, Charalabos and LaMont, J Thomas},
  journal={New England Journal of Medicine},
  volume={330},
  number={4},
  pages={257--262},
  year={1994},
  publisher={Mass Medical Soc}
}

@article{olszak2012microbial,
  title={Microbial exposure during early life has persistent effects on natural killer T cell function},
  author={Olszak, Torsten and An, Dingding and Zeissig, Sebastian and Vera, Miguel Pinilla and Richter, Julia and Franke, Andre and Glickman, Jonathan N and Siebert, Reiner and Baron, Rebecca M and Kasper, Dennis L and others},
  journal={Science},
  volume={336},
  number={6080},
  pages={489--493},
  year={2012},
  publisher={American Association for the Advancement of Science}
}

@article{eberl2004thymic,
  title={Thymic Origin of Intestinal $\alpha${\ss} T Cells Revealed by Fate Mapping of ROR$\gamma$t+ Cells},
  author={Eberl, G{\'e}rard and Littman, Dan R},
  journal={Science},
  volume={305},
  number={5681},
  pages={248--251},
  year={2004},
  publisher={American Association for the Advancement of Science}
}

@article{sawa2011ror,
  title={ROR [gamma] t+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota},
  author={Sawa, Shinichiro and Lochner, Matthias and Satoh-Takayama, Naoko and Dulauroy, Sophie and B{\'e}rard, Marion and Kleinschek, Melanie and Cua, Daniel and Di Santo, James P and Eberl, G{\'e}rard},
  journal={Nature immunology},
  volume={12},
  number={4},
  pages={320--326},
  year={2011},
  publisher={Nature Publishing Group}
}

@article{chua2012polyclonal,
  title={Polyclonal Mucosa-Associated Invariant T Cells Have Unique Innate Functions in Bacterial Infection},
  author={Chua, W.J. and Truscott, S.M. and Eickhoff, C.S. and Blazevic, A. and Hoft, D.F. and Hansen, T.H.},
  journal={Infection and Immunity},
  volume={80},
  number={9},
  pages={3256--3267},
  year={2012},
  publisher={Am Soc Microbiol}
}

@article{gold2010human,
  title={Human mucosal associated invariant T cells detect bacterially infected cells},
  author={Gold, M.C. and Cerri, S. and Smyk-Pearson, S. and Cansler, M.E. and Vogt, T.M. and Delepine, J. and Winata, E. and Swarbrick, G.M. and Chua, W.J. and Yik, YL and others},
  journal={PLoS biology},
  volume={8},
  number={6},
  pages={e1000407},
  year={2010},
  publisher={Public Library of Science}
}

@article{kjer2012mr1,
  title={MR1 presents microbial vitamin B metabolites to MAIT cells},
  author={Kjer-Nielsen, L. and Patel, O. and Corbett, A.J. and Le Nours, J. and Meehan, B. and Liu, L. and Bhati, M. and Chen, Z. and Kostenko, L. and Reantragoon, R. and others},
  journal={Nature},
  year={2012},
  publisher={Nature Publishing Group}
}

@article{le2010antimicrobial,
  title={Antimicrobial activity of mucosal-associated invariant T cells},
  author={Le Bourhis, L. and Martin, E. and P{\'e}guillet, I. and Guihot, A. and Froux, N. and Cor{\'e}, M. and L{\'e}vy, E. and Dusseaux, M. and Meyssonnier, V. and Premel, V. and others},
  journal={Nature immunology},
  volume={11},
  number={8},
  pages={701--708},
  year={2010},
  publisher={Nature Publishing Group}
}

@article{hao2011probiotics,
  title={Probiotics for preventing acute upper respiratory tract infections},
  author={Hao, Qiukui and Lu, Zhenchan and Dong, Bi Rong and Huang, Chang Quan and Wu, Taixiang},
  journal={Cochrane Database Syst Rev},
  volume={9},
  number={9},
  year={2011},
  publisher={Wiley Online Library}
}

@article{bartlett2002antibiotic,
  title={Antibiotic-associated diarrhea},
  author={Bartlett, John G},
  journal={New England Journal of Medicine},
  volume={346},
  number={5},
  pages={334--339},
  year={2002},
  publisher={Mass Medical Soc}
}

@article{handley2012pathogenic,
  title={Pathogenic Simian Immunodeficiency Virus Infection Is Associated with Expansion of the Enteric Virome},
  author={Handley, Scott A and Thackray, Larissa B and Zhao, Guoyan and Presti, Rachel and Miller, Andrew D and Droit, Lindsay and Abbink, Peter and Maxfield, Lori F and Kambal, Amal and Duan, Erning and others},
  journal={Cell},
  volume={151},
  number={2},
  pages={253--266},
  year={2012},
  publisher={Elsevier}
}

@article{moon2012viral,
  title={Viral interactions with the host and microbiota in the intestine},
  author={Moon, Clara and Stappenbeck, Thaddeus S},
  journal={Current Opinion in Immunology},
  year={2012},
  publisher={Elsevier}
}

@article{kyne2002health,
  title={Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile},
  author={Kyne, Lorraine and Hamel, Mary Beth and Polavaram, Rajashekhar and Kelly, Ciar{\'a}n P},
  journal={Clinical Infectious Diseases},
  volume={34},
  number={3},
  pages={346--353},
  year={2002},
  publisher={Oxford University Press}
}

@article{kyne2000asymptomatic,
  title={Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A},
  author={Kyne, Lorraine and Warny, Michel and Qamar, Amir and Kelly, Ciar{\'a}n P},
  journal={New England Journal of Medicine},
  volume={342},
  number={6},
  pages={390--397},
  year={2000},
  publisher={Mass Medical Soc}
}

@article{wilcox2007viral,
  title={Viral gastroenteritis increases the reports of Clostridium difficile infection},
  author={Wilcox, M and Fawley, W},
  journal={Journal of Hospital Infection},
  volume={66},
  number={4},
  pages={395--396},
  year={2007},
  publisher={Elsevier}
}

@article{taur2007adherence,
  title={Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection},
  author={Taur, Ying and Smith, Miriam A},
  journal={Clinical infectious diseases},
  volume={44},
  number={6},
  pages={769--774},
  year={2007},
  publisher={Oxford University Press}
}

@article{raz2000chronic,
  title={Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection},
  author={RAZ, RAUL and SCHILLER, DAVID and NICOLLE, LINDSAY E},
  journal={The Journal of urology},
  volume={164},
  number={4},
  pages={1254--1258},
  year={2000},
  publisher={Elsevier}
}

@article{raz2000recurrent,
  title={Recurrent urinary tract infections in postmenopausal women},
  author={Raz, Raul and Gennesin, Yoshua and Wasser, Joseph and Stoler, Zmira and Rosenfeld, Sophia and Rottensterich, Elimelech and Stamm, Walter E},
  journal={Clinical infectious diseases},
  volume={30},
  number={1},
  pages={152--156},
  year={2000},
  publisher={Oxford University Press}
}

@article{jepson2008cranberries,
  title={Cranberries for preventing urinary tract infections},
  author={Jepson, Ruth G and Craig, Jonathan C},
  journal={Cochrane Database Syst Rev},
  volume={1},
  year={2008},
  publisher={Wiley Online Library}
}

@article{vogel2004optimal,
  title={Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial},
  author={Vogel, Thomas and Verreault, Ren{\'e} and Gourdeau, Marie and Morin, Mich{\`e}le and Grenier-Gosselin, Lise and Rochette, Louis},
  journal={Canadian Medical Association Journal},
  volume={170},
  number={4},
  pages={469--473},
  year={2004},
  publisher={Can Med Assoc}
}

@article{walker2000antibiotics,
  title={Why are antibiotics prescribed for asymptomatic bacteriuria in institutionalized elderly people?: A qualitative study of physicians' and nurses' perceptions},
  author={Walker, Susan and McGeer, Allison and Simor, Andrew E and Armstrong-Evans, Maxine and Loeb, Mark},
  journal={Canadian Medical Association Journal},
  volume={163},
  number={3},
  pages={273--277},
  year={2000},
  publisher={Can Med Assoc}
}

@article{bentley2000practice,
  title={Practice guideline for evaluation of fever and infection in long-term care facilities},
  author={Bentley, David W and Bradley, Suzanne and High, Kevin and Schoenbaum, Stephen and Taler, George and Yoshikawa, Thomas T},
  journal={Clinical infectious diseases},
  volume={31},
  number={3},
  pages={640--653},
  year={2000},
  publisher={Oxford University Press}
}

@article{wullt2003host,
  title={The host response to urinary tract infection.},
  author={Wullt, Bjorn and Bergsten, G and Fischer, H and Godaly, G and Karpman, D and Leijonhufvud, I and Lundstedt, AC and Samuelsson, P and Samuelsson, M and Svensson, ML and others},
  journal={Infectious disease clinics of North America},
  volume={17},
  number={2},
  pages={279},
  year={2003}
}

@article{nicolle1994urinary,
  title={Urinary tract infection in the elderly},
  author={Nicolle, LE},
  journal={Journal of Antimicrobial Chemotherapy},
  volume={33},
  number={suppl A},
  pages={99--109},
  year={1994},
  publisher={Br Soc Antimicrob Chemo}
}

@article{hooton2010diagnosis,
  title={Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America},
  author={Hooton, Thomas M and Bradley, Suzanne F and Cardenas, Diana D and Colgan, Richard and Geerlings, Suzanne E and Rice, James C and Saint, Sanjay and Schaeffer, Anthony J and Tambayh, Paul A and Tenke, Peter and others},
  journal={Clinical Infectious Diseases},
  volume={50},
  number={5},
  pages={625--663},
  year={2010},
  publisher={Oxford University Press}
}

@article{nicolle2005infectious,
  title={Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults},
  author={Nicolle, Lindsay E and Bradley, Suzanne and Colgan, Richard and Rice, James C and Schaeffer, Anthony and Hooton, Thomas M},
  journal={Clinical Infectious Diseases},
  pages={643--654},
  year={2005},
  publisher={JSTOR}
}

@article{nicolle2002urinary,
  title={Urinary tract infection in geriatric and institutionalized patients},
  author={Nicolle, Lindsay E},
  journal={Current opinion in Urology},
  volume={12},
  number={1},
  pages={51--55},
  year={2002},
  publisher={LWW}
}

@article{gupta2011international,
  title={International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases},
  author={Gupta, Kalpana and Hooton, Thomas M and Naber, Kurt G and Wullt, Bj{\"o}rn and Colgan, Richard and Miller, Loren G and Moran, Gregory J and Nicolle, Lindsay E and Raz, Raul and Schaeffer, Anthony J and others},
  journal={Clinical Infectious Diseases},
  volume={52},
  number={5},
  pages={e103--e120},
  year={2011},
  publisher={Oxford University Press}
}

@article{mcmurdo2000urinary,
  title={Urinary tract infection in old age: over-diagnosed and over-treated.},
  author={McMurdo, ME and Gillespie, ND},
  journal={Age and ageing},
  volume={29},
  number={4},
  pages={297--298},
  year={2000},
  publisher={Br Geriatrics Soc}
}

@article{sommer2009functional,
  title={Functional characterization of the antibiotic resistance reservoir in the human microflora},
  author={Sommer, Morten OA and Dantas, Gautam and Church, George M},
  journal={science},
  volume={325},
  number={5944},
  pages={1128--1131},
  year={2009},
  publisher={American Association for the Advancement of Science}
}

@article{bisno1996streptococcal,
  title={Streptococcal infections of skin and soft tissues},
  author={Bisno, Alan L and Stevens, Dennis L},
  journal={New England Journal of Medicine},
  volume={334},
  number={4},
  pages={240--246},
  year={1996},
  publisher={Mass Medical Soc}
}

@article{blumberg2003american,
  title={American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.},
  author={Blumberg, HM and Burman, WJ and Chaisson, RE and Daley, CL and Etkind, SC and Friedman, LN and Fujiwara, P. and Grzemska, M. and Hopewell, PC and Iseman, MD and others},
  journal={American journal of respiratory and critical care medicine},
  volume={167},
  number={4},
  pages={603},
  year={2003}
}

@article{wormser2006clinical,
  title={The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America},
  author={Wormser, Gary P and Dattwyler, Raymond J and Shapiro, Eugene D and Halperin, John J and Steere, Allen C and Klempner, Mark S and Krause, Peter J and Bakken, Johan S and Strle, Franc and Stanek, Gerold and others},
  journal={Clinical Infectious Diseases},
  volume={43},
  number={9},
  pages={1089--1134},
  year={2006},
  publisher={Oxford University Press}
}

@article{auburtin2006detrimental,
  title={Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: The PNEUMOREA prospective multicenter study*},
  author={Auburtin, Marc and Wolff, Michel and Charpentier, Julien and Varon, Emmanuelle and Le Tulzo, Yves and Girault, Christophe and Mohammedi, Isma{\"e}l and Renard, Beno{\^\i}t and Mourvillier, Bruno and Bruneel, Fabrice and others},
  journal={Critical care medicine},
  volume={34},
  number={11},
  pages={2758--2765},
  year={2006},
  publisher={LWW}
}

@article{tunkel2004practice,
  title={Practice guidelines for the management of bacterial meningitis},
  author={Tunkel, Allan R and Hartman, Barry J and Kaplan, Sheldon L and Kaufman, Bruce A and Roos, Karen L and Scheld, W Michael and Whitley, Richard J},
  journal={Clinical infectious diseases},
  volume={39},
  number={9},
  pages={1267--1284},
  year={2004},
  publisher={Oxford University Press}
}

@article{tunkel2008management,
  title={The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America},
  author={Tunkel, Allan R and Glaser, Carol A and Bloch, Karen C and Sejvar, James J and Marra, Christina M and Roos, Karen L and Hartman, Barry J and Kaplan, Sheldon L and Scheld, W Michael and Whitley, Richard J},
  journal={Clinical infectious diseases},
  volume={47},
  number={3},
  pages={303--327},
  year={2008},
  publisher={Oxford University Press}
}

@article{dajcs2004effectiveness,
  title={Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis},
  author={Dajcs, Joseph J and Thibodeaux, Brett A and Marquart, Mary E and Girgis, Dalia O and Traidej, Mullika and O'Callaghan, Richard J},
  journal={Antimicrobial agents and chemotherapy},
  volume={48},
  number={6},
  pages={1948--1952},
  year={2004},
  publisher={Am Soc Microbiol}
}

@article{zoetendal1998temperature,
  title={Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria},
  author={Zoetendal, Erwin G and Akkermans, Antoon DL and De Vos, Willem M},
  journal={Applied and environmental microbiology},
  volume={64},
  number={10},
  pages={3854--3859},
  year={1998},
  publisher={Am Soc Microbiol}
}

@article{ng2007current,
  title={Current use of antibiotic prophylaxis in breast surgery: a nationwide survey},
  author={Ng, Darren and Trivedi, Prateesh M and Sharma, Anup K and Banerjee, Dibyesh},
  journal={The Breast},
  volume={16},
  number={1},
  pages={68--72},
  year={2007},
  publisher={Elsevier}
}

@article{salkind2001patient,
  title={Is this patient allergic to penicillin?},
  author={Salkind, Alan R and Cuddy, Paul G and Foxworth, John W},
  journal={JAMA: the journal of the American Medical Association},
  volume={285},
  number={19},
  pages={2498--2505},
  year={2001},
  publisher={Am Med Assoc}
}

@article{charneski2011impact,
  title={Impact of an antimicrobial allergy label in the medical record on clinical outcomes in hospitalized patients},
  author={Charneski, Lisa and Deshpande, Gaurav and Smith, Sheila Weiss},
  journal={Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  volume={31},
  number={8},
  pages={742--747},
  year={2011},
  publisher={Wiley Online Library}
}

@article{lutomski2008antibiotic,
  title={Antibiotic allergies in the medical record: effect on drug selection and assessment of validity},
  author={Lutomski, Dave M and LaFollette, Jennifer A and Biaglow, Michael A and Haglund, Lisa A},
  journal={Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  volume={28},
  number={11},
  pages={1348--1353},
  year={2008},
  publisher={Wiley Online Library}
}

@article{zuckerman2010sct,
  title={SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state},
  author={Zuckerman, T and Benyamini, N and Sprecher, H and Fineman, R and Finkelstein, R and Rowe, JM and Oren, I},
  journal={Bone marrow transplantation},
  volume={46},
  number={9},
  pages={1226--1230},
  year={2010},
  publisher={Nature Publishing Group}
}

@article{saidel2012randomized,
  title={A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage},
  author={Saidel-Odes, Lisa and Polachek, Hana and Peled, Nehama and Riesenberg, Klaris and Schlaeffer, Francisc and Trabelsi, Yafa and Eskira, Seada and Yousef, Baha and Smolykov, Rozalia and Codish, Shlomi and others},
  journal={Infection Control and Hospital Epidemiology},
  volume={33},
  number={1},
  pages={14--19},
  year={2012},
  publisher={JSTOR}
}

@article{sanborn2008cutaneous,
  title={Cutaneous reactions to chemotherapy: commonly seen, less described, little understood},
  author={Sanborn, Rachel E and Sauer, David A},
  journal={Dermatologic clinics},
  volume={26},
  number={1},
  pages={103--119},
  year={2008},
  publisher={Elsevier}
}

@article{nishio2012immunoregulation,
  title={Immunoregulation by the gut microbiota},
  author={Nishio, Junko and Honda, Kenya},
  journal={Cellular and Molecular Life Sciences},
  volume={69},
  number={21},
  pages={3635--3650},
  year={2012},
  publisher={Springer}
}

@article{white2009statistical,
  title={Statistical methods for detecting differentially abundant features in clinical metagenomic samples},
  author={White, James Robert and Nagarajan, Niranjan and Pop, Mihai},
  journal={PLoS computational biology},
  volume={5},
  number={4},
  pages={e1000352},
  year={2009},
  publisher={Public Library of Science}
}

@article{lawley2009antibiotic,
  title={Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts},
  author={Lawley, Trevor D and Clare, Simon and Walker, Alan W and Goulding, David and Stabler, Richard A and Croucher, Nicholas and Mastroeni, Piero and Scott, Paul and Raisen, Claire and Mottram, Lynda and others},
  journal={Infection and immunity},
  volume={77},
  number={9},
  pages={3661--3669},
  year={2009},
  publisher={Am Soc Microbiol}
}

@article{werner2011impact,
  title={Impact of training sets on classification of high-throughput bacterial 16s rRNA gene surveys},
  author={Werner, J.J. and Koren, O. and Hugenholtz, P. and DeSantis, T.Z. and Walters, W.A. and Caporaso, J.G. and Angenent, L.T. and Knight, R. and Ley, R.E.},
  journal={The ISME journal},
  volume={6},
  number={1},
  pages={94--103},
  year={2011},
  publisher={Nature Publishing Group}
}

@article{wisplinghoff2004nosocomial,
  title={Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study},
  author={Wisplinghoff, Hilmar and Bischoff, Tammy and Tallent, Sandra M and Seifert, Harald and Wenzel, Richard P and Edmond, Michael B},
  journal={Clinical Infectious Diseases},
  volume={39},
  number={3},
  pages={309--317},
  year={2004},
  publisher={Oxford University Press}
}

@article{freter1962vivo,
  title={In vivo and in vitro Antagonism of Intestinal Bacteria Against Shigella flexneri: II. The Inhibitory Mechanism},
  author={Freter, Rolf},
  journal={The Journal of infectious diseases},
  volume={110},
  number={1},
  pages={38--46},
  year={1962},
  publisher={JSTOR}
}

@article{maxmen2011evolution,
  title={Evolution: A can of worms},
  author={Maxmen, Amy},
  journal={Nature},
  volume={470},
  pages={161--162},
  year={2011}
}

@article{baumgart2007inflammatory,
  title={Inflammatory bowel disease: cause and immunobiology},
  author={Baumgart, Daniel C and Carding, Simon R},
  journal={The Lancet},
  volume={369},
  number={9573},
  pages={1627--1640},
  year={2007},
  publisher={Elsevier}
}

@article{endt2010microbiota,
  title={The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea},
  author={Endt, Kathrin and Stecher, B{\"a}rbel and Chaffron, Samuel and Slack, Emma and Tchitchek, Nicolas and Benecke, Arndt and Van Maele, Laurye and Sirard, Jean-Claude and Mueller, Andreas J and Heikenwalder, Mathias and others},
  journal={PLoS pathogens},
  volume={6},
  number={9},
  pages={e1001097},
  year={2010},
  publisher={Public Library of Science}
}

@article{antonopoulos2009reproducible,
  title={Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation},
  author={Antonopoulos, Dionysios A and Huse, Susan M and Morrison, Hilary G and Schmidt, Thomas M and Sogin, Mitchell L and Young, Vincent B},
  journal={Infection and immunity},
  volume={77},
  number={6},
  pages={2367--2375},
  year={2009},
  publisher={Am Soc Microbiol}
}

@article{lupp2007host,
  title={Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae},
  author={Lupp, Claudia and Robertson, Marilyn L and Wickham, Mark E and Sekirov, Inna and Champion, Olivia L and Gaynor, Erin C and Finlay, B Brett},
  journal={Cell host \& microbe},
  volume={2},
  number={2},
  pages={119--129},
  year={2007},
  publisher={Elsevier}
}

@article{okada2010hygiene,
  title={The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update},
  author={Okada, H and Kuhn, C and Feillet, H and Bach, J-F},
  journal={Clinical \& Experimental Immunology},
  volume={160},
  number={1},
  pages={1--9},
  year={2010},
  publisher={Wiley Online Library}
}

@article{palmer2007development,
  title={Development of the human infant intestinal microbiota},
  author={Palmer, Chana and Bik, Elisabeth M and DiGiulio, Daniel B and Relman, David A and Brown, Patrick O},
  journal={PLoS biology},
  volume={5},
  number={7},
  pages={e177},
  year={2007},
  publisher={Public Library of Science}
}

@article{maynard2012reciprocal,
  title={Reciprocal interactions of the intestinal microbiota and immune system},
  author={Maynard, Craig L and Elson, Charles O and Hatton, Robin D and Weaver, Casey T},
  journal={Nature},
  volume={489},
  number={7415},
  pages={231--241},
  year={2012},
  publisher={Nature Publishing Group}
}

@article{neofytos2009epidemiology,
  title={Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry},
  author={Neofytos, D and Horn, D and Anaissie, E and Steinbach, W and Olyaei, A and Fishman, J and Pfaller, M and Chang, C and Webster, K and Marr, K},
  journal={Clinical Infectious Diseases},
  volume={48},
  number={3},
  pages={265--273},
  year={2009},
  publisher={Oxford University Press}
}

@article{neofytos2007treatment,
  title={Treatment of adenovirus disease in stem cell transplant recipients with cidofovir},
  author={Neofytos, Dionissios and Ojha, Ambrish and Mookerjee, Bijoyesh and Wagner, John and Filicko, Joanne and Ferber, Andres and Dessain, Scott and Grosso, Dolores and Brunner, Janet and Flomenberg, Neal and others},
  journal={Biology of Blood and Marrow Transplantation},
  volume={13},
  number={1},
  pages={74--81},
  year={2007},
  publisher={Elsevier}
}

@article{hesselmar2013pacifier,
  title={Pacifier Cleaning Practices and Risk of Allergy Development},
  author={Hesselmar, Bill and Sj{\"o}berg, Fei and Saalman, Robert and {\AA}berg, Nils and Adlerberth, Ingegerd and Wold, Agnes E},
  journal={Pediatrics},
  volume={131},
  number={6},
  pages={e1829--e1837},
  year={2013},
  publisher={Am Acad Pediatrics}
}

@article{khan2010breast,
  title={Breast augmentation, antibiotic prophylaxis, and infection: comparative analysis of 1,628 primary augmentation mammoplasties assessing the role and efficacy of antibiotics prophylaxis duration},
  author={Khan, Umar Daraz},
  journal={Aesthetic plastic surgery},
  volume={34},
  number={1},
  pages={42--47},
  year={2010},
  publisher={Springer}
}

@article{brahmbhatt2012national,
  title={National Practice Patterns in Preoperative and Postoperative Antibiotic Prophylaxis in Breast Procedures Requiring Drains: Survey of the American Society of Breast Surgeons},
  author={Brahmbhatt, Rushin D and Huebner, Marianne and Scow, Jeffrey S and Harmsen, W Scott and Boughey, Judy C and Harris, Ann M and Goede, Donna and Jakub, James W and Hieken, Tina J and Degnim, Amy C},
  journal={Annals of Surgical Oncology},
  pages={1--7},
  year={2012},
  publisher={Springer}
}

@article{phillips2012systematic,
  title={A Systematic Review of Antibiotic Use and Infection in Breast Reconstruction: What is the Evidence?},
  author={Phillips, B.T. and Bishawi, M. and Dagum, A.B. and Khan, S.U. and Bui, D.T.},
  journal={Plastic and Reconstructive Surgery},
  year={2012},
  publisher={LWW}
}

@article{cordeiro2006single,
  title={A single surgeon’s 12-year experience with tissue expander/implant breast reconstruction: Part I. A prospective analysis of early complications},
  author={Cordeiro, Peter G and McCarthy, Colleen M},
  journal={Plastic and reconstructive surgery},
  volume={118},
  number={4},
  pages={825--831},
  year={2006},
  publisher={LWW}
}

@article{cordeiro2006single,
  title={A single surgeon's 12-year experience with tissue expander/implant breast reconstruction: part II. An analysis of long-term complications, aesthetic outcomes, and patient satisfaction},
  author={Cordeiro, Peter G and McCarthy, Colleen M},
  journal={Plastic and reconstructive surgery},
  volume={118},
  number={4},
  pages={832--839},
  year={2006},
  publisher={LWW}
}

@article{mccarthy2008predicting,
  title={Predicting complications following expander/implant breast reconstruction: An outcomes analysis based on preoperative clinical risk},
  author={McCarthy, Colleen M and Mehrara, Babak J and Riedel, Elyn and Davidge, Kristen and Hinson, Akili and Disa, Joseph J and Cordeiro, Peter G and Pusic, Andrea L},
  journal={Plastic and reconstructive surgery},
  volume={121},
  number={6},
  pages={1886},
  year={2008}
}

@article{wright2002comparative,
  title={Comparative pharmacodynamics of three newer fluoroquinolones versus six strains of staphylococci in an in vitro model under aerobic and anaerobic conditions},
  author={Wright, David H and Gunderson, Brent W and Hovde, Laurie B and Ross, Gigi H and Ibrahim, Khalid H and Rotschafer, John C},
  journal={Antimicrobial agents and chemotherapy},
  volume={46},
  number={5},
  pages={1561--1563},
  year={2002},
  publisher={Am Soc Microbiol}
}

@article{martin2004use,
  title={The use of fluoroquinolones in the treatment of skin infections},
  author={Martin, Steven J and Zeigler, Dustin G},
  journal={Expert opinion on pharmacotherapy},
  volume={5},
  number={2},
  pages={237--246},
  year={2004},
  publisher={Ashley Publications Ltd London, UK}
}

@article{lister2001pharmacodynamics,
  title={Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmacodynamic model},
  author={Lister, Philip D},
  journal={Clinical infectious diseases},
  volume={32},
  number={Supplement 1},
  pages={S33--S38},
  year={2001},
  publisher={Oxford University Press}
}

@article{chen1991postoperative,
  title={Postoperative infections in breast surgery},
  author={Chen, J and Gutkin, Z and Bawnik, J},
  journal={Journal of Hospital Infection},
  volume={17},
  number={1},
  pages={61--65},
  year={1991},
  publisher={Elsevier}
}

@article{bunn2006prophylactic,
  title={Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery},
  author={Bunn, F and Cunningham, ME and Handscomb, K},
  journal={Cochrane Database Syst Rev},
  volume={2},
  year={2006},
  publisher={Wiley Online Library}
}

@article{neofytos2010epidemiology,
  title={Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients},
  author={Neofytos, D and Fishman, JA and Horn, D and Anaissie, E and Chang, C-H and Olyaei, A and Pfaller, M and Steinbach, WJ and Webster, KM and Marr, KA},
  journal={Transplant Infectious Disease},
  volume={12},
  number={3},
  pages={220--229},
  year={2010},
  publisher={Wiley Online Library}
}

@article{bloom2012detectable,
  title={Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy},
  author={Bloom, Chloe I and Graham, Christine M and Berry, Matthew PR and Wilkinson, Katalin A and Oni, Tolu and Rozakeas, Fotini and Xu, Zhaohui and Rossello-Urgell, Jose and Chaussabel, Damien and Banchereau, Jacques and others},
  journal={PloS one},
  volume={7},
  number={10},
  pages={e46191},
  year={2012},
  publisher={Public Library of Science}
}

@article{skraban2013gut,
  title={Gut Microbiota Patterns Associated with Colonization of Different Clostridium difficile Ribotypes},
  author={Skraban, Jure and Dzeroski, Saso and Zenko, Bernard and Mongus, Domen and Gangl, Simon and Rupnik, Maja},
  journal={PloS one},
  volume={8},
  number={2},
  pages={e58005},
  year={2013},
  publisher={Public Library of Science}
}

@article{blijlevens2005prospective,
  title={Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant},
  author={Blijlevens, NMA and Donnelly, JP and De Pauw, BE},
  journal={Bone marrow transplantation},
  volume={35},
  number={7},
  pages={707--711},
  year={2005},
  publisher={Nature Publishing Group}
}

@article{walsh2002evaluation,
  title={Evaluation of a new Etest for detecting metallo-$\beta$-lactamases in routine clinical testing},
  author={Walsh, Timothy R and Bolmstr{\"o}m, Anne and Qw{\"a}rnstr{\"o}m, Anette and Gales, Ana},
  journal={Journal of Clinical Microbiology},
  volume={40},
  number={8},
  pages={2755--2759},
  year={2002},
  publisher={Am Soc Microbiol}
}

@article{schloss2009high,
  title={A high-throughput DNA sequence aligner for microbial ecology studies},
  author={Schloss, P.D.},
  journal={PLoS One},
  volume={4},
  number={12},
  pages={e8230},
  year={2009},
  publisher={Public Library of Science}
}

@article{sun2011host,
  title={Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease},
  author={Sun, Lulu and Nava, Gerardo M and Stappenbeck, Thaddeus S},
  journal={Current opinion in gastroenterology},
  volume={27},
  number={4},
  pages={321--327},
  year={2011},
  publisher={LWW}
}

@article{xavier2007unravelling,
  title={Unravelling the pathogenesis of inflammatory bowel disease},
  author={Xavier, RJ and Podolsky, DK},
  journal={Nature},
  volume={448},
  number={7152},
  pages={427--434},
  year={2007},
  publisher={Nature Publishing Group}
}

@article{penders2006factors,
  title={Factors influencing the composition of the intestinal microbiota in early infancy},
  author={Penders, John and Thijs, Carel and Vink, Cornelis and Stelma, Foekje F and Snijders, Bianca and Kummeling, Ischa and van den Brandt, Piet A and Stobberingh, Ellen E},
  journal={Pediatrics},
  volume={118},
  number={2},
  pages={511--521},
  year={2006},
  publisher={Am Acad Pediatrics}
}

@article{schloss2011reducing,
  title={Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies},
  author={Schloss, Patrick D and Gevers, Dirk and Westcott, Sarah L},
  journal={PloS one},
  volume={6},
  number={12},
  pages={e27310},
  year={2011},
  publisher={Public Library of Science}
}

@article{rolfe1984role,
  title={Role of volatile fatty acids in colonization resistance to Clostridium difficile.},
  author={Rolfe, RIAL D},
  journal={Infection and immunity},
  volume={45},
  number={1},
  pages={185--191},
  year={1984},
  publisher={Am Soc Microbiol}
}

@article{xu2003genomic,
  title={A genomic view of the human-Bacteroides thetaiotaomicron symbiosis},
  author={Xu, Jian and Bjursell, Magnus K and Himrod, Jason and Deng, Su and Carmichael, Lynn K and Chiang, Herbert C and Hooper, Lora V and Gordon, Jeffrey I},
  journal={Science},
  volume={299},
  number={5615},
  pages={2074--2076},
  year={2003},
  publisher={American Association for the Advancement of Science}
}

@article{miller2004cellular,
  title={Cellular and physiological effects of short-chain fatty acids},
  author={Miller, Steven J},
  journal={Mini reviews in medicinal chemistry},
  volume={4},
  number={8},
  pages={839--845},
  year={2004},
  publisher={Bentham Science Publishers}
}

@article{rolain2010new,
  title={New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?},
  author={Rolain, JM and Parola, P and Cornaglia, G},
  journal={Clinical Microbiology and Infection},
  volume={16},
  number={12},
  pages={1699--1701},
  year={2010},
  publisher={Wiley Online Library}
}

@article{yong2009characterization,
  title={Characterization of a new metallo-$\beta$-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India},
  author={Yong, Dongeun and Toleman, Mark A and Giske, Christian G and Cho, Hyun S and Sundman, Kristina and Lee, Kyungwon and Walsh, Timothy R},
  journal={Antimicrobial agents and chemotherapy},
  volume={53},
  number={12},
  pages={5046--5054},
  year={2009},
  publisher={Am Soc Microbiol}
}

@article{walsh2011new,
  title={The new medical challenge: why NDM-1? Why Indian?},
  author={Walsh, Timothy R and Toleman, Mark A},
  journal={Expert review of anti-infective therapy},
  volume={9},
  number={2},
  pages={137--141},
  year={2011},
  publisher={Expert Reviews Ltd London, UK}
}

@article{walsh2011dissemination,
  title={Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study},
  author={Walsh, Timothy R and Weeks, Janis and Livermore, David M and Toleman, Mark A},
  journal={The Lancet infectious diseases},
  volume={11},
  number={5},
  pages={355--362},
  year={2011},
  publisher={Elsevier}
}

@article{haas2011chimeric,
  title={Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons},
  author={Haas, Brian J and Gevers, Dirk and Earl, Ashlee M and Feldgarden, Mike and Ward, Doyle V and Giannoukos, Georgia and Ciulla, Dawn and Tabbaa, Diana and Highlander, Sarah K and Sodergren, Erica and others},
  journal={Genome research},
  volume={21},
  number={3},
  pages={494--504},
  year={2011},
  publisher={Cold Spring Harbor Lab}
}

@article{faith1992conservation,
  title={Conservation evaluation and phylogenetic diversity},
  author={Faith, Daniel P},
  journal={Biological Conservation},
  volume={61},
  number={1},
  pages={1--10},
  year={1992},
  publisher={Elsevier}
}

@article{schloss2009introducing,
  title={Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities},
  author={Schloss, Patrick D and Westcott, Sarah L and Ryabin, Thomas and Hall, Justine R and Hartmann, Martin and Hollister, Emily B and Lesniewski, Ryan A and Oakley, Brian B and Parks, Donovan H and Robinson, Courtney J and others},
  journal={Applied and environmental microbiology},
  volume={75},
  number={23},
  pages={7537--7541},
  year={2009},
  publisher={Am Soc Microbiol}
}

@article{heinze2001solution,
  title={A solution to the problem of monotone likelihood in Cox regression},
  author={Heinze, Georg and Schemper, Michael},
  journal={Biometrics},
  volume={57},
  number={1},
  pages={114--119},
  year={2001},
  publisher={Wiley Online Library}
}

@article{abubucker2012metabolic,
  title={Metabolic reconstruction for metagenomic data and its application to the human microbiome},
  author={Abubucker, Sahar and Segata, Nicola and Goll, Johannes and Schubert, Alyxandria M and Izard, Jacques and Cantarel, Brandi L and Rodriguez-Mueller, Beltran and Zucker, Jeremy and Thiagarajan, Mathangi and Henrissat, Bernard and others},
  journal={PLoS computational biology},
  volume={8},
  number={6},
  pages={e1002358},
  year={2012},
  publisher={Public Library of Science}
}

@article{costello2009bacterial,
  title={Bacterial community variation in human body habitats across space and time},
  author={Costello, Elizabeth K and Lauber, Christian L and Hamady, Micah and Fierer, Noah and Gordon, Jeffrey I and Knight, Rob},
  journal={Science},
  volume={326},
  number={5960},
  pages={1694--1697},
  year={2009},
  publisher={American Association for the Advancement of Science}
}

@article{mandell2007infectious,
  title={Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults},
  author={Mandell, L.A. and Wunderink, R.G. and Anzueto, A. and Bartlett, J.G. and Campbell, G.D. and Dean, N.C. and Dowell, S.F. and File Jr, T.M. and Musher, D.M. and Niederman, M.S. and others},
  journal={Clinical Infectious Diseases},
  volume={44},
  number={Supplement 2},
  pages={S27--S72},
  year={2007},
  publisher={Oxford University Press}
}

@article{flint2012microbial,
  title={Microbial degradation of complex carbohydrates in the gut},
  author={Flint, Harry J and Scott, Karen P and Duncan, Sylvia H and Louis, Petra and Forano, Evelyne},
  journal={Gut Microbes},
  volume={3},
  number={4},
  pages={289--306},
  year={2012},
  publisher={Landes Bioscience}
}

@article{ubeda2013intestinal
,	author	= {Ubeda, Carles and Bucci, Vanni and Caballero, Silvia and Djukovic, Ana and Toussaint, Nora C and Equinda, Michele and Lipuma, Lauren and Ling, Lilan and Gobourne, Asia and No, Daniel and Taur, Ying and Jenq, Robert R and van den Brink, Marcel R M and Xavier, Joao B and Pamer, Eric G}
,	title	= {Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization.}
,	journal	= {Infection and immunity}
,	year	= {2013}
,	volume	= {81}
,	number	= {3}
,	pages	= {965--73}
,	month	= {Mar}
,	journal-iso	= {Infect. Immun.}
,	doi	= {10.1128/IAI.01197-12}
,	pmid	= {23319552}
,	abstract	= {Bacteria causing infections in hospitalized patients are increasingly antibiotic resistant. Classical infection control practices are only partially effective at preventing spread of antibiotic-resistant bacteria within hospitals. Because the density of intestinal colonization by the highly antibiotic-resistant bacterium vancomycin-resistant Enterococcus (VRE) can exceed 10(9) organisms per gram of feces, even optimally implemented hygiene protocols often fail. Decreasing the density of intestinal colonization, therefore, represents an important approach to limit VRE transmission. We demonstrate that reintroduction of a diverse intestinal microbiota to densely VRE-colonized mice eliminates VRE from the intestinal tract. While oxygen-tolerant members of the microbiota are ineffective at eliminating VRE, administration of obligate anaerobic commensal bacteria to mice results in a billionfold reduction in the density of intestinal VRE colonization. 16S rRNA gene sequence analysis of intestinal bacterial populations isolated from mice that cleared VRE following microbiota reconstitution revealed that recolonization with a microbiota that contains Barnesiella correlates with VRE elimination. Characterization of the fecal microbiota of patients undergoing allogeneic hematopoietic stem cell transplantation demonstrated that intestinal colonization with Barnesiella confers resistance to intestinal domination and bloodstream infection with VRE. Our studies indicate that obligate anaerobic bacteria belonging to the Barnesiella genus enable clearance of intestinal VRE colonization and may provide novel approaches to prevent the spread of highly antibiotic-resistant bacteria.}
}

@article{hamilton2012standardized,
  title={Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection},
  author={Hamilton, Matthew J and Weingarden, Alexa R and Sadowsky, Michael J and Khoruts, Alexander},
  journal={The American journal of gastroenterology},
  volume={107},
  number={5},
  pages={761--767},
  year={2012},
  publisher={Nature Publishing Group}
}

@article{alonso2012epidemiology
,	author	= {Alonso, Carolyn D and Treadway, Suzanne B and Hanna, David B and Huff, Carol Ann and Neofytos, Dionissios and Carroll, Karen C and Marr, Kieren A}
,	title	= {Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.}
,	journal	= {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America}
,	year	= {2012}
,	volume	= {54}
,	number	= {8}
,	pages	= {1053--63}
,	month	= {Apr}
,	journal-iso	= {Clin. Infect. Dis.}
,	doi	= {10.1093/cid/cir1035}
,	pmid	= {22412059}
,	abstract	= {Background. Clostridium difficile is the leading cause of infectious diarrhea among hospitalized patients and is a major concern for patients undergoing hematopoietic stem cell transplantation (HSCT). Risk factors and the natural history of C. difficile infection (CDI) are poorly understood in this population. Methods. We performed a retrospective nested case-control study to describe the epidemiology, timing, and risk factors for CDI among adult patients who received HSCTs at our center from January 2003 through December 2008. Results. The overall 1-year incidence of CDI was 9.2% among HSCTs performed (n = 999). The median time to diagnosis of CDI was short among both autologous and allogeneic HSCT recipients (6.5 days and 33 days, respectively). Risk factors for CDI in allogeneic HSCT recipients included receipt of chemotherapy prior to conditioning for HSCT, broad-spectrum antimicrobial use, and acute graft-versus-host disease (GVHD; adjusted odds ratio [AOR], 4.45; 95% confidence interval [CI], 1.54-12.84; P = .006). There was a strong relationship between early CDI and subsequent development of gastrointestinal tract GVHD in the year following allogeneic HSCT (P < .001). Gastrointestinal GVHD was also strongly associated with an increased risk for recurrent CDI (AOR, 4.23 [95% CI, 1.20-14.86]; P = .02). Conclusions. These results highlight the high incidence and early timing of CDI after HSCT. Early timing, coupled with the noted risk of pretransplant chemotherapy, suggests that the natural history of disease in some patients may involve colonization prior to HSCT. A potentially important interplay between CDI and GVHD involving the gastrointestinal tract was observed.}
}

@article{leung2010incidence
,	author	= {Leung, Sharon and Metzger, Brian S and Currie, Brian P}
,	title	= {Incidence of Clostridium difficile infection in patients with acute leukemia and lymphoma after allogeneic hematopoietic stem cell transplantation.}
,	journal	= {Infection control and hospital epidemiology}
,	year	= {2010}
,	volume	= {31}
,	number	= {3}
,	pages	= {313--5}
,	month	= {Mar}
,	journal-iso	= {Infect Control Hosp Epidemiol}
,	doi	= {10.1086/651066}
,	pmid	= {20109075}
}

@article{chopra2010clostridium,
  title={Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients},
  author={Chopra, Teena and Alangaden, George J and Chandrasekar, Pranatharthi},
  journal={Expert Review of Anti-infective Therapy},
  volume={8},
  number={10},
  pages={1113--1119},
  year={2010}
}

@article{yuen1998clinical,
  title={Clinical significance of alimentary tract microbes in bone marrow transplant recipients},
  author={Yuen, Kwok-yung and Woo, Patrick CY and Liang, Raymond HS and Chiu, Edmund KW and Chen, Frederick FE and Wong, Samson SY and Lau, Yu-lung and Ha, Sau-yin and Peiris, JS and Siau, Hong and others},
  journal={Diagnostic microbiology and infectious disease},
  volume={30},
  number={2},
  pages={75--81},
  year={1998},
  publisher={Elsevier}
}

@article{cole2009ribosomal,
  title={The Ribosomal Database Project: improved alignments and new tools for rRNA analysis},
  author={Cole, JR and Wang, Q. and Cardenas, E. and Fish, J. and Chai, B. and Farris, RJ and Kulam-Syed-Mohideen, AS and McGarrell, DM and Marsh, T. and Garrity, GM and others},
  journal={Nucleic acids research},
  volume={37},
  number={suppl 1},
  pages={D141--D145},
  year={2009},
  publisher={Oxford Univ Press}
}

@article{wang2007naive
,	author	= {Wang, Qiong and Garrity, George M and Tiedje, James M and Cole, James R}
,	title	= {Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy.}
,	journal	= {Applied and environmental microbiology}
,	year	= {2007}
,	volume	= {73}
,	number	= {16}
,	pages	= {5261--7}
,	month	= {Aug}
,	journal-iso	= {Appl. Environ. Microbiol.}
,	pmid	= {17586664}
,	abstract	= {The Ribosomal Database Project (RDP) Classifier, a na\"ive Bayesian classifier, can rapidly and accurately classify bacterial 16S rRNA sequences into the new higher-order taxonomy proposed in Bergey's Taxonomic Outline of the Prokaryotes (2nd ed., release 5.0, Springer-Verlag, New York, NY, 2004). It provides taxonomic assignments from domain to genus, with confidence estimates for each assignment. The majority of classifications (98%) were of high estimated confidence (> or = 95%) and high accuracy (98%). In addition to being tested with the corpus of 5,014 type strain sequences from Bergey's outline, the RDP Classifier was tested with a corpus of 23,095 rRNA sequences as assigned by the NCBI into their alternative higher-order taxonomy. The results from leave-one-out testing on both corpora show that the overall accuracies at all levels of confidence for near-full-length and 400-base segments were 89% or above down to the genus level, and the majority of the classification errors appear to be due to anomalies in the current taxonomies. For shorter rRNA segments, such as those that might be generated by pyrosequencing, the error rate varied greatly over the length of the 16S rRNA gene, with segments around the V2 and V4 variable regions giving the lowest error rates. The RDP Classifier is suitable both for the analysis of single rRNA sequences and for the analysis of libraries of thousands of sequences. Another related tool, RDP Library Compare, was developed to facilitate microbial-community comparison based on 16S rRNA gene sequence libraries. It combines the RDP Classifier with a statistical test to flag taxa differentially represented between samples. The RDP Classifier and RDP Library Compare are available online at http://rdp.cme.msu.edu/.}
}

@article{desantis2006greengenes,
  title={Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB},
  author={DeSantis, Todd Z and Hugenholtz, Philip and Larsen, Neils and Rojas, Mark and Brodie, Eoin L and Keller, Keith and Huber, Thomas and Dalevi, Daniel and Hu, Ping and Andersen, Gary L},
  journal={Applied and environmental microbiology},
  volume={72},
  number={7},
  pages={5069--5072},
  year={2006},
  publisher={Am Soc Microbiol}
}

@article{smith2013gut,
  title={Gut microbiomes of Malawian twin pairs discordant for kwashiorkor},
  author={Smith, Michelle I and Yatsunenko, Tanya and Manary, Mark J and Trehan, Indi and Mkakosya, Rajhab and Cheng, Jiye and Kau, Andrew L and Rich, Stephen S and Concannon, Patrick and Mychaleckyj, Josyf C and others},
  journal={Science},
  volume={339},
  number={6119},
  pages={548--554},
  year={2013},
  publisher={American Association for the Advancement of Science}
}

@article{haiser2013predicting,
  title={Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta},
  author={Haiser, Henry J and Gootenberg, David B and Chatman, Kelly and Sirasani, Gopal and Balskus, Emily P and Turnbaugh, Peter J},
  journal={Science},
  volume={341},
  number={6143},
  pages={295--298},
  year={2013},
  publisher={American Association for the Advancement of Science}
}

@article{pmid:24109065,
  title={Acute bacterial meningitis management in adults is inadequate: a multi-centre audit and survey.},
  author={Needham, Edward J and William Brown, J and Senaratne, Dhaneesha Ns and Mariam Karimi, A and Gibson, Thomas A and Brown, Emily E and Kim, Sooha and Thorpe, John W and Boyle, Adrian and Coles, Alasdair J},
  journal={Journal of neurology, neurosurgery, and psychiatry},
  journal-iso={J. Neurol. Neurosurg. Psychiatr.},
  volume={84},
  number={11},
  year={2013},
  month={Nov},
  pages={e2},
  doi={10.1136/jnnp-2013-306573.8},
  pmid={24109065},
  abstract={Acute bacterial meningitis (ABM) carries a 20-50% mortality rate with significant morbidity in survivors. Appropriate investigations and expeditious treatment (particularly antibiotics and often steroids) significantly improve outcomes. The National Institute for Clinical and Health Excellence (NICE) has not published guidance directing management in adults despite robust evidence informing treatment. We aimed to evaluate the investigation and initial management of suspected ABM against a European guideline1 in five East Anglian hospitals. We subsequently explored whether the results reflected insufficient knowledge by inviting all doctors in these emergency and acute medical departments to complete a survey.Clinical coding searches over 12 months at 5 hospitals for any type of meningitis identified 32 patients with proven ABM (bacteria in cerebrospinal fluid or typical composition) or those treated as ABM if lumbar puncture (LP) was omitted. 28 patients (88%) survived to discharge. Blood culture collection preceded antibiotics in 28 patients (88%). LP was attempted in 26 patients (81%), all undergoing prior head imaging; 19 patients (73%) merited this scan suggesting that LP (and subsequent antibiotics) were unnecessarily delayed in 7 patients (27%). LP was performed within the recommended 4 hours in 17 patients (65%); the median time to LP was 218 minutes (range: 5-1235). Median time to antibiotic administration from first documented suspicion of ABM was 72 minutes (range: 0-4740); 9 patients (28%) were treated within the recommended 30 minutes. 29 patients (94%) were treated according to local antibiotic policy (or had valid reasoning for deviation). High dose corticosteroids, recommended for non-meningococcal ABM before or with the first antibiotic dose, were given to 11 patients (34%); the remainder had no documented contraindication although 2 patients (6%) later cultured meningococcus. Median time to steroid administration was 17 hours, 16 hours after antibiotics. 25 patients (78%) had seizures or reduced conscious level at presentation; 12 of these (48%) received acyclovir. Survey: 101 doctors (22 consultants, 41 registrars and 38 junior doctors; response rate 62%) completed an online questionnaire addressing ABM management in adults against European guidance.(1) 18 doctors (18%) correctly identified the indications for head imaging before LP; 1% identified all contraindications to LP. 32% selected the correct indications and 1% the correct contraindications to high-dose corticosteroids. 62% referred to (non-existent) NICE guidelines; none were aware of the European guidelines.1 The majority felt their undergraduate and postgraduate training in managing ABM sufficient and reported a median confidence of 7/10 (where 10=fully confident) in it's management.Unjustified variance from European guidelines occurred in one or more aspect of every patient's management. Significant deficits in knowledge, particularly regarding expeditious antibiotic and steroid therapy, appear to be contributory despite reasonable self-reported confidence. Beyond local education we recommend development of a NICE guideline for managing ABM in adults.}
}


% BEGIN:Original PubMed XML
%  <PubmedArticle>
%    <MedlineCitation Owner="NLM" Status="In-Data-Review">
%      <PMID Version="1">24109065</PMID>
%      <DateCreated>
%        <Year>2013</Year>
%        <Month>10</Month>
%        <Day>10</Day>
%      </DateCreated>
%      <Article PubModel="Print">
%        <Journal>
%          <ISSN IssnType="Electronic">1468-330X</ISSN>
%          <JournalIssue CitedMedium="Internet">
%            <Volume>84</Volume>
%            <Issue>11</Issue>
%            <PubDate>
%              <Year>2013</Year>
%              <Month>Nov</Month>
%            </PubDate>
%          </JournalIssue>
%          <Title>Journal of neurology, neurosurgery, and psychiatry</Title>
%          <ISOAbbreviation>J. Neurol. Neurosurg. Psychiatr.</ISOAbbreviation>
%        </Journal>
%        <ArticleTitle>Acute bacterial meningitis management in adults is inadequate: a multi-centre audit and survey.</ArticleTitle>
%        <Pagination>
%          <MedlinePgn>e2</MedlinePgn>
%        </Pagination>
%        <ELocationID EIdType="doi" ValidYN="Y">10.1136/jnnp-2013-306573.8</ELocationID>
%        <Abstract>
%          <AbstractText Label="UNLABELLED">Acute bacterial meningitis (ABM) carries a 20-50% mortality rate with significant morbidity in survivors. Appropriate investigations and expeditious treatment (particularly antibiotics and often steroids) significantly improve outcomes. The National Institute for Clinical and Health Excellence (NICE) has not published guidance directing management in adults despite robust evidence informing treatment. We aimed to evaluate the investigation and initial management of suspected ABM against a European guideline1 in five East Anglian hospitals. We subsequently explored whether the results reflected insufficient knowledge by inviting all doctors in these emergency and acute medical departments to complete a survey.</AbstractText>
%          <AbstractText Label="AUDIT" NlmCategory="UNASSIGNED">Clinical coding searches over 12 months at 5 hospitals for any type of meningitis identified 32 patients with proven ABM (bacteria in cerebrospinal fluid or typical composition) or those treated as ABM if lumbar puncture (LP) was omitted. 28 patients (88%) survived to discharge. Blood culture collection preceded antibiotics in 28 patients (88%). LP was attempted in 26 patients (81%), all undergoing prior head imaging; 19 patients (73%) merited this scan suggesting that LP (and subsequent antibiotics) were unnecessarily delayed in 7 patients (27%). LP was performed within the recommended 4 hours in 17 patients (65%); the median time to LP was 218 minutes (range: 5-1235). Median time to antibiotic administration from first documented suspicion of ABM was 72 minutes (range: 0-4740); 9 patients (28%) were treated within the recommended 30 minutes. 29 patients (94%) were treated according to local antibiotic policy (or had valid reasoning for deviation). High dose corticosteroids, recommended for non-meningococcal ABM before or with the first antibiotic dose, were given to 11 patients (34%); the remainder had no documented contraindication although 2 patients (6%) later cultured meningococcus. Median time to steroid administration was 17 hours, 16 hours after antibiotics. 25 patients (78%) had seizures or reduced conscious level at presentation; 12 of these (48%) received acyclovir. Survey: 101 doctors (22 consultants, 41 registrars and 38 junior doctors; response rate 62%) completed an online questionnaire addressing ABM management in adults against European guidance.(1) 18 doctors (18%) correctly identified the indications for head imaging before LP; 1% identified all contraindications to LP. 32% selected the correct indications and 1% the correct contraindications to high-dose corticosteroids. 62% referred to (non-existent) NICE guidelines; none were aware of the European guidelines.1 The majority felt their undergraduate and postgraduate training in managing ABM sufficient and reported a median confidence of 7/10 (where 10=fully confident) in it's management.</AbstractText>
%          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Unjustified variance from European guidelines occurred in one or more aspect of every patient's management. Significant deficits in knowledge, particularly regarding expeditious antibiotic and steroid therapy, appear to be contributory despite reasonable self-reported confidence. Beyond local education we recommend development of a NICE guideline for managing ABM in adults.</AbstractText>
%        </Abstract>
%        <Affiliation>Norfolk and Norwich University Hospital; Addenbrooke's Hospital; University of Cambridge.</Affiliation>
%        <AuthorList CompleteYN="Y">
%          <Author ValidYN="Y">
%            <LastName>Needham</LastName>
%            <ForeName>Edward J</ForeName>
%            <Initials>EJ</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>William Brown</LastName>
%            <ForeName>J</ForeName>
%            <Initials>J</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Senaratne</LastName>
%            <ForeName>Dhaneesha Ns</ForeName>
%            <Initials>DN</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Mariam Karimi</LastName>
%            <ForeName>A</ForeName>
%            <Initials>A</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Gibson</LastName>
%            <ForeName>Thomas A</ForeName>
%            <Initials>TA</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Brown</LastName>
%            <ForeName>Emily E</ForeName>
%            <Initials>EE</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Kim</LastName>
%            <ForeName>Sooha</ForeName>
%            <Initials>S</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Thorpe</LastName>
%            <ForeName>John W</ForeName>
%            <Initials>JW</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Boyle</LastName>
%            <ForeName>Adrian</ForeName>
%            <Initials>A</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Coles</LastName>
%            <ForeName>Alasdair J</ForeName>
%            <Initials>AJ</Initials>
%          </Author>
%        </AuthorList>
%        <Language>eng</Language>
%        <PublicationTypeList>
%          <PublicationType>Journal Article</PublicationType>
%        </PublicationTypeList>
%      </Article>
%      <MedlineJournalInfo>
%        <Country>England</Country>
%        <MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA>
%        <NlmUniqueID>2985191R</NlmUniqueID>
%        <ISSNLinking>0022-3050</ISSNLinking>
%      </MedlineJournalInfo>
%      <CitationSubset>IM</CitationSubset>
%      <KeywordList Owner="NOTNLM">
%        <Keyword MajorTopicYN="N">PARKINSON'S DISEASE</Keyword>
%        <Keyword MajorTopicYN="N">STROKE</Keyword>
%      </KeywordList>
%    </MedlineCitation>
%    <PubmedData>
%      <History>
%        <PubMedPubDate PubStatus="entrez">
%          <Year>2013</Year>
%          <Month>10</Month>
%          <Day>11</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="pubmed">
%          <Year>2013</Year>
%          <Month>10</Month>
%          <Day>11</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="medline">
%          <Year>2013</Year>
%          <Month>10</Month>
%          <Day>11</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%      </History>
%      <PublicationStatus>ppublish</PublicationStatus>
%      <ArticleIdList>
%        <ArticleId IdType="pii">jnnp-2013-306573.8</ArticleId>
%        <ArticleId IdType="doi">10.1136/jnnp-2013-306573.8</ArticleId>
%        <ArticleId IdType="pubmed">24109065</ArticleId>
%      </ArticleIdList>
%    </PubmedData>
%  </PubmedArticle>
% END:Original PubMed XML


@article{pmid:19836068,
  title={Induction of intestinal Th17 cells by segmented filamentous bacteria.},
  author={Ivanov, Ivaylo I and Atarashi, Koji and Manel, Nicolas and Brodie, Eoin L and Shima, Tatsuichiro and Karaoz, Ulas and Wei, Dongguang and Goldfarb, Katherine C and Santee, Clark A and Lynch, Susan V and Tanoue, Takeshi and Imaoka, Akemi and Itoh, Kikuji and Takeda, Kiyoshi and Umesaki, Yoshinori and Honda, Kenya and Littman, Dan R},
  journal={Cell},
  journal-iso={Cell},
  volume={139},
  number={3},
  year={2009},
  month={Oct},
  pages={485--98},
  doi={10.1016/j.cell.2009.09.033},
  pmid={19836068},
  abstract={The gastrointestinal tract of mammals is inhabited by hundreds of distinct species of commensal microorganisms that exist in a mutualistic relationship with the host. How commensal microbiota influence the host immune system is poorly understood. We show here that colonization of the small intestine of mice with a single commensal microbe, segmented filamentous bacterium (SFB), is sufficient to induce the appearance of CD4(+) T helper cells that produce IL-17 and IL-22 (Th17 cells) in the lamina propria. SFB adhere tightly to the surface of epithelial cells in the terminal ileum of mice with Th17 cells but are absent from mice that have few Th17 cells. Colonization with SFB was correlated with increased expression of genes associated with inflammation and antimicrobial defenses and resulted in enhanced resistance to the intestinal pathogen Citrobacter rodentium. Thus, manipulation of this commensal-regulated pathway may provide new opportunities for enhancing mucosal immunity and treating autoimmune disease.}
}


% BEGIN:Original PubMed XML
%  <PubmedArticle>
%    <MedlineCitation Owner="NLM" Status="MEDLINE">
%      <PMID Version="1">19836068</PMID>
%      <DateCreated>
%        <Year>2009</Year>
%        <Month>11</Month>
%        <Day>02</Day>
%      </DateCreated>
%      <DateCompleted>
%        <Year>2009</Year>
%        <Month>12</Month>
%        <Day>03</Day>
%      </DateCompleted>
%      <DateRevised>
%        <Year>2013</Year>
%        <Month>05</Month>
%        <Day>31</Day>
%      </DateRevised>
%      <Article PubModel="Print">
%        <Journal>
%          <ISSN IssnType="Electronic">1097-4172</ISSN>
%          <JournalIssue CitedMedium="Internet">
%            <Volume>139</Volume>
%            <Issue>3</Issue>
%            <PubDate>
%              <Year>2009</Year>
%              <Month>Oct</Month>
%              <Day>30</Day>
%            </PubDate>
%          </JournalIssue>
%          <Title>Cell</Title>
%          <ISOAbbreviation>Cell</ISOAbbreviation>
%        </Journal>
%        <ArticleTitle>Induction of intestinal Th17 cells by segmented filamentous bacteria.</ArticleTitle>
%        <Pagination>
%          <MedlinePgn>485-98</MedlinePgn>
%        </Pagination>
%        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cell.2009.09.033</ELocationID>
%        <Abstract>
%          <AbstractText>The gastrointestinal tract of mammals is inhabited by hundreds of distinct species of commensal microorganisms that exist in a mutualistic relationship with the host. How commensal microbiota influence the host immune system is poorly understood. We show here that colonization of the small intestine of mice with a single commensal microbe, segmented filamentous bacterium (SFB), is sufficient to induce the appearance of CD4(+) T helper cells that produce IL-17 and IL-22 (Th17 cells) in the lamina propria. SFB adhere tightly to the surface of epithelial cells in the terminal ileum of mice with Th17 cells but are absent from mice that have few Th17 cells. Colonization with SFB was correlated with increased expression of genes associated with inflammation and antimicrobial defenses and resulted in enhanced resistance to the intestinal pathogen Citrobacter rodentium. Thus, manipulation of this commensal-regulated pathway may provide new opportunities for enhancing mucosal immunity and treating autoimmune disease.</AbstractText>
%        </Abstract>
%        <Affiliation>Molecular Pathogenesis Program, The Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY 10016, USA.</Affiliation>
%        <AuthorList CompleteYN="Y">
%          <Author ValidYN="Y">
%            <LastName>Ivanov</LastName>
%            <ForeName>Ivaylo I</ForeName>
%            <Initials>II</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Atarashi</LastName>
%            <ForeName>Koji</ForeName>
%            <Initials>K</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Manel</LastName>
%            <ForeName>Nicolas</ForeName>
%            <Initials>N</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Brodie</LastName>
%            <ForeName>Eoin L</ForeName>
%            <Initials>EL</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Shima</LastName>
%            <ForeName>Tatsuichiro</ForeName>
%            <Initials>T</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Karaoz</LastName>
%            <ForeName>Ulas</ForeName>
%            <Initials>U</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Wei</LastName>
%            <ForeName>Dongguang</ForeName>
%            <Initials>D</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Goldfarb</LastName>
%            <ForeName>Katherine C</ForeName>
%            <Initials>KC</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Santee</LastName>
%            <ForeName>Clark A</ForeName>
%            <Initials>CA</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Lynch</LastName>
%            <ForeName>Susan V</ForeName>
%            <Initials>SV</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Tanoue</LastName>
%            <ForeName>Takeshi</ForeName>
%            <Initials>T</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Imaoka</LastName>
%            <ForeName>Akemi</ForeName>
%            <Initials>A</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Itoh</LastName>
%            <ForeName>Kikuji</ForeName>
%            <Initials>K</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Takeda</LastName>
%            <ForeName>Kiyoshi</ForeName>
%            <Initials>K</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Umesaki</LastName>
%            <ForeName>Yoshinori</ForeName>
%            <Initials>Y</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Honda</LastName>
%            <ForeName>Kenya</ForeName>
%            <Initials>K</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Littman</LastName>
%            <ForeName>Dan R</ForeName>
%            <Initials>DR</Initials>
%          </Author>
%        </AuthorList>
%        <Language>eng</Language>
%        <DataBankList CompleteYN="Y">
%          <DataBank>
%            <DataBankName>GEO</DataBankName>
%            <AccessionNumberList>
%              <AccessionNumber>GSE18348</AccessionNumber>
%            </AccessionNumberList>
%          </DataBank>
%        </DataBankList>
%        <GrantList CompleteYN="Y">
%          <Grant>
%            <GrantID>AI33856</GrantID>
%            <Acronym>AI</Acronym>
%            <Agency>NIAID NIH HHS</Agency>
%            <Country>United States</Country>
%          </Grant>
%          <Grant>
%            <GrantID>R01 AI033856-16</GrantID>
%            <Acronym>AI</Acronym>
%            <Agency>NIAID NIH HHS</Agency>
%            <Country>United States</Country>
%          </Grant>
%          <Grant>
%            <Agency>Howard Hughes Medical Institute</Agency>
%            <Country>United States</Country>
%          </Grant>
%        </GrantList>
%        <PublicationTypeList>
%          <PublicationType>Journal Article</PublicationType>
%          <PublicationType>Research Support, N.I.H., Extramural</PublicationType>
%          <PublicationType>Research Support, Non-U.S. Gov't</PublicationType>
%          <PublicationType>Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
%        </PublicationTypeList>
%      </Article>
%      <MedlineJournalInfo>
%        <Country>United States</Country>
%        <MedlineTA>Cell</MedlineTA>
%        <NlmUniqueID>0413066</NlmUniqueID>
%        <ISSNLinking>0092-8674</ISSNLinking>
%      </MedlineJournalInfo>
%      <ChemicalList>
%        <Chemical>
%          <RegistryNumber>0</RegistryNumber>
%          <NameOfSubstance>Interleukin-17</NameOfSubstance>
%        </Chemical>
%        <Chemical>
%          <RegistryNumber>0</RegistryNumber>
%          <NameOfSubstance>Interleukins</NameOfSubstance>
%        </Chemical>
%        <Chemical>
%          <RegistryNumber>0</RegistryNumber>
%          <NameOfSubstance>Serum Amyloid A Protein</NameOfSubstance>
%        </Chemical>
%        <Chemical>
%          <RegistryNumber>0</RegistryNumber>
%          <NameOfSubstance>interleukin-22</NameOfSubstance>
%        </Chemical>
%      </ChemicalList>
%      <CitationSubset>IM</CitationSubset>
%      <CommentsCorrectionsList>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Arthritis Rheum. 2006 Feb;54(2):621-7</RefSource>
%          <PMID Version="1">16447240</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Science. 2005 Mar 25;307(5717):1915-20</RefSource>
%          <PMID Version="1">15790844</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>J Clin Invest. 2006 May;116(5):1310-6</RefSource>
%          <PMID Version="1">16670770</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nature. 2006 May 11;441(7090):231-4</RefSource>
%          <PMID Version="1">16648837</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Curr Top Microbiol Immunol. 2006;308:1-18</RefSource>
%          <PMID Version="1">16922084</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Science. 2006 Aug 25;313(5790):1126-30</RefSource>
%          <PMID Version="1">16931762</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>J Immunol. 2006 Sep 15;177(6):4072-9</RefSource>
%          <PMID Version="1">16951371</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Biochem Biophys Res Commun. 2000 Feb 16;268(2):405-8</RefSource>
%          <PMID Version="1">10679217</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>J Infect Dis. 2000 Mar;181(3):1027-33</RefSource>
%          <PMID Version="1">10720527</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Int J Syst Evol Microbiol. 2000 Jan;50 Pt 1:145-8</RefSource>
%          <PMID Version="1">10826798</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Genes Dev. 2000 Jul 15;14(14):1693-711</RefSource>
%          <PMID Version="1">10898785</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Science. 2003 Feb 14;299(5609):1057-61</RefSource>
%          <PMID Version="1">12522256</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nat Immunol. 2003 Apr;4(4):330-6</RefSource>
%          <PMID Version="1">12612578</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nat Immunol. 2003 Apr;4(4):337-42</RefSource>
%          <PMID Version="1">12612581</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Genome Biol. 2003;4(5):P3</RefSource>
%          <PMID Version="1">12734009</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Ann Rheum Dis. 2003 Oct;62(10):976-82</RefSource>
%          <PMID Version="1">12972477</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Curr Opin Immunol. 2003 Dec;15(6):690-6</RefSource>
%          <PMID Version="1">14630204</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>J Exp Med. 2003 Dec 15;198(12):1951-7</RefSource>
%          <PMID Version="1">14662908</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1981-6</RefSource>
%          <PMID Version="1">14766966</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nat Rev Immunol. 2004 Jun;4(6):478-85</RefSource>
%          <PMID Version="1">15173836</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Infect Immun. 1974 Oct;10(4):948-56</RefSource>
%          <PMID Version="1">4426712</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Lab Anim. 1985 Apr;19(2):111-8</RefSource>
%          <PMID Version="1">3889493</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Lab Anim. 1987 Jan;21(1):48-52</RefSource>
%          <PMID Version="1">3560864</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>J Rheumatol. 1989 Aug;16(8):1061-8</RefSource>
%          <PMID Version="1">2585403</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Infect Immun. 1993 Jan;61(1):303-6</RefSource>
%          <PMID Version="1">8418051</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Lab Anim. 1993 Apr;27(2):141-50</RefSource>
%          <PMID Version="1">8501895</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Annu Rev Immunol. 1994;12:635-73</RefSource>
%          <PMID Version="1">7912089</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Int J Syst Bacteriol. 1995 Oct;45(4):780-2</RefSource>
%          <PMID Version="1">7547299</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Immunity. 2008 Oct 17;29(4):637-49</RefSource>
%          <PMID Version="1">18835196</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Immunology. 2009 Feb;126(2):177-85</RefSource>
%          <PMID Version="1">19125888</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nat Protoc. 2009;4(1):44-57</RefSource>
%          <PMID Version="1">19131956</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Gastroenterology. 2009 Jan;136(1):257-67</RefSource>
%          <PMID Version="1">18992745</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nature. 2009 Mar 5;458(7234):78-82</RefSource>
%          <PMID Version="1">19262671</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Immunity. 2006 Feb;24(2):179-89</RefSource>
%          <PMID Version="1">16473830</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Gastroenterology. 2005 Apr;128(4):891-906</RefSource>
%          <PMID Version="1">15825073</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Cell. 2005 Jul 15;122(1):107-18</RefSource>
%          <PMID Version="1">16009137</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Immunol Rev. 2005 Aug;206:260-76</RefSource>
%          <PMID Version="1">16048554</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Appl Environ Microbiol. 2006 Sep;72(9):6288-98</RefSource>
%          <PMID Version="1">16957256</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Cell. 2006 Sep 22;126(6):1121-33</RefSource>
%          <PMID Version="1">16990136</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>J Exp Med. 2006 Oct 30;203(11):2473-83</RefSource>
%          <PMID Version="1">17030949</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Science. 2006 Dec 1;314(5804):1461-3</RefSource>
%          <PMID Version="1">17068223</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nature. 2006 Dec 21;444(7122):1027-31</RefSource>
%          <PMID Version="1">17183312</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>N Engl J Med. 2007 Feb 8;356(6):580-92</RefSource>
%          <PMID Version="1">17287478</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nat Immunol. 2007 Apr;8(4):345-50</RefSource>
%          <PMID Version="1">17375096</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Microb Ecol. 2007 Apr;53(3):371-83</RefSource>
%          <PMID Version="1">17334858</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Gastroenterology. 2008 Feb;134(2):577-94</RefSource>
%          <PMID Version="1">18242222</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Infect Immun. 2008 Mar;76(3):907-15</RefSource>
%          <PMID Version="1">18160481</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Semin Immunol. 2007 Dec;19(6):377-82</RefSource>
%          <PMID Version="1">18054248</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nat Med. 2008 Mar;14(3):282-9</RefSource>
%          <PMID Version="1">18264109</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nature. 2008 May 8;453(7192):236-40</RefSource>
%          <PMID Version="1">18368049</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nature. 2008 May 29;453(7195):620-5</RefSource>
%          <PMID Version="1">18509436</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Science. 2008 Jun 20;320(5883):1647-51</RefSource>
%          <PMID Version="1">18497261</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nature. 2008 Oct 9;455(7214):808-12</RefSource>
%          <PMID Version="1">18716618</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nature. 2008 Oct 9;455(7214):804-7</RefSource>
%          <PMID Version="1">18724361</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Cell Host Microbe. 2008 Oct 16;4(4):337-49</RefSource>
%          <PMID Version="1">18854238</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nat Rev Immunol. 2008 Nov;8(11):829-35</RefSource>
%          <PMID Version="1">18949018</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Microbiol Immunol. 1995;39(8):555-62</RefSource>
%          <PMID Version="1">7494493</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nature. 1996 Oct 31;383(6603):787-93</RefSource>
%          <PMID Version="1">8893001</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Infect Immun. 1999 Apr;67(4):1992-2000</RefSource>
%          <PMID Version="1">10085047</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Infect Immun. 1999 Jul;67(7):3504-11</RefSource>
%          <PMID Version="1">10377132</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Appl Environ Microbiol. 1999 Aug;65(8):3287-92</RefSource>
%          <PMID Version="1">10427008</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Eur J Biochem. 1999 Oct;265(2):501-23</RefSource>
%          <PMID Version="1">10504381</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>J Exp Med. 2005 Jan 17;201(2):233-40</RefSource>
%          <PMID Version="1">15657292</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="CommentIn">
%          <RefSource>Gastroenterology. 2010 Jul;139(1):351-3</RefSource>
%          <PMID Version="1">20510226</PMID>
%        </CommentsCorrections>
%      </CommentsCorrectionsList>
%      <MeshHeadingList>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Animals</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Cell Differentiation</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Citrobacter rodentium</DescriptorName>
%          <QualifierName MajorTopicYN="N">immunology</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Gram-Positive Bacteria</DescriptorName>
%          <QualifierName MajorTopicYN="Y">immunology</QualifierName>
%          <QualifierName MajorTopicYN="N">physiology</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Immunity, Mucosal</DescriptorName>
%          <QualifierName MajorTopicYN="N">immunology</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Interleukin-17</DescriptorName>
%          <QualifierName MajorTopicYN="N">immunology</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Interleukins</DescriptorName>
%          <QualifierName MajorTopicYN="N">immunology</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Intestinal Mucosa</DescriptorName>
%          <QualifierName MajorTopicYN="Y">immunology</QualifierName>
%          <QualifierName MajorTopicYN="Y">microbiology</QualifierName>
%          <QualifierName MajorTopicYN="N">physiology</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Mice</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Mucous Membrane</DescriptorName>
%          <QualifierName MajorTopicYN="N">immunology</QualifierName>
%          <QualifierName MajorTopicYN="N">microbiology</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Serum Amyloid A Protein</DescriptorName>
%          <QualifierName MajorTopicYN="N">metabolism</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Specific Pathogen-Free Organisms</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Symbiosis</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">T-Lymphocytes, Helper-Inducer</DescriptorName>
%          <QualifierName MajorTopicYN="Y">immunology</QualifierName>
%        </MeshHeading>
%      </MeshHeadingList>
%      <OtherID Source="NLM">NIHMS158224</OtherID>
%      <OtherID Source="NLM">PMC2796826</OtherID>
%    </MedlineCitation>
%    <PubmedData>
%      <History>
%        <PubMedPubDate PubStatus="received">
%          <Year>2009</Year>
%          <Month>5</Month>
%          <Day>26</Day>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="revised">
%          <Year>2009</Year>
%          <Month>9</Month>
%          <Day>2</Day>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="accepted">
%          <Year>2009</Year>
%          <Month>9</Month>
%          <Day>30</Day>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="entrez">
%          <Year>2009</Year>
%          <Month>10</Month>
%          <Day>20</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="pubmed">
%          <Year>2009</Year>
%          <Month>10</Month>
%          <Day>20</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="medline">
%          <Year>2009</Year>
%          <Month>12</Month>
%          <Day>16</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%      </History>
%      <PublicationStatus>ppublish</PublicationStatus>
%      <ArticleIdList>
%        <ArticleId IdType="pii">S0092-8674(09)01248-3</ArticleId>
%        <ArticleId IdType="doi">10.1016/j.cell.2009.09.033</ArticleId>
%        <ArticleId IdType="pubmed">19836068</ArticleId>
%        <ArticleId IdType="pmc">PMC2796826</ArticleId>
%        <ArticleId IdType="mid">NIHMS158224</ArticleId>
%      </ArticleIdList>
%    </PubmedData>
%  </PubmedArticle>
% END:Original PubMed XML


@article{roddie2009allogeneic,
  title={Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity},
  author={Roddie, C and Paul, JPV and Benjamin, R and Gallimore, CI and Xerry, J and Gray, JJ and Peggs, KS and Morris, EC and Thomson, KJ and Ward, KN},
  journal={Clinical infectious diseases},
  volume={49},
  number={7},
  pages={1061--1068},
  year={2009},
  publisher={Oxford University Press}
}

@article{flomenberg1994increasing,
  title={Increasing incidence of adenovirus disease in bone marrow transplant recipients},
  author={Flomenberg, Phyllis and Babbitt, Jill and Drobyski, William R and Ash, Robert C and Carrigan, Donald R and Sedmak, Gerald V and McAuliffe, Timothy and Camitta, Bruce and Horowitz, Mary M and Bunin, Nancy and others},
  journal={Journal of Infectious Diseases},
  volume={169},
  number={4},
  pages={775--781},
  year={1994},
  publisher={Oxford University Press}
}

@article{mcdonald2010hepatobiliary,
  title={Hepatobiliary complications of hematopoietic cell transplantation, 40 years on},
  author={McDonald, George B},
  journal={Hepatology},
  volume={51},
  number={4},
  pages={1450--1460},
  year={2010},
  publisher={Wiley Online Library}
}

@article{mcdonald2011improved
,	author	= {McDonald, Daniel and Price, Morgan N and Goodrich, Julia and Nawrocki, Eric P and DeSantis, Todd Z and Probst, Alexander and Andersen, Gary L and Knight, Rob and Hugenholtz, Philip}
,	title	= {An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea.}
,	journal	= {The ISME journal}
,	year	= {2012}
,	volume	= {6}
,	number	= {3}
,	pages	= {610--8}
,	month	= {Mar}
,	journal-iso	= {ISME J}
,	doi	= {10.1038/ismej.2011.139}
,	pmid	= {22134646}
,	abstract	= {Reference phylogenies are crucial for providing a taxonomic framework for interpretation of marker gene and metagenomic surveys, which continue to reveal novel species at a remarkable rate. Greengenes is a dedicated full-length 16S rRNA gene database that provides users with a curated taxonomy based on de novo tree inference. We developed a 'taxonomy to tree' approach for transferring group names from an existing taxonomy to a tree topology, and used it to apply the Greengenes, National Center for Biotechnology Information (NCBI) and cyanoDB (Cyanobacteria only) taxonomies to a de novo tree comprising 408,315 sequences. We also incorporated explicit rank information provided by the NCBI taxonomy to group names (by prefixing rank designations) for better user orientation and classification consistency. The resulting merged taxonomy improved the classification of 75% of the sequences by one or more ranks relative to the original NCBI taxonomy with the most pronounced improvements occurring in under-classified environmental sequences. We also assessed candidate phyla (divisions) currently defined by NCBI and present recommendations for consolidation of 34 redundantly named groups. All intermediate results from the pipeline, which includes tree inference, jackknifing and transfer of a donor taxonomy to a recipient tree (tax2tree) are available for download. The improved Greengenes taxonomy should provide important infrastructure for a wide range of megasequencing projects studying ecosystems on scales ranging from our own bodies (the Human Microbiome Project) to the entire planet (the Earth Microbiome Project). The implementation of the software can be obtained from http://sourceforge.net/projects/tax2tree/.}
}

@article{heit1973mortality,
  title={Mortality of secondary disease in antibiotic-treated mouse radiation chimeras},
  author={Heit, H and Wilson, R and Fliedner, TM and Kohne, E},
  journal={Germfree research. Biological effect of gnotobiotic environments. Academic Press, New York},
  pages={477--483},
  year={1973}
}

@article{faulkner1988influence,
  title={The influence of the gut flora on graft versus host disease (GvHD) following allogeneic bone marrow transplantation--experimental observations and possible mechanisms.},
  author={Faulkner, L and Rapson, N and Moore, R and Cohen, J},
  journal={Progress in clinical and biological research},
  volume={272},
  pages={195},
  year={1988}
}

@article{schmeiser1985influence,
  title={The influence of the microbial flora on incidence of graft-versus-host disease in human allogeneic bone marrow transplantation.},
  author={Schmeiser, Th and Kurrle, E and Arnold, R and Heit, W and Krieger, D and Kubanek, B and Heimpel, H},
  journal={Progress in clinical and biological research},
  volume={181},
  pages={433},
  year={1985}
}

@comment { BIBTEX_AUTO - GS }
@article{van1974mitigation,
  title={Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora},
  author={Van Bekkum, DW and Roodenburg, J and Heidt, PJ and Van der Waaij, D},
  journal={Journal of the National Cancer Institute},
  volume={52},
  number={2},
  pages={401--404},
  year={1974},
  publisher={Oxford University Press}
}

@inproceedings{pollard1976role,
  title={The role of microflora in development of graft-versus-host disease.},
  author={Pollard, M and Chang, CF and Srivastava, KK},
  booktitle={Transplantation proceedings},
  volume={8},
  number={4},
  pages={533--536},
  year={1976}
}

@article{vossen1990prevention,
  title={Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation},
  author={Vossen, JM and Heidt, PJ and Van Den Berg, H and Gerritsen, EJA and Hermans, J and Dooren, LJ},
  journal={European Journal of Clinical Microbiology and Infectious Diseases},
  volume={9},
  number={1},
  pages={14--23},
  year={1990},
  publisher={Springer}
}

@article{guiot1985selective,
  title={Selective or complete elimination of the endogenous flora during allogeneic bone marrow transplantation?},
  author={Guiot, HF and van der Meer, JW and Zwaan, FE and Mulder, CJ and Biemond, J and Klasen, EC},
  journal={Progress in clinical and biological research},
  volume={181},
  pages={429},
  year={1985}
}

@article{fimls1983early,
  title={Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: effects of prophylactic measures},
  author={FIMLS, RA Clift},
  journal={Infection},
  volume={11},
  number={5},
  pages={243--250},
  year={1983},
  publisher={Springer}
}

@article{shendure2008next,
  title={Next-generation DNA sequencing},
  author={Shendure, Jay and Ji, Hanlee},
  journal={Nature biotechnology},
  volume={26},
  number={10},
  pages={1135--1145},
  year={2008},
  publisher={Nature Publishing Group}
}

@article{mardis2008next,
  title={Next-generation DNA sequencing methods},
  author={Mardis, Elaine R},
  journal={Annu. Rev. Genomics Hum. Genet.},
  volume={9},
  pages={387--402},
  year={2008},
  publisher={Annual Reviews}
}

@article{shim1998primary,
  title={Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea.},
  author={Shim, Janet K and Johnson, Stuart and Samore, Matthew H and Bliss, Donna Z and Gerding, Dale N and others},
  journal={Lancet},
  volume={351},
  number={9103},
  pages={633},
  year={1998}
}

@article{nossa2010design,
  title={Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome},
  author={Nossa, Carlos W and Oberdorf, William E and Yang, Liying and Aas, J{\o}rn A and Paster, Bruce J and DeSantis, Todd Z and Brodie, Eoin L and Malamud, Daniel and Poles, Michael A and Pei, Zhiheng},
  journal={World journal of gastroenterology: WJG},
  volume={16},
  number={33},
  pages={4135},
  year={2010},
  publisher={Baishideng Publishing Group Co., Ltd.}
}

@article{snitkin2012tracking,
  title={Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing},
  author={Snitkin, Evan S and Zelazny, Adrian M and Thomas, Pamela J and Stock, Frida and Henderson, David K and Palmore, Tara N and Segre, Julia A and others},
  journal={Science Translational Medicine},
  volume={4},
  number={148},
  pages={148ra116--148ra116},
  year={2012},
  publisher={American Association for the Advancement of Science}
}

@article{samore1994clostridium,
  title={Clostridium difficile colonization and diarrhea at a tertiary care hospital},
  author={Samore, M.H. and DeGirolami, P.C. and Tlucko, A. and Lichtenberg, D.A. and Melvin, Z.A. and Karchmer, A.W.},
  journal={Clinical infectious diseases},
  volume={18},
  number={2},
  pages={181--187},
  year={1994},
  publisher={Oxford University Press}
}

@article{ryder2010assessment,
  title={Assessment of Clostridium difficile infections by quantitative detection of tcdB toxin by use of a real-time cell analysis system},
  author={Ryder, Alex B and Huang, Ying and Li, Haijing and Zheng, Min and Wang, Xiaobo and Stratton, Charles W and Xu, Xiao and Tang, Yi-Wei},
  journal={Journal of clinical microbiology},
  volume={48},
  number={11},
  pages={4129--4134},
  year={2010},
  publisher={Am Soc Microbiol}
}

@article{kuczynski2011experimental,
  title={Experimental and analytical tools for studying the human microbiome},
  author={Kuczynski, Justin and Lauber, Christian L and Walters, William A and Parfrey, Laura Wegener and Clemente, Jos{\'e} C and Gevers, Dirk and Knight, Rob},
  journal={Nature Reviews Genetics},
  volume={13},
  number={1},
  pages={47--58},
  year={2011},
  publisher={Nature Publishing Group}
}

@article{eckburg2005diversity,
  title={Diversity of the human intestinal microbial flora},
  author={Eckburg, Paul B and Bik, Elisabeth M and Bernstein, Charles N and Purdom, Elizabeth and Dethlefsen, Les and Sargent, Michael and Gill, Steven R and Nelson, Karen E and Relman, David A},
  journal={Science},
  volume={308},
  number={5728},
  pages={1635--1638},
  year={2005},
  publisher={American Association for the Advancement of Science}
}

@article{tringe2005metagenomics,
  title={Metagenomics: DNA sequencing of environmental samples},
  author={Tringe, Susannah Green and Rubin, Edward M},
  journal={Nature reviews genetics},
  volume={6},
  number={11},
  pages={805--814},
  year={2005},
  publisher={Nature Publishing Group}
}

@article{wilcox2012overcoming,
  title={Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection},
  author={Wilcox, MH},
  journal={Clinical Microbiology and Infection},
  volume={18},
  number={s6},
  pages={13--20},
  year={2012},
  publisher={Wiley Online Library}
}

@article{wilcox2012changing,
  title={Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England},
  author={Wilcox, MH and Shetty, N and Fawley, WN and Shemko, M and Coen, P and Birtles, A and Cairns, M and Curran, MD and Dodgson, KJ and Green, SM and others},
  journal={Clinical infectious diseases},
  volume={55},
  number={8},
  pages={1056--1063},
  year={2012},
  publisher={Oxford University Press}
}

@article{cordeiro2008breast,
  title={Breast reconstruction after surgery for breast cancer},
  author={Cordeiro, Peter G},
  journal={New England Journal of Medicine},
  volume={359},
  number={15},
  pages={1590--1601},
  year={2008},
  publisher={Mass Medical Soc}
}

@article{dethlefsen2007ecological,
  title={An ecological and evolutionary perspective on human--microbe mutualism and disease},
  author={Dethlefsen, Les and McFall-Ngai, Margaret and Relman, David A},
  journal={Nature},
  volume={449},
  number={7164},
  pages={811--818},
  year={2007},
  publisher={Nature Publishing Group}
}

@article{relman2012microbiology,
  title={Microbiology: Learning about who we are},
  author={Relman, David A},
  journal={Nature},
  volume={486},
  number={7402},
  pages={194--195},
  year={2012},
  publisher={Nature Publishing Group}
}

@article{chen2012human,
  title={Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer},
  author={Chen, Weiguang and Liu, Fanlong and Ling, Zongxin and Tong, Xiaojuan and Xiang, Charlie},
  journal={PloS one},
  volume={7},
  number={6},
  pages={e39743},
  year={2012},
  publisher={Public Library of Science}
}

@article{morgan2012dysfunction,
  title={Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment},
  author={Morgan, Xochitl C and Tickle, Timothy L and Sokol, Harry and Gevers, Dirk and Devaney, Kathryn L and Ward, Doyle V and Reyes, Joshua A and Shah, Samir A and LeLeiko, Neal and Snapper, Scott B and others},
  journal={Genome Biol},
  volume={13},
  number={9},
  pages={R79},
  year={2012}
}

@article{baden2005prophylactic,
  title={Prophylactic antimicrobial agents and the importance of fitness},
  author={Baden, Lindsey R},
  journal={New England Journal of Medicine},
  volume={353},
  number={10},
  pages={1052--1054},
  year={2005},
  publisher={Mass Medical Soc}
}

@article{lowy2010treatment,
  title={Treatment with monoclonal antibodies against Clostridium difficile toxins},
  author={Lowy, Israel and Molrine, Deborah C and Leav, Brett A and Blair, Barbra M and Baxter, Roger and Gerding, Dale N and Nichol, Geoffrey and Thomas Jr, William D and Leney, Mark and Sloan, Susan and others},
  journal={New England Journal of Medicine},
  volume={362},
  number={3},
  pages={197--205},
  year={2010},
  publisher={Mass Medical Soc}
}

@article{pamer2007immune,
  title={Immune responses to commensal and environmental microbes},
  author={Pamer, Eric G},
  journal={Nature immunology},
  volume={8},
  number={11},
  pages={1173--1178},
  year={2007},
  publisher={Nature Publishing Group}
}

@article{round2009gut,
  title={The gut microbiota shapes intestinal immune responses during health and disease},
  author={Round, June L and Mazmanian, Sarkis K},
  journal={Nature Reviews Immunology},
  volume={9},
  number={5},
  pages={313--323},
  year={2009},
  publisher={Nature Publishing Group}
}

@article{ray2012azithromycin,
  title={Azithromycin and the risk of cardiovascular death},
  author={Ray, Wayne A and Murray, Katherine T and Hall, Kathi and Arbogast, Patrick G and Stein, C Michael},
  journal={New England Journal of Medicine},
  volume={366},
  number={20},
  pages={1881--1890},
  year={2012},
  publisher={Mass Medical Soc}
}

@article{reeves2011interplay
,	author	= {Reeves, Angela E and Theriot, Casey M and Bergin, Ingrid L and Huffnagle, Gary B and Schloss, Patrick D and Young, Vincent B}
,	title	= {The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection.}
,	journal	= {Gut microbes}
,	volume	= {2}
,	number	= {3}
,	pages	= {145--58}
,	journal-iso	= {Gut Microbes}
,	pmid	= {21804357}
,	abstract	= {Clostridium difficile infection (CDI) arises in the setting of antibiotic administration where disruption of the normal indigenous gut microbiota leads to susceptibility to C. difficile colonization and colitis. Using a murine model of CDI, we demonstrate that changes in the community structure of the indigenous gut microbiota are associated with the loss of colonization resistance against C. difficile. Several antibiotic regimens were tested in combination for the ability to overcome colonization resistance, including a five antibiotic cocktail consisting of kanamycin, gentamicin, colistin, metronidazole, and vancomycin administered in drinking water for three days, a single intraperitoneal dose of clindamycin or 10 days of cefoperazone in drinking water. Following antibiotic treatment animals were challenged with 105 colony forming units of C. difficile strain VPI 10463 via oral gavage. Animals that received the antibiotic cocktail and clindamycin prior to C. difficile challenge followed one of two clinical courses, either becoming clinically ill and moribund within 2-4 days post challenge, or remaining clinically well. Animals that became clinically ill developed histologically severe colitis. These histopathologic findings were significantly less severe in animals that remained clinically well. Analysis of 16S rRNA gene sequences retrieved from gut tissue at necropsy demonstrated that Proteobacteria dominated the gut microbiota in clinically ill animals. In contrast, the gut microbial community of clinically well animals more closely resembled untreated animals, which were dominated by members of the Firmicutes. All animals that received cefoperazone treatment prior to C. difficile challenge were clinically ill and moribund by 2-5 days post challenge in a dose dependent manner. The gut communities in these animals were dominated by C.difficile suggesting that cefoperazone treatment resulted in a greater loss in colonization resistance. Thus, the severity of colitis that arises in this system reflects the interplay between the expansion of C. difficile in the gut community and the ecologic dynamics of the indigenous microbial community as it recovers from antibiotic perturbation. We demonstrate that altering the balance of these two opposing processes alters clinical outcome and thus may lead to novel preventative and therapeutic approaches for CDI.}
}

@article{vujkovic2013dysbiosis,
  title={Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism},
  author={Vujkovic-Cvijin, Ivan and Dunham, Richard M and Iwai, Shoko and Maher, Michael C and Albright, Rebecca G and Broadhurst, Mara J and Hernandez, Ryan D and Lederman, Michael M and Huang, Yong and Somsouk, Ma and others},
  journal={Science translational medicine},
  volume={5},
  number={193},
  pages={193ra91--193ra91},
  year={2013},
  publisher={American Association for the Advancement of Science}
}

@article{winter2013dynamics,
  title={The dynamics of gut-associated microbial communities during inflammation},
  author={Winter, Sebastian E and Lopez, Christopher A and B{\"a}umler, Andreas J},
  journal={EMBO reports},
  year={2013},
  publisher={Nature Publishing Group}
}

@article{jones1971mortality,
  title={Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras},
  author={Jones, J Miriam and Wilson, Raphael and Bealmear, Patricia M},
  journal={Radiation research},
  volume={45},
  number={3},
  pages={577--588},
  year={1971},
  publisher={Academic Press, Inc.}
}

@article{zirakzadeh2007vancomycin,
  title={Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients},
  author={Zirakzadeh, A and Gastineau, DA and Mandrekar, JN and Burke, JP and Johnston, PB and Patel, R},
  journal={Bone marrow transplantation},
  volume={41},
  number={4},
  pages={385--392},
  year={2007},
  publisher={Nature Publishing Group}
}

@article{storb1983graft,
  title={Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings: beneficial effect of a protective environment},
  author={Storb, Rainer and Prentice, Ross L and Buckner, C Dean and Clift, RA and Appelbaum, Fred and Deeg, Joachim and Doney, Kristine and Hansen, John A and Mason, Mark and Sanders, Jean E and others},
  journal={New England Journal of Medicine},
  volume={308},
  number={6},
  pages={302--307},
  year={1983},
  publisher={Mass Medical Soc}
}

@article{thomas2013penicillin,
  title={Penicillin to Prevent Recurrent Leg Cellulitis},
  author={Thomas, Kim S and Crook, Angela M and Nunn, Andrew J and Foster, Katharine A and Mason, James M and Chalmers, Joanne R and Nasr, Ibrahim S and Brindle, Richard J and English, John and Meredith, Sarah K and others},
  journal={New England Journal of Medicine},
  volume={368},
  number={18},
  pages={1695--1703},
  year={2013},
  publisher={Mass Medical Soc}
}

@article{furusawa2013commensal,
  title={Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells},
  author={Furusawa, Yukihiro and Obata, Yuuki and Fukuda, Shinji and Endo, Takaho A and Nakato, Gaku and Takahashi, Daisuke and Nakanishi, Yumiko and Uetake, Chikako and Kato, Keiko and Kato, Tamotsu and others},
  journal={Nature},
  year={2013},
  publisher={Nature Publishing Group}
}

@article{mcdonald2005epidemic,
  title={An epidemic, toxin gene--variant strain of Clostridium difficile},
  author={McDonald, L Clifford and Killgore, George E and Thompson, Angela and Owens Jr, Robert C and Kazakova, Sophia V and Sambol, Susan P and Johnson, Stuart and Gerding, Dale N},
  journal={New England Journal of Medicine},
  volume={353},
  number={23},
  pages={2433--2441},
  year={2005},
  publisher={Mass Medical Soc}
}

@article{turnbaugh2008core,
  title={A core gut microbiome in obese and lean twins},
  author={Turnbaugh, Peter J and Hamady, Micah and Yatsunenko, Tanya and Cantarel, Brandi L and Duncan, Alexis and Ley, Ruth E and Sogin, Mitchell L and Jones, William J and Roe, Bruce A and Affourtit, Jason P and others},
  journal={Nature},
  volume={457},
  number={7228},
  pages={480--484},
  year={2008},
  publisher={Nature Publishing Group}
}

@article{smith2013microbial,
  title={The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis},
  author={Smith, Patrick M and Howitt, Michael R and Panikov, Nicolai and Michaud, Monia and Gallini, Carey Ann and Bohlooly-Y, Mohammad and Glickman, Jonathan N and Garrett, Wendy S},
  journal={Science},
  volume={341},
  number={6145},
  pages={569--573},
  year={2013},
  publisher={American Association for the Advancement of Science}
}

@article{arpaia2013metabolites,
  title={Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation},
  author={Arpaia, Nicholas and Campbell, Clarissa and Fan, Xiying and Dikiy, Stanislav and van der Veeken, Joris and Liu, Hui and Cross, Justin R and Pfeffer, Klaus and Coffer, Paul J and Rudensky, Alexander Y and others},
  journal={Nature},
  year={2013},
  publisher={Nature Publishing Group}
}

@article{feero2011microbial,
  title={Microbial genomics and infectious diseases},
  author={Feero, W Gregory and Guttmacher, Alan E and Relman, David A},
  journal={New England Journal of Medicine},
  volume={365},
  number={4},
  pages={347--357},
  year={2011},
  publisher={Mass Medical Soc}
}

@article{platt1990perioperative,
  title={Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery},
  author={Platt, R and Zaleznik, DF and Hopkins, CC and Dellinger, EP and Karchmer, AW and Bryan, CS and Burke, JF and Wikler, MA and Marino, SK and Holbrook, KF and others},
  journal={New England Journal of Medicine},
  volume={322},
  number={3},
  pages={153--160},
  year={1990},
  publisher={Mass Medical Soc}
}

@article{pmid:24352797,
  title={2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8).},
  author={James, Paul A and Oparil, Suzanne and Carter, Barry L and Cushman, William C and Dennison-Himmelfarb, Cheryl and Handler, Joel and Lackland, Daniel T and Lefevre, Michael L and Mackenzie, Thomas D and Ogedegbe, Olugbenga and Smith, Sidney C and Svetkey, Laura P and Taler, Sandra J and Townsend, Raymond R and Wright, Jackson T and Narva, Andrew S and Ortiz, Eduardo},
  journal={JAMA : the journal of the American Medical Association},
  journal-iso={JAMA},
  year={2013},
  month={Dec},
  doi={10.1001/jama.2013.284427},
  pmid={24352797},
  abstract={Hypertension is the most common condition seen in primary care and leads to myocardial infarction, stroke, renal failure, and death if not detected early and treated appropriately. Patients want to be assured that blood pressure (BP) treatment will reduce their disease burden, while clinicians want guidance on hypertension management using the best scientific evidence. This report takes a rigorous, evidence-based approach to recommend treatment thresholds, goals, and medications in the management of hypertension in adults. Evidence was drawn from randomized controlled trials, which represent the gold standard for determining efficacy and effectiveness. Evidence quality and recommendations were graded based on their effect on important outcomes. There is strong evidence to support treating hypertensive persons aged 60 years or older to a BP goal of less than 150/90 mm Hg and hypertensive persons 30 through 59 years of age to a diastolic goal of less than 90 mm Hg; however, there is insufficient evidence in hypertensive persons younger than 60 years for a systolic goal, or in those younger than 30 years for a diastolic goal, so the panel recommends a BP of less than 140/90 mm Hg for those groups based on expert opinion. The same thresholds and goals are recommended for hypertensive adults with diabetes or nondiabetic chronic kidney disease (CKD) as for the general hypertensive population younger than 60 years. There is moderate evidence to support initiating drug treatment with an angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, calcium channel blocker, or thiazide-type diuretic in the nonblack hypertensive population, including those with diabetes. In the black hypertensive population, including those with diabetes, a calcium channel blocker or thiazide-type diuretic is recommended as initial therapy. There is moderate evidence to support initial or add-on antihypertensive therapy with an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in persons with CKD to improve kidney outcomes. Although this guideline provides evidence-based recommendations for the management of high BP and should meet the clinical needs of most patients, these recommendations are not a substitute for clinical judgment, and decisions about care must carefully consider and incorporate the clinical characteristics and circumstances of each individual patient.}
}


% BEGIN:Original PubMed XML
%  <PubmedArticle>
%    <MedlineCitation Status="Publisher" Owner="NLM">
%      <PMID Version="1">24352797</PMID>
%      <DateCreated>
%        <Year>2013</Year>
%        <Month>12</Month>
%        <Day>19</Day>
%      </DateCreated>
%      <Article PubModel="Print-Electronic">
%        <Journal>
%          <ISSN IssnType="Electronic">1538-3598</ISSN>
%          <JournalIssue CitedMedium="Internet">
%            <PubDate>
%              <Year>2013</Year>
%              <Month>Dec</Month>
%              <Day>18</Day>
%            </PubDate>
%          </JournalIssue>
%          <Title>JAMA : the journal of the American Medical Association</Title>
%          <ISOAbbreviation>JAMA</ISOAbbreviation>
%        </Journal>
%        <ArticleTitle>2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8).</ArticleTitle>
%        <Pagination>
%          <MedlinePgn />
%        </Pagination>
%        <ELocationID EIdType="doi">10.1001/jama.2013.284427</ELocationID>
%        <Abstract>
%          <AbstractText NlmCategory="UNLABELLED">Hypertension is the most common condition seen in primary care and leads to myocardial infarction, stroke, renal failure, and death if not detected early and treated appropriately. Patients want to be assured that blood pressure (BP) treatment will reduce their disease burden, while clinicians want guidance on hypertension management using the best scientific evidence. This report takes a rigorous, evidence-based approach to recommend treatment thresholds, goals, and medications in the management of hypertension in adults. Evidence was drawn from randomized controlled trials, which represent the gold standard for determining efficacy and effectiveness. Evidence quality and recommendations were graded based on their effect on important outcomes. There is strong evidence to support treating hypertensive persons aged 60 years or older to a BP goal of less than 150/90 mm Hg and hypertensive persons 30 through 59 years of age to a diastolic goal of less than 90 mm Hg; however, there is insufficient evidence in hypertensive persons younger than 60 years for a systolic goal, or in those younger than 30 years for a diastolic goal, so the panel recommends a BP of less than 140/90 mm Hg for those groups based on expert opinion. The same thresholds and goals are recommended for hypertensive adults with diabetes or nondiabetic chronic kidney disease (CKD) as for the general hypertensive population younger than 60 years. There is moderate evidence to support initiating drug treatment with an angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, calcium channel blocker, or thiazide-type diuretic in the nonblack hypertensive population, including those with diabetes. In the black hypertensive population, including those with diabetes, a calcium channel blocker or thiazide-type diuretic is recommended as initial therapy. There is moderate evidence to support initial or add-on antihypertensive therapy with an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in persons with CKD to improve kidney outcomes. Although this guideline provides evidence-based recommendations for the management of high BP and should meet the clinical needs of most patients, these recommendations are not a substitute for clinical judgment, and decisions about care must carefully consider and incorporate the clinical characteristics and circumstances of each individual patient.</AbstractText>
%        </Abstract>
%        <AuthorList>
%          <Author>
%            <LastName>James</LastName>
%            <ForeName>Paul A</ForeName>
%            <Initials>PA</Initials>
%            <Affiliation>University of Iowa, Iowa City.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Oparil</LastName>
%            <ForeName>Suzanne</ForeName>
%            <Initials>S</Initials>
%            <Affiliation>University of Alabama at Birmingham School of Medicine.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Carter</LastName>
%            <ForeName>Barry L</ForeName>
%            <Initials>BL</Initials>
%            <Affiliation>University of Iowa, Iowa City.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Cushman</LastName>
%            <ForeName>William C</ForeName>
%            <Initials>WC</Initials>
%            <Affiliation>Memphis Veterans Affairs Medical Center and the University of Tennessee, Memphis.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Dennison-Himmelfarb</LastName>
%            <ForeName>Cheryl</ForeName>
%            <Initials>C</Initials>
%            <Affiliation>Johns Hopkins University School of Nursing, Baltimore, Maryland.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Handler</LastName>
%            <ForeName>Joel</ForeName>
%            <Initials>J</Initials>
%            <Affiliation>Kaiser Permanente, Anaheim, California.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Lackland</LastName>
%            <ForeName>Daniel T</ForeName>
%            <Initials>DT</Initials>
%            <Affiliation>Medical University of South Carolina, Charleston.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Lefevre</LastName>
%            <ForeName>Michael L</ForeName>
%            <Initials>ML</Initials>
%            <Affiliation>University of Missouri, Columbia.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Mackenzie</LastName>
%            <ForeName>Thomas D</ForeName>
%            <Initials>TD</Initials>
%            <Affiliation>Denver Health and Hospital Authority and the University of Colorado School of Medicine, Denver.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Ogedegbe</LastName>
%            <ForeName>Olugbenga</ForeName>
%            <Initials>O</Initials>
%            <Affiliation>New York University School of Medicine, New York, New York.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Smith</LastName>
%            <ForeName>Sidney C</ForeName>
%            <Initials>SC</Initials>
%            <Suffix>Jr</Suffix>
%            <Affiliation>University of North Carolina at Chapel Hill.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Svetkey</LastName>
%            <ForeName>Laura P</ForeName>
%            <Initials>LP</Initials>
%            <Affiliation>Duke University, Durham, North Carolina.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Taler</LastName>
%            <ForeName>Sandra J</ForeName>
%            <Initials>SJ</Initials>
%            <Affiliation>Mayo Clinic College of Medicine, Rochester, Minnesota.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Townsend</LastName>
%            <ForeName>Raymond R</ForeName>
%            <Initials>RR</Initials>
%            <Affiliation>University of Pennsylvania, Philadelphia.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Wright</LastName>
%            <ForeName>Jackson T</ForeName>
%            <Initials>JT</Initials>
%            <Suffix>Jr</Suffix>
%            <Affiliation>Case Western Reserve University, Cleveland, Ohio.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Narva</LastName>
%            <ForeName>Andrew S</ForeName>
%            <Initials>AS</Initials>
%            <Affiliation>National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.</Affiliation>
%          </Author>
%          <Author>
%            <LastName>Ortiz</LastName>
%            <ForeName>Eduardo</ForeName>
%            <Initials>E</Initials>
%            <Affiliation>at the time of the project,National Heart, Lung, and Blood Institute, Bethesda, Maryland17currently with ProVation Medical, Wolters Kluwer Health, Minneapolis, Minnesota.</Affiliation>
%          </Author>
%        </AuthorList>
%        <Language>ENG</Language>
%        <PublicationTypeList>
%          <PublicationType>JOURNAL ARTICLE</PublicationType>
%        </PublicationTypeList>
%        <ArticleDate DateType="Electronic">
%          <Year>2013</Year>
%          <Month>12</Month>
%          <Day>18</Day>
%        </ArticleDate>
%      </Article>
%      <MedlineJournalInfo>
%        <MedlineTA>JAMA</MedlineTA>
%        <NlmUniqueID>7501160</NlmUniqueID>
%        <ISSNLinking>0098-7484</ISSNLinking>
%      </MedlineJournalInfo>
%    </MedlineCitation>
%    <PubmedData>
%      <History>
%        <PubMedPubDate PubStatus="entrez">
%          <Year>2013</Year>
%          <Month>12</Month>
%          <Day>20</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="pubmed">
%          <Year>2013</Year>
%          <Month>12</Month>
%          <Day>20</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="medline">
%          <Year>2013</Year>
%          <Month>12</Month>
%          <Day>20</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%      </History>
%      <PublicationStatus>aheadofprint</PublicationStatus>
%      <ArticleIdList>
%        <ArticleId IdType="pii">1791497</ArticleId>
%        <ArticleId IdType="doi">10.1001/jama.2013.284427</ArticleId>
%        <ArticleId IdType="pubmed">24352797</ArticleId>
%      </ArticleIdList>
%    </PubmedData>
%  </PubmedArticle>
% END:Original PubMed XML


@article{almyroudis2005pre,
  title={Pre-and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients},
  author={Almyroudis, NG and Fuller, A and Jakubowski, A and Sepkowitz, K and Jaffe, D and Small, TN and Kiehn, TE and Pamer, E and Papanicolaou, GA},
  journal={Transplant infectious disease},
  volume={7},
  number={1},
  pages={11--17},
  year={2005},
  publisher={Wiley Online Library}
}

@article{pattani2013probiotics,
  title={Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis},
  author={Pattani, Reena and Palda, Valerie A and Hwang, Stephen W and Shah, Prakeshkumar S},
  journal={Open Medicine},
  volume={7},
  number={2},
  pages={56--67},
  year={2013}
}

@article{goldenberg2013probiotics,
  title={Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children},
  author={Goldenberg, Joshua Z and Ma, Stephanie SY and Saxton, Jane D and Martzen, Mark R and Vandvik, Per O and Thorlund, Kristian and Guyatt, Gordon H and Johnston, Bradley C},
  journal={status and date: New, published in},
  number={5},
  year={2013},
  publisher={Wiley Online Library}
}

@article{d2002probiotics,
  title={Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis},
  author={D'Souza, Aloysius L and Rajkumar, Chakravarthi and Cooke, Jonathan and Bulpitt, Christopher J},
  journal={Bmj},
  volume={324},
  number={7350},
  pages={1361},
  year={2002},
  publisher={BMJ}
}

@article{manichanh2010reshaping,
  title={Reshaping the gut microbiome with bacterial transplantation and antibiotic intake},
  author={Manichanh, Chaysavanh and Reeder, Jens and Gibert, Prudence and Varela, Encarna and Llopis, Marta and Antolin, Maria and Guigo, Roderic and Knight, Rob and Guarner, Francisco},
  journal={Genome research},
  volume={20},
  number={10},
  pages={1411--1419},
  year={2010},
  publisher={Cold Spring Harbor Lab}
}

@article{blaser2009consequences,
  title={What are the consequences of the disappearing human microbiota?},
  author={Blaser, Martin J and Falkow, Stanley},
  journal={Nature Reviews Microbiology},
  volume={7},
  number={12},
  pages={887--894},
  year={2009},
  publisher={Nature Publishing Group}
}

@article{gerding2008treatment,
  title={Treatment of Clostridium difficile infection},
  author={Gerding, Dale N and Muto, Carlene A and Owens, Robert C},
  journal={Clinical Infectious Diseases},
  volume={46},
  number={Supplement 1},
  pages={S32--S42},
  year={2008},
  publisher={Oxford University Press}
}

@article{strachan1989hay,
  title={Hay fever, hygiene, and household size.},
  author={Strachan, David P},
  journal={BMJ: British Medical Journal},
  volume={299},
  number={6710},
  pages={1259},
  year={1989},
  publisher={BMJ Group}
}

@article{lee2010genomic,
  title={Genomic insights into bifidobacteria},
  author={Lee, Ju-Hoon and O'Sullivan, Daniel J},
  journal={Microbiology and Molecular Biology Reviews},
  volume={74},
  number={3},
  pages={378--416},
  year={2010},
  publisher={Am Soc Microbiol}
}

@article{hopkins2003nondigestible,
  title={Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro},
  author={Hopkins, Mark J and Macfarlane, George T},
  journal={Applied and environmental microbiology},
  volume={69},
  number={4},
  pages={1920--1927},
  year={2003},
  publisher={Am Soc Microbiol}
}

@article{reid2010microbiota,
  title={Microbiota restoration: natural and supplemented recovery of human microbial communities},
  author={Reid, Gregor and Younes, Jessica A and Van der Mei, Henny C and Gloor, Gregory B and Knight, Rob and Busscher, Henk J},
  journal={Nature Reviews Microbiology},
  volume={9},
  number={1},
  pages={27--38},
  year={2010},
  publisher={Nature Publishing Group}
}

@article{mcfarland2006meta,
  title={Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease},
  author={McFarland, Lynne V},
  journal={The American journal of gastroenterology},
  volume={101},
  number={4},
  pages={812--822},
  year={2006},
  publisher={Nature Publishing Group}
}

@comment { BIBTEX_AUTO - GS }
@article{pmid:2566734,
  title={Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients.},
  author={Tvede, M and Rask-Madsen, J},
  journal={Lancet (London, England)},
  journal-iso={Lancet},
  volume={1},
  number={8648},
  year={1989},
  month={May},
  pages={1156--60},
  pmid={2566734},
  abstract={Six patients with chronic relapsing diarrhoea caused by Clostridium difficile were treated with rectal instillation of homologous faeces (one patient) or a mixture of ten different facultatively aerobic and anaerobic bacteria diluted in sterile saline (five patients). The mixture led to a prompt loss of Cl difficile and its toxin from the stools and to bowel colonisation by Bacteroides sp, which had not been present in pre-treatment stool samples. Strains of Escherichia coli, Cl bifermentans, and Peptostreptococcus productus in the mixture inhibited the in-vitro growth of Cl difficile, which in turn inhibited the growth of Bacteroides ovatus, Bacteroides vulgatus, and Bacteroides thetaiotaomicron. The finding that Bacteroides sp had been absent during the patients' illness but was present after recovery suggests that the absence of Bacteroides sp may result in chronic relapsing Cl difficile diarrhoea, and that its presence may prevent colonisation by Cl difficile.}
}


% BEGIN:Original PubMed XML
%  <PubmedArticle>
%    <MedlineCitation Owner="NLM" Status="MEDLINE">
%      <PMID Version="1">2566734</PMID>
%      <DateCreated>
%        <Year>1989</Year>
%        <Month>06</Month>
%        <Day>28</Day>
%      </DateCreated>
%      <DateCompleted>
%        <Year>1989</Year>
%        <Month>06</Month>
%        <Day>28</Day>
%      </DateCompleted>
%      <DateRevised>
%        <Year>2015</Year>
%        <Month>06</Month>
%        <Day>16</Day>
%      </DateRevised>
%      <Article PubModel="Print">
%        <Journal>
%          <ISSN IssnType="Print">0140-6736</ISSN>
%          <JournalIssue CitedMedium="Print">
%            <Volume>1</Volume>
%            <Issue>8648</Issue>
%            <PubDate>
%              <Year>1989</Year>
%              <Month>May</Month>
%              <Day>27</Day>
%            </PubDate>
%          </JournalIssue>
%          <Title>Lancet (London, England)</Title>
%          <ISOAbbreviation>Lancet</ISOAbbreviation>
%        </Journal>
%        <ArticleTitle>Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients.</ArticleTitle>
%        <Pagination>
%          <MedlinePgn>1156-60</MedlinePgn>
%        </Pagination>
%        <Abstract>
%          <AbstractText>Six patients with chronic relapsing diarrhoea caused by Clostridium difficile were treated with rectal instillation of homologous faeces (one patient) or a mixture of ten different facultatively aerobic and anaerobic bacteria diluted in sterile saline (five patients). The mixture led to a prompt loss of Cl difficile and its toxin from the stools and to bowel colonisation by Bacteroides sp, which had not been present in pre-treatment stool samples. Strains of Escherichia coli, Cl bifermentans, and Peptostreptococcus productus in the mixture inhibited the in-vitro growth of Cl difficile, which in turn inhibited the growth of Bacteroides ovatus, Bacteroides vulgatus, and Bacteroides thetaiotaomicron. The finding that Bacteroides sp had been absent during the patients' illness but was present after recovery suggests that the absence of Bacteroides sp may result in chronic relapsing Cl difficile diarrhoea, and that its presence may prevent colonisation by Cl difficile.</AbstractText>
%        </Abstract>
%        <AuthorList CompleteYN="Y">
%          <Author ValidYN="Y">
%            <LastName>Tvede</LastName>
%            <ForeName>M</ForeName>
%            <Initials>M</Initials>
%            <AffiliationInfo>
%              <Affiliation>Department of Clinical Microbiology, Rigshospitalet, Statens Seruminstitut, Denmark.</Affiliation>
%            </AffiliationInfo>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Rask-Madsen</LastName>
%            <ForeName>J</ForeName>
%            <Initials>J</Initials>
%          </Author>
%        </AuthorList>
%        <Language>eng</Language>
%        <PublicationTypeList>
%          <PublicationType UI="D016428">Journal Article</PublicationType>
%        </PublicationTypeList>
%      </Article>
%      <MedlineJournalInfo>
%        <Country>ENGLAND</Country>
%        <MedlineTA>Lancet</MedlineTA>
%        <NlmUniqueID>2985213R</NlmUniqueID>
%        <ISSNLinking>0140-6736</ISSNLinking>
%      </MedlineJournalInfo>
%      <CitationSubset>AIM</CitationSubset>
%      <CitationSubset>IM</CitationSubset>
%      <CommentsCorrectionsList>
%        <CommentsCorrections RefType="CommentIn">
%          <RefSource>Lancet. 1989 Sep 2;2(8662):558</RefSource>
%          <PMID Version="1">2570250</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="CommentIn">
%          <RefSource>Lancet. 1989 Nov 4;2(8671):1096</RefSource>
%          <PMID Version="1">2572812</PMID>
%        </CommentsCorrections>
%      </CommentsCorrectionsList>
%      <MeshHeadingList>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" UI="D000285">Administration, Rectal</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="Y" UI="D001419">Bacteria</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" UI="D001439">Bacteroides</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" UI="D002908">Chronic Disease</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" UI="D003013">Clostridium</DescriptorName>
%          <QualifierName MajorTopicYN="N" UI="Q000254">growth &amp; development</QualifierName>
%          <QualifierName MajorTopicYN="N" UI="Q000302">isolation &amp; purification</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" UI="D003015">Clostridium Infections</DescriptorName>
%          <QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
%          <QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" UI="D003967">Diarrhea</DescriptorName>
%          <QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
%          <QualifierName MajorTopicYN="Y" UI="Q000628">therapy</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" UI="D004733">Enema</DescriptorName>
%          <QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="Y" UI="D005243">Feces</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" UI="D012008">Recurrence</DescriptorName>
%        </MeshHeading>
%      </MeshHeadingList>
%    </MedlineCitation>
%    <PubmedData>
%      <History>
%        <PubMedPubDate PubStatus="pubmed">
%          <Year>1989</Year>
%          <Month>5</Month>
%          <Day>27</Day>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="medline">
%          <Year>1989</Year>
%          <Month>5</Month>
%          <Day>27</Day>
%          <Hour>0</Hour>
%          <Minute>1</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="entrez">
%          <Year>1989</Year>
%          <Month>5</Month>
%          <Day>27</Day>
%          <Hour>0</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%      </History>
%      <PublicationStatus>ppublish</PublicationStatus>
%      <ArticleIdList>
%        <ArticleId IdType="pubmed">2566734</ArticleId>
%        <ArticleId IdType="pii">S0140-6736(89)92749-9</ArticleId>
%      </ArticleIdList>
%    </PubmedData>
%  </PubmedArticle>
% END:Original PubMed XML


@article{kelly2013fecal,
  title={Fecal microbiota transplantation--an old therapy comes of age},
  author={Kelly, Ciar{\'a}n P and others},
  journal={N Engl J Med},
  volume={368},
  number={5},
  pages={474--5},
  year={2013}
}

@article{louie2011fidaxomicin,
  title={Fidaxomicin versus vancomycin for Clostridium difficile infection},
  author={Louie, Thomas J and Miller, Mark A and Mullane, Kathleen M and Weiss, Karl and Lentnek, Arnold and Golan, Yoav and Gorbach, Sherwood and Sears, Pamela and Shue, Youe-Kong},
  journal={New England Journal of Medicine},
  volume={364},
  number={5},
  pages={422--431},
  year={2011},
  publisher={Mass Medical Soc}
}

@article{mullane2011efficacy,
  title={Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections},
  author={Mullane, Kathleen M and Miller, Mark A and Weiss, Karl and Lentnek, Arnold and Golan, Yoav and Sears, Pamela S and Shue, Youe-Kong and Louie, Thomas J and Gorbach, Sherwood L},
  journal={Clinical infectious diseases},
  volume={53},
  number={5},
  pages={440--447},
  year={2011},
  publisher={Oxford University Press}
}

@article{cohen2010clinical,
  title={Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)},
  author={Cohen, Stuart H and Gerding, Dale N and Johnson, Stuart and Kelly, Ciaran P and Loo, Vivian G and L Clifford McDonald, MD and Pepin, Jacques and Wilcox, Mark H},
  journal={infection control and hospital epidemiology},
  volume={31},
  number={5},
  pages={431--455},
  year={2010},
  publisher={JSTOR}
}

@article{kaltsas2012clinical
,	author	= {Kaltsas, Anna and Simon, Matt and Unruh, Larissa H and Son, Crystal and Wroblewski, Danielle and Musser, Kimberlee A and Sepkowitz, Kent and Babady, N Esther and Kamboj, Mini}
,	title	= {Clinical and laboratory characteristics of Clostridium difficile infection in patients with discordant diagnostic test results.}
,	journal	= {Journal of clinical microbiology}
,	year	= {2012}
,	volume	= {50}
,	number	= {4}
,	pages	= {1303--7}
,	month	= {Apr}
,	journal-iso	= {J. Clin. Microbiol.}
,	doi	= {10.1128/JCM.05711-11}
,	pmid	= {22238444}
,	abstract	= {The aim of this study was to compare the clinical and laboratory characteristics of Clostridium difficile infection (CDI) in patients with discordant test results for the cytotoxin assay (CYT) and PCR assays. A retrospective study from May to August 2008 and March to May 2010 was performed. CDI was diagnosed in 128 patients. PCR increased the yield of C. difficile cases by 2-fold compared to that of the CYT assay. Fifty-six cases (44%) were detected by PCR only (CYT negative). Forty-nine percent of patients with non-NAP1 strains were detected by PCR only, compared to 28% of those infected with NAP1 strains (P < 0.05). No significant differences were found in the clinical severity of illness and outcome among patients that tested positive for CDI by both tests (CYT and PCR) compared to those that tested positive by PCR only.}
}

@article{curry2013use,
  title={Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission},
  author={Curry, Scott R and Muto, Carlene A and Schlackman, Jessica L and Pasculle, A William and Shutt, Kathleen A and Marsh, Jane W and Harrison, Lee H},
  journal={Clinical infectious diseases},
  volume={57},
  number={8},
  pages={1094--1102},
  year={2013},
  publisher={Oxford University Press}
}

@article{curry2013use,
  title={Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission},
  author={Curry, Scott R and Muto, Carlene A and Schlackman, Jessica L and Pasculle, A William and Shutt, Kathleen A and Marsh, Jane W and Harrison, Lee H},
  journal={Clinical infectious diseases},
  volume={57},
  number={8},
  pages={1094--1102},
  year={2013},
  publisher={Oxford University Press}
}

@article{mcfarland2002breaking,
  title={Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease},
  author={McFarland, Lynne V and Elmer, Gary W and Surawicz, Christina M},
  journal={The American journal of gastroenterology},
  volume={97},
  number={7},
  pages={1769--1775},
  year={2002},
  publisher={Nature Publishing Group}
}

@article{deakin2012clostridium,
  title={The Clostridium difficile spo0A gene is a persistence and transmission factor},
  author={Deakin, Laura J and Clare, Simon and Fagan, Robert P and Dawson, Lisa F and Pickard, Derek J and West, Michael R and Wren, Brendan W and Fairweather, Neil F and Dougan, Gordon and Lawley, Trevor D},
  journal={Infection and immunity},
  volume={80},
  number={8},
  pages={2704--2711},
  year={2012},
  publisher={Am Soc Microbiol}
}

@article{sorg2008bile,
  title={Bile salts and glycine as cogerminants for Clostridium difficile spores},
  author={Sorg, Joseph A and Sonenshein, Abraham L},
  journal={Journal of bacteriology},
  volume={190},
  number={7},
  pages={2505--2512},
  year={2008},
  publisher={Am Soc Microbiol}
}

@article{wardwell2011current,
  title={Current concepts of the intestinal microbiota and the pathogenesis of infection},
  author={Wardwell, Leslie H and Huttenhower, Curtis and Garrett, Wendy S},
  journal={Current infectious disease reports},
  volume={13},
  number={1},
  pages={28--34},
  year={2011},
  publisher={Springer}
}

@article{koren2013guide,
  title={A guide to enterotypes across the human body: Meta-analysis of microbial community structures in human microbiome datasets},
  author={Koren, Omry and Knights, Dan and Gonzalez, Antonio and Waldron, Levi and Segata, Nicola and Knight, Rob and Huttenhower, Curtis and Ley, Ruth E},
  journal={PLoS computational biology},
  volume={9},
  number={1},
  pages={e1002863},
  year={2013},
  publisher={Public Library of Science}
}

@article{fimlaid2013global,
  title={Global analysis of the sporulation pathway of Clostridium difficile},
  author={Fimlaid, Kelly A and Bond, Jeffrey P and Schutz, Kristin C and Putnam, Emily E and Leung, Jacqueline M and Lawley, Trevor D and Shen, Aimee},
  journal={PLoS genetics},
  volume={9},
  number={8},
  pages={e1003660},
  year={2013},
  publisher={Public Library of Science}
}

@article{avery2000high,
  title={High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients},
  author={Avery, R and Pohlman, B and Adal, K and Bolwell, B and Goldman, M and Kalaycio, M and Hall, G and Andresen, S and Mossad, S and Schmitt, S and others},
  journal={Bone marrow transplantation},
  volume={25},
  number={1},
  pages={67--69},
  year={2000},
  publisher={Nature Publishing Group}
}

@article{arumugam2011enterotypes,
  title={Enterotypes of the human gut microbiome},
  author={Arumugam, Manimozhiyan and Raes, Jeroen and Pelletier, Eric and Le Paslier, Denis and Yamada, Takuji and Mende, Daniel R and Fernandes, Gabriel R and Tap, Julien and Bruls, Thomas and Batto, Jean-Michel and others},
  journal={Nature},
  volume={473},
  number={7346},
  pages={174--180},
  year={2011},
  publisher={Nature Publishing Group}
}

@article{teshima2012gvhd,
  title={GVHD-associated immunodeficiency: soil or seed?},
  author={Teshima, T.},
  journal={Blood},
  volume={119},
  number={24},
  pages={5618--5619},
  year={2012},
  publisher={American Society of Hematology}
}

@article{kontoyiannis2011treat,
  title={How I treat mucormycosis},
  author={Kontoyiannis, Dimitrios P and Lewis, Russell E},
  journal={Blood},
  volume={118},
  number={5},
  pages={1216--1224},
  year={2011},
  publisher={American Society of Hematology}
}

@article{francis2013bile,
  title={Bile Acid Recognition by the Clostridium difficile Germinant Receptor, CspC, Is Important for Establishing Infection},
  author={Francis, Michael B and Allen, Charlotte A and Shrestha, Ritu and Sorg, Joseph A},
  journal={PLoS pathogens},
  volume={9},
  number={5},
  pages={e1003356},
  year={2013},
  publisher={Public Library of Science}
}

@article{naaber2011quantification,
  title={Quantification of Clostridium difficile in antibiotic-associated-diarrhea patients},
  author={Naaber, Paul and {\v{S}}t{\v{s}}epetova, Jelena and Smidt, Imbi and R{\"a}tsep, Merle and K{\~o}ljalg, Siiri and L{\~o}ivukene, Krista and Jaanim{\"a}e, Liis and L{\"o}hr, Iren H and Nat{\aa}s, Olav B and Truusalu, Kai and others},
  journal={Journal of clinical microbiology},
  volume={49},
  number={10},
  pages={3656--3658},
  year={2011},
  publisher={Am Soc Microbiol}
}

@article{rowlings1997ibmtr,
  title={IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade.},
  author={Rowlings, PA and Przepiorka, D and Klein, JP and Gale, RP and Passweg, JR and Henslee-Downey, PJ and Cahn, JY and Calderwood, S and Gratwohl, A and Soci{\'e}, G and others},
  journal={British journal of haematology},
  volume={97},
  number={4},
  pages={855},
  year={1997}
}

@article{chopra2011recent
,	author	= {Chopra, Teena and Chandrasekar, Pranatharthi and Salimnia, Hossein and Heilbrun, Lance K and Smith, Daryn and Alangaden, George J}
,	title	= {Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation.}
,	journal	= {Clinical transplantation}
,	volume	= {25}
,	number	= {1}
,	pages	= {E82--7}
,	journal-iso	= {Clin Transplant}
,	doi	= {10.1111/j.1399-0012.2010.01331.x}
,	pmid	= {20973823}
,	abstract	= {Given the limited information on Clostridium difficile infection (CDI) during hematopoietic stem cell transplantation (HSCT), we examined the recent epidemiology of CDI in HSCT recipients at our institution. During the two-yr retrospective study period (2005-2006), 361 transplants were performed: 60% allogeneic and 40% autologous. Among all hospitalized patients in a non-outbreak setting, CDI rates in HSCT recipients were ninefold higher than those in general patients and 1.4-fold higher than those in patients with cancer (24.0 vs. 2.6 vs. 16.8/10,000 patient-days respectively). Sixty-two episodes of CDI occurred in 51 (14%) HSCT recipients: 39 (18%) allogeneic vs. 12 (8%) autologous (p = 0.01). Almost half of CDI episodes occurred within 30 d post-HSCT and 22% before HSCT. Clostridium difficile toxin assay was initially positive in 28% of the first, 31% of the second and 27% of the third stool samples tested. All but one patient responded to therapy with metronidazole or vancomycin. Severe CDI occurred in one patient and recurrent CDI in two patients. CDI is common during HSCT especially in allogeneic transplants during the peri-HSCT period. Prospective studies to better define the epidemiology and identify unique risk factors for CDI and more accurate tests to confirm the diagnosis in this population are needed.© 2010 John Wiley & Sons A/S.}
}

@article{chakrabarti2000clostridium
,	author	= {Chakrabarti, S and Lees, A and Jones, S G and Milligan, D W}
,	title	= {Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality.}
,	journal	= {Bone marrow transplantation}
,	year	= {2000}
,	volume	= {26}
,	number	= {8}
,	pages	= {871--6}
,	month	= {Oct}
,	journal-iso	= {Bone Marrow Transplant.}
,	pmid	= {11081387}
,	abstract	= {We retrospectively evaluated 75 allogeneic stem cell transplant recipients to ascertain the incidence, risk factors and outcome of infection with Clostridium difficile. Ten patients (13%) had Clostridium difficile infection at a median of 38 days (range day -6 to day +72) following the transplant. There was no difference in the duration or severity of diarrhoea in patients with Clostridium difficile infection compared to the uninfected patients and no relationship to the prior antibiotic or chemotherapy usage, age, gender, underlying disease, donor type, CMV serostatus, total body irradiation or time to engraftment. The incidence of viral infections was increased in patients infected with Clostridium difficile (7/10 vs 15/65, P = 0.005, odds ratio 7.7), but the strongest association was with GVHD >grade 2 (5/10 vs 6/65 uninfected patients, P = 0.004, odds ratio 9.8). Patients infected with Clostridium difficile also suffered a higher non-relapse mortality with 7/10 patients succumbing to either GVHD or infections, compared to 19/65 patients in the uninfected group (P = 0.02, odds ratio 5.6). Thus Clostridium difficile infections in our study had a strong association with GVHD and increased non-relapse mortality. It is possible that Clostridium difficile toxin might predispose to increased severity of GVHD leading to an adverse outcome.}
}

@article{nerandzic2012reduced,
  title={Reduced acquisition and overgrowth of vancomycin-resistant enterococci and candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection},
  author={Nerandzic, Michelle M and Mullane, Kathleen and Miller, Mark A and Babakhani, Farah and Donskey, Curtis J},
  journal={Clinical infectious diseases},
  volume={55},
  number={suppl 2},
  pages={S121--S126},
  year={2012},
  publisher={Oxford University Press}
}

@article{ley2010obesity,
  title={Obesity and the human microbiome},
  author={Ley, Ruth E},
  journal={Current opinion in gastroenterology},
  volume={26},
  number={1},
  pages={5--11},
  year={2010},
  publisher={LWW}
}

@article{subbaramaiah2012increased,
  title={Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women},
  author={Subbaramaiah, Kotha and Morris, Patrick G and Zhou, Xi Kathy and Morrow, Monica and Du, Baoheng and Giri, Dilip and Kopelovich, Levy and Hudis, Clifford A and Dannenberg, Andrew J},
  journal={Cancer discovery},
  volume={2},
  number={4},
  pages={356--365},
  year={2012},
  publisher={AACR}
}

@article{pmid:21258094,
  title={Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.},
  author={Freifeld, Alison G and Bow, Eric J and Sepkowitz, Kent A and Boeckh, Michael J and Ito, James I and Mullen, Craig A and Raad, Issam I and Rolston, Kenneth V and Young, Jo-Anne H and Wingard, John R and Infectious Diseases Society of America},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  journal-iso={Clin. Infect. Dis.},
  volume={52},
  number={4},
  year={2011},
  month={Feb},
  pages={e56--93},
  doi={10.1093/cid/cir073},
  pmid={21258094},
  abstract={This document updates and expands the initial Infectious Diseases Society of America (IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in 2002. It is intended as a guide for the use of antimicrobial agents in managing patients with cancer who experience chemotherapy-induced fever and neutropenia. Recent advances in antimicrobial drug development and technology, clinical trial results, and extensive clinical experience have informed the approaches and recommendations herein. Because the previous iteration of this guideline in 2002, we have a developed a clearer definition of which populations of patients with cancer may benefit most from antibiotic, antifungal, and antiviral prophylaxis. Furthermore, categorizing neutropenic patients as being at high risk or low risk for infection according to presenting signs and symptoms, underlying cancer, type of therapy, and medical comorbidities has become essential to the treatment algorithm. Risk stratification is a recommended starting point for managing patients with fever and neutropenia. In addition, earlier detection of invasive fungal infections has led to debate regarding optimal use of empirical or preemptive antifungal therapy, although algorithms are still evolving. What has not changed is the indication for immediate empirical antibiotic therapy. It remains true that all patients who present with fever and neutropenia should be treated swiftly and broadly with antibiotics to treat both gram-positive and gram-negative pathogens. Finally, we note that all Panel members are from institutions in the United States or Canada; thus, these guidelines were developed in the context of North American practices. Some recommendations may not be as applicable outside of North America, in areas where differences in available antibiotics, in the predominant pathogens, and/or in health care-associated economic conditions exist. Regardless of venue, clinical vigilance and immediate treatment are the universal keys to managing neutropenic patients with fever and/or infection.}
}


% BEGIN:Original PubMed XML
%  <PubmedArticle>
%    <MedlineCitation Owner="NLM" Status="MEDLINE">
%      <PMID Version="1">21258094</PMID>
%      <DateCreated>
%        <Year>2011</Year>
%        <Month>01</Month>
%        <Day>24</Day>
%      </DateCreated>
%      <DateCompleted>
%        <Year>2011</Year>
%        <Month>04</Month>
%        <Day>26</Day>
%      </DateCompleted>
%      <DateRevised>
%        <Year>2011</Year>
%        <Month>05</Month>
%        <Day>05</Day>
%      </DateRevised>
%      <Article PubModel="Print">
%        <Journal>
%          <ISSN IssnType="Electronic">1537-6591</ISSN>
%          <JournalIssue CitedMedium="Internet">
%            <Volume>52</Volume>
%            <Issue>4</Issue>
%            <PubDate>
%              <Year>2011</Year>
%              <Month>Feb</Month>
%              <Day>15</Day>
%            </PubDate>
%          </JournalIssue>
%          <Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title>
%          <ISOAbbreviation>Clin. Infect. Dis.</ISOAbbreviation>
%        </Journal>
%        <ArticleTitle>Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.</ArticleTitle>
%        <Pagination>
%          <MedlinePgn>e56-93</MedlinePgn>
%        </Pagination>
%        <Abstract>
%          <AbstractText>This document updates and expands the initial Infectious Diseases Society of America (IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in 2002. It is intended as a guide for the use of antimicrobial agents in managing patients with cancer who experience chemotherapy-induced fever and neutropenia. Recent advances in antimicrobial drug development and technology, clinical trial results, and extensive clinical experience have informed the approaches and recommendations herein. Because the previous iteration of this guideline in 2002, we have a developed a clearer definition of which populations of patients with cancer may benefit most from antibiotic, antifungal, and antiviral prophylaxis. Furthermore, categorizing neutropenic patients as being at high risk or low risk for infection according to presenting signs and symptoms, underlying cancer, type of therapy, and medical comorbidities has become essential to the treatment algorithm. Risk stratification is a recommended starting point for managing patients with fever and neutropenia. In addition, earlier detection of invasive fungal infections has led to debate regarding optimal use of empirical or preemptive antifungal therapy, although algorithms are still evolving. What has not changed is the indication for immediate empirical antibiotic therapy. It remains true that all patients who present with fever and neutropenia should be treated swiftly and broadly with antibiotics to treat both gram-positive and gram-negative pathogens. Finally, we note that all Panel members are from institutions in the United States or Canada; thus, these guidelines were developed in the context of North American practices. Some recommendations may not be as applicable outside of North America, in areas where differences in available antibiotics, in the predominant pathogens, and/or in health care-associated economic conditions exist. Regardless of venue, clinical vigilance and immediate treatment are the universal keys to managing neutropenic patients with fever and/or infection.</AbstractText>
%        </Abstract>
%        <Affiliation>Department of Medicine, University of Nebraska Medical Center, Omaha, Nebraska.</Affiliation>
%        <AuthorList CompleteYN="Y">
%          <Author ValidYN="Y">
%            <LastName>Freifeld</LastName>
%            <ForeName>Alison G</ForeName>
%            <Initials>AG</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Bow</LastName>
%            <ForeName>Eric J</ForeName>
%            <Initials>EJ</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Sepkowitz</LastName>
%            <ForeName>Kent A</ForeName>
%            <Initials>KA</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Boeckh</LastName>
%            <ForeName>Michael J</ForeName>
%            <Initials>MJ</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Ito</LastName>
%            <ForeName>James I</ForeName>
%            <Initials>JI</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Mullen</LastName>
%            <ForeName>Craig A</ForeName>
%            <Initials>CA</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Raad</LastName>
%            <ForeName>Issam I</ForeName>
%            <Initials>II</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Rolston</LastName>
%            <ForeName>Kenneth V</ForeName>
%            <Initials>KV</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Young</LastName>
%            <ForeName>Jo-Anne H</ForeName>
%            <Initials>JA</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Wingard</LastName>
%            <ForeName>John R</ForeName>
%            <Initials>JR</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Infectious Diseases Society of America</LastName>
%          </Author>
%        </AuthorList>
%        <Language>eng</Language>
%        <PublicationTypeList>
%          <PublicationType>Journal Article</PublicationType>
%          <PublicationType>Practice Guideline</PublicationType>
%          <PublicationType>Research Support, Non-U.S. Gov't</PublicationType>
%        </PublicationTypeList>
%      </Article>
%      <MedlineJournalInfo>
%        <Country>United States</Country>
%        <MedlineTA>Clin Infect Dis</MedlineTA>
%        <NlmUniqueID>9203213</NlmUniqueID>
%        <ISSNLinking>1058-4838</ISSNLinking>
%      </MedlineJournalInfo>
%      <ChemicalList>
%        <Chemical>
%          <RegistryNumber>0</RegistryNumber>
%          <NameOfSubstance>Anti-Infective Agents</NameOfSubstance>
%        </Chemical>
%        <Chemical>
%          <RegistryNumber>0</RegistryNumber>
%          <NameOfSubstance>Antineoplastic Agents</NameOfSubstance>
%        </Chemical>
%      </ChemicalList>
%      <CitationSubset>IM</CitationSubset>
%      <MeshHeadingList>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Anti-Infective Agents</DescriptorName>
%          <QualifierName MajorTopicYN="Y">administration &amp; dosage</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
%          <QualifierName MajorTopicYN="N">administration &amp; dosage</QualifierName>
%          <QualifierName MajorTopicYN="N">adverse effects</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Communicable Diseases</DescriptorName>
%          <QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Fever of Unknown Origin</DescriptorName>
%          <QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Humans</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Neoplasms</DescriptorName>
%          <QualifierName MajorTopicYN="Y">complications</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Neutropenia</DescriptorName>
%          <QualifierName MajorTopicYN="N">chemically induced</QualifierName>
%          <QualifierName MajorTopicYN="Y">complications</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
%        </MeshHeading>
%      </MeshHeadingList>
%    </MedlineCitation>
%    <PubmedData>
%      <History>
%        <PubMedPubDate PubStatus="entrez">
%          <Year>2011</Year>
%          <Month>1</Month>
%          <Day>25</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="pubmed">
%          <Year>2011</Year>
%          <Month>1</Month>
%          <Day>25</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="medline">
%          <Year>2011</Year>
%          <Month>4</Month>
%          <Day>27</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%      </History>
%      <PublicationStatus>ppublish</PublicationStatus>
%      <ArticleIdList>
%        <ArticleId IdType="pii">cir073</ArticleId>
%        <ArticleId IdType="doi">10.1093/cid/cir073</ArticleId>
%        <ArticleId IdType="pubmed">21258094</ArticleId>
%      </ArticleIdList>
%    </PubmedData>
%  </PubmedArticle>
% END:Original PubMed XML


@article{shahinas2012toward,
  title={Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing},
  author={Shahinas, Dea and Silverman, Michael and Sittler, Taylor and Chiu, Charles and Kim, Peter and Allen-Vercoe, Emma and Weese, Scott and Wong, Andrew and Low, Donald E and Pillai, Dylan R},
  journal={MBio},
  volume={3},
  number={5},
  year={2012},
  publisher={Am Soc Microbiol}
}

@article{pmid:23842501,
  title={Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.},
  author={Atarashi, Koji and Tanoue, Takeshi and Oshima, Kenshiro and Suda, Wataru and Nagano, Yuji and Nishikawa, Hiroyoshi and Fukuda, Shinji and Saito, Takuro and Narushima, Seiko and Hase, Koji and Kim, Sangwan and Fritz, Joëlle V and Wilmes, Paul and Ueha, Satoshi and Matsushima, Kouji and Ohno, Hiroshi and Olle, Bernat and Sakaguchi, Shimon and Taniguchi, Tadatsugu and Morita, Hidetoshi and Hattori, Masahira and Honda, Kenya},
  journal={Nature},
  journal-iso={Nature},
  volume={500},
  number={7461},
  year={2013},
  month={Aug},
  pages={232--6},
  doi={10.1038/nature12331},
  pmid={23842501},
  abstract={Manipulation of the gut microbiota holds great promise for the treatment of inflammatory and allergic diseases. Although numerous probiotic microorganisms have been identified, there remains a compelling need to discover organisms that elicit more robust therapeutic responses, are compatible with the host, and can affect a specific arm of the host immune system in a well-controlled, physiological manner. Here we use a rational approach to isolate CD4(+)FOXP3(+) regulatory T (Treg)-cell-inducing bacterial strains from the human indigenous microbiota. Starting with a healthy human faecal sample, a sequence of selection steps was applied to obtain mice colonized with human microbiota enriched in Treg-cell-inducing species. From these mice, we isolated and selected 17 strains of bacteria on the basis of their high potency in enhancing Treg cell abundance and inducing important anti-inflammatory molecules--including interleukin-10 (IL-) and inducible T-cell co-stimulator (ICOS)--in Treg cells upon inoculation into germ-free mice. Genome sequencing revealed that the 17 strains fall within clusters IV, XIVa and XVIII of Clostridia, which lack prominent toxins and virulence factors. The 17 strains act as a community to provide bacterial antigens and a TGF-β-rich environment to help expansion and differentiation of Treg cells. Oral administration of the combination of 17 strains to adult mice attenuated disease in models of colitis and allergic diarrhoea. Use of the isolated strains may allow for tailored therapeutic manipulation of human immune disorders.}
}


% BEGIN:Original PubMed XML
%  <PubmedArticle>
%    <MedlineCitation Owner="NLM" Status="MEDLINE">
%      <PMID Version="1">23842501</PMID>
%      <DateCreated>
%        <Year>2013</Year>
%        <Month>08</Month>
%        <Day>08</Day>
%      </DateCreated>
%      <DateCompleted>
%        <Year>2013</Year>
%        <Month>08</Month>
%        <Day>19</Day>
%      </DateCompleted>
%      <DateRevised>
%        <Year>2013</Year>
%        <Month>10</Month>
%        <Day>23</Day>
%      </DateRevised>
%      <Article PubModel="Print-Electronic">
%        <Journal>
%          <ISSN IssnType="Electronic">1476-4687</ISSN>
%          <JournalIssue CitedMedium="Internet">
%            <Volume>500</Volume>
%            <Issue>7461</Issue>
%            <PubDate>
%              <Year>2013</Year>
%              <Month>Aug</Month>
%              <Day>8</Day>
%            </PubDate>
%          </JournalIssue>
%          <Title>Nature</Title>
%          <ISOAbbreviation>Nature</ISOAbbreviation>
%        </Journal>
%        <ArticleTitle>Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.</ArticleTitle>
%        <Pagination>
%          <MedlinePgn>232-6</MedlinePgn>
%        </Pagination>
%        <ELocationID EIdType="doi" ValidYN="Y">10.1038/nature12331</ELocationID>
%        <Abstract>
%          <AbstractText>Manipulation of the gut microbiota holds great promise for the treatment of inflammatory and allergic diseases. Although numerous probiotic microorganisms have been identified, there remains a compelling need to discover organisms that elicit more robust therapeutic responses, are compatible with the host, and can affect a specific arm of the host immune system in a well-controlled, physiological manner. Here we use a rational approach to isolate CD4(+)FOXP3(+) regulatory T (Treg)-cell-inducing bacterial strains from the human indigenous microbiota. Starting with a healthy human faecal sample, a sequence of selection steps was applied to obtain mice colonized with human microbiota enriched in Treg-cell-inducing species. From these mice, we isolated and selected 17 strains of bacteria on the basis of their high potency in enhancing Treg cell abundance and inducing important anti-inflammatory molecules--including interleukin-10 (IL-) and inducible T-cell co-stimulator (ICOS)--in Treg cells upon inoculation into germ-free mice. Genome sequencing revealed that the 17 strains fall within clusters IV, XIVa and XVIII of Clostridia, which lack prominent toxins and virulence factors. The 17 strains act as a community to provide bacterial antigens and a TGF-β-rich environment to help expansion and differentiation of Treg cells. Oral administration of the combination of 17 strains to adult mice attenuated disease in models of colitis and allergic diarrhoea. Use of the isolated strains may allow for tailored therapeutic manipulation of human immune disorders.</AbstractText>
%        </Abstract>
%        <Affiliation>RIKEN Center for Integrative Medical Sciences (IMS-RCAI), 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.</Affiliation>
%        <AuthorList CompleteYN="Y">
%          <Author ValidYN="Y">
%            <LastName>Atarashi</LastName>
%            <ForeName>Koji</ForeName>
%            <Initials>K</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Tanoue</LastName>
%            <ForeName>Takeshi</ForeName>
%            <Initials>T</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Oshima</LastName>
%            <ForeName>Kenshiro</ForeName>
%            <Initials>K</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Suda</LastName>
%            <ForeName>Wataru</ForeName>
%            <Initials>W</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Nagano</LastName>
%            <ForeName>Yuji</ForeName>
%            <Initials>Y</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Nishikawa</LastName>
%            <ForeName>Hiroyoshi</ForeName>
%            <Initials>H</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Fukuda</LastName>
%            <ForeName>Shinji</ForeName>
%            <Initials>S</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Saito</LastName>
%            <ForeName>Takuro</ForeName>
%            <Initials>T</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Narushima</LastName>
%            <ForeName>Seiko</ForeName>
%            <Initials>S</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Hase</LastName>
%            <ForeName>Koji</ForeName>
%            <Initials>K</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Kim</LastName>
%            <ForeName>Sangwan</ForeName>
%            <Initials>S</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Fritz</LastName>
%            <ForeName>Joëlle V</ForeName>
%            <Initials>JV</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Wilmes</LastName>
%            <ForeName>Paul</ForeName>
%            <Initials>P</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Ueha</LastName>
%            <ForeName>Satoshi</ForeName>
%            <Initials>S</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Matsushima</LastName>
%            <ForeName>Kouji</ForeName>
%            <Initials>K</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Ohno</LastName>
%            <ForeName>Hiroshi</ForeName>
%            <Initials>H</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Olle</LastName>
%            <ForeName>Bernat</ForeName>
%            <Initials>B</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Sakaguchi</LastName>
%            <ForeName>Shimon</ForeName>
%            <Initials>S</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Taniguchi</LastName>
%            <ForeName>Tadatsugu</ForeName>
%            <Initials>T</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Morita</LastName>
%            <ForeName>Hidetoshi</ForeName>
%            <Initials>H</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Hattori</LastName>
%            <ForeName>Masahira</ForeName>
%            <Initials>M</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Honda</LastName>
%            <ForeName>Kenya</ForeName>
%            <Initials>K</Initials>
%          </Author>
%        </AuthorList>
%        <Language>eng</Language>
%        <PublicationTypeList>
%          <PublicationType>Journal Article</PublicationType>
%          <PublicationType>Research Support, Non-U.S. Gov't</PublicationType>
%        </PublicationTypeList>
%        <ArticleDate DateType="Electronic">
%          <Year>2013</Year>
%          <Month>07</Month>
%          <Day>10</Day>
%        </ArticleDate>
%      </Article>
%      <MedlineJournalInfo>
%        <Country>England</Country>
%        <MedlineTA>Nature</MedlineTA>
%        <NlmUniqueID>0410462</NlmUniqueID>
%        <ISSNLinking>0028-0836</ISSNLinking>
%      </MedlineJournalInfo>
%      <ChemicalList>
%        <Chemical>
%          <RegistryNumber>0</RegistryNumber>
%          <NameOfSubstance>Inducible T-Cell Co-Stimulator Protein</NameOfSubstance>
%        </Chemical>
%        <Chemical>
%          <RegistryNumber>0</RegistryNumber>
%          <NameOfSubstance>RNA, Ribosomal, 16S</NameOfSubstance>
%        </Chemical>
%        <Chemical>
%          <RegistryNumber>130068-27-8</RegistryNumber>
%          <NameOfSubstance>Interleukin-10</NameOfSubstance>
%        </Chemical>
%      </ChemicalList>
%      <CitationSubset>IM</CitationSubset>
%      <CommentsCorrectionsList>
%        <CommentsCorrections RefType="CommentIn">
%          <RefSource>Nat Biotechnol. 2013 Sep;31(9):813</RefSource>
%          <PMID Version="1">24022160</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="CommentIn">
%          <RefSource>Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):504</RefSource>
%          <PMID Version="1">23877531</PMID>
%        </CommentsCorrections>
%      </CommentsCorrectionsList>
%      <MeshHeadingList>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Adult</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Animals</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Cell Proliferation</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Clostridium</DescriptorName>
%          <QualifierName MajorTopicYN="N">classification</QualifierName>
%          <QualifierName MajorTopicYN="N">genetics</QualifierName>
%          <QualifierName MajorTopicYN="Y">immunology</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Colitis</DescriptorName>
%          <QualifierName MajorTopicYN="N">microbiology</QualifierName>
%          <QualifierName MajorTopicYN="N">pathology</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Colon</DescriptorName>
%          <QualifierName MajorTopicYN="N">immunology</QualifierName>
%          <QualifierName MajorTopicYN="N">microbiology</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Disease Models, Animal</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Feces</DescriptorName>
%          <QualifierName MajorTopicYN="N">microbiology</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Germ-Free Life</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Humans</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Inducible T-Cell Co-Stimulator Protein</DescriptorName>
%          <QualifierName MajorTopicYN="N">metabolism</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Interleukin-10</DescriptorName>
%          <QualifierName MajorTopicYN="N">metabolism</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Male</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Metagenome</DescriptorName>
%          <QualifierName MajorTopicYN="N">genetics</QualifierName>
%          <QualifierName MajorTopicYN="Y">immunology</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Mice</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Mice, SCID</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">RNA, Ribosomal, 16S</DescriptorName>
%          <QualifierName MajorTopicYN="N">genetics</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Rats</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Rats, Inbred F344</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">T-Lymphocytes, Regulatory</DescriptorName>
%          <QualifierName MajorTopicYN="N">cytology</QualifierName>
%          <QualifierName MajorTopicYN="Y">physiology</QualifierName>
%        </MeshHeading>
%      </MeshHeadingList>
%    </MedlineCitation>
%    <PubmedData>
%      <History>
%        <PubMedPubDate PubStatus="received">
%          <Year>2012</Year>
%          <Month>9</Month>
%          <Day>14</Day>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="accepted">
%          <Year>2013</Year>
%          <Month>5</Month>
%          <Day>22</Day>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="aheadofprint">
%          <Year>2013</Year>
%          <Month>7</Month>
%          <Day>10</Day>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="entrez">
%          <Year>2013</Year>
%          <Month>7</Month>
%          <Day>12</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="pubmed">
%          <Year>2013</Year>
%          <Month>7</Month>
%          <Day>12</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="medline">
%          <Year>2013</Year>
%          <Month>8</Month>
%          <Day>21</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%      </History>
%      <PublicationStatus>ppublish</PublicationStatus>
%      <ArticleIdList>
%        <ArticleId IdType="pii">nature12331</ArticleId>
%        <ArticleId IdType="doi">10.1038/nature12331</ArticleId>
%        <ArticleId IdType="pubmed">23842501</ArticleId>
%      </ArticleIdList>
%    </PubmedData>
%  </PubmedArticle>
% END:Original PubMed XML


@article{10.1371/journal.ppat.1003829,
    author = {Mutlu, , Ece A. AND Keshavarzian, , Ali AND Losurdo, , John AND Swanson, , Garth AND Siewe, , Basile AND Forsyth, , Christopher AND French, , Audrey AND DeMarais, , Patricia AND Sun, , Yan AND Koenig, , Lars AND Cox, , Stephen AND Engen, , Phillip AND Chakradeo, , Prachi AND Abbasi, , Rawan AND Gorenz, , Annika AND Burns, , Charles AND Landay, , Alan},
    journal = {PLoS Pathog},
    publisher = {Public Library of Science},
    title = {A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects},
    year = {2014},
    month = {02},
    volume = {10},
    url = {http://dx.doi.org/10.1371%2Fjournal.ppat.1003829},
    pages = {e1003829},
    abstract = {<title>Author Summary</title><p>Human immunodeficiency virus (HIV) infection related illness progresses despite the control of the virus itself by medications that stop the replication of the virus. This happens because the immune system gets activated. While the causes for such activation of the immune system are not exactly known, immune activation in HIV infection may be occurring as a result of bacteria or their products in the digestive tract. This study looks at the types of bacteria that reside in the lower intestinal tract in patients infected with human immunodeficiency virus, using state of the art sequencing technology, that can simultaneously look at thousands of bacteria. We have found that the bacteria at the end of the small bowel (an area also called the terminal ileum), at the right and left sides of the large intestine and in the stool is different in patients infected with the human immunodeficiency virus. HIV patients harbor more bacteria that have been linked to other human diseases and have been previously described as harmful. This finding is new and could open up a new frontier of study that could now pave the way to gain a deeper understanding of how the HIV causes illness.</p>},
    number = {2},
    doi = {10.1371/journal.ppat.1003829}
}        

@article{viola2014breast,
  title={Breast tissue expander-related infections: perioperative antimicrobial regimens.},
  author={Viola, George M and Raad, Issam I and Rolston, Kenneth V},
  journal={Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America},
  volume={35},
  number={1},
  pages={75--81},
  year={2014}
}

@article{van2010role,
  title={The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis},
  author={Van Vliet, Michel J and Harmsen, Hermie JM and de Bont, Eveline SJM and Tissing, Wim JE},
  journal={PLoS pathogens},
  volume={6},
  number={5},
  pages={e1000879},
  year={2010},
  publisher={Public Library of Science}
}

@article{buffie2012profound
,	author	= {Buffie, Charlie G and Jarchum, Irene and Equinda, Michele and Lipuma, Lauren and Gobourne, Asia and Viale, Agnes and Ubeda, Carles and Xavier, Joao and Pamer, Eric G}
,	title	= {Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis.}
,	journal	= {Infection and immunity}
,	year	= {2012}
,	volume	= {80}
,	number	= {1}
,	pages	= {62--73}
,	month	= {Jan}
,	journal-iso	= {Infect. Immun.}
,	doi	= {10.1128/IAI.05496-11}
,	pmid	= {22006564}
,	abstract	= {Antibiotic-induced changes in the intestinal microbiota predispose mammalian hosts to infection with antibiotic-resistant pathogens. Clostridium difficile is a Gram-positive intestinal pathogen that causes colitis and diarrhea in patients following antibiotic treatment. Clindamycin predisposes patients to C. difficile colitis. Here, we have used Roche-454 16S rRNA gene pyrosequencing to longitudinally characterize the intestinal microbiota of mice following clindamycin treatment in the presence or absence of C. difficile infection. We show that a single dose of clindamycin markedly reduces the diversity of the intestinal microbiota for at least 28 days, with an enduring loss of ca. 90% of normal microbial taxa from the cecum. Loss of microbial complexity results in dramatic sequential expansion and contraction of a subset of bacterial taxa that are minor contributors to the microbial consortium prior to antibiotic treatment. Inoculation of clindamycin-treated mice with C. difficile (VPI 10463) spores results in rapid development of diarrhea and colitis, with a 4- to 5-day period of profound weight loss and an associated 40 to 50% mortality rate. Recovering mice resolve diarrhea and regain weight but remain highly infected with toxin-producing vegetative C. difficile bacteria and, in comparison to the acute stage of infection, have persistent, albeit ameliorated cecal and colonic inflammation. The microbiota of "recovered" mice remains highly restricted, and mice remain susceptible to C. difficile infection at least 10 days following clindamycin, suggesting that resolution of diarrhea and weight gain may result from the activation of mucosal immune defenses.}
}

@article{wreghitt2003cytomegalovirus,
  title={Cytomegalovirus infection in immunocompetent patients},
  author={Wreghitt, TG and Teare, EL and Sule, O and Devi, R and Rice, P},
  journal={Clinical infectious diseases},
  volume={37},
  number={12},
  pages={1603--1606},
  year={2003},
  publisher={Oxford University Press}
}

@article{klemola1970infectious,
  title={Infectious-mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies},
  author={Klemola, Erkki and von Essen, Robert and Henle, Gertrude and Henle, Werner},
  journal={Journal of Infectious Diseases},
  volume={121},
  number={6},
  pages={608--614},
  year={1970},
  publisher={Oxford University Press}
}

@article{dholakia1994susceptibilities,
  title={Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones.},
  author={Dholakia, Nizar and Rolston, KV and Ho, Dah Hsi and LeBlanc, Barbara and Bodey, Gerald P},
  journal={Antimicrobial agents and chemotherapy},
  volume={38},
  number={4},
  pages={848--852},
  year={1994},
  publisher={Am Soc Microbiol}
}

@article{tarshis2001once,
  title={Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study},
  author={Tarshis, Gary A and Miskin, Barry M and Jones, Terry M and Champlin, John and Wingert, Kevin J and Breen, Jeanne D and Brown, Michael J},
  journal={Antimicrobial agents and chemotherapy},
  volume={45},
  number={8},
  pages={2358--2362},
  year={2001},
  publisher={Am Soc Microbiol}
}

@article{nichols1997multicenter,
  title={Multicenter, randomized study comparing levofloxacin and ciprofloxacin for uncomplicated skin and skin structure infections},
  author={NICHOLS, RONALD LEE and SMITH, JEFFREY W and GENTRY, LAYNE O and GEZON, JOHN and CAMPBELL, THERESA and SOKOL, PAUL and WILLIAMS, R REX},
  journal={Southern medical journal},
  volume={90},
  number={12},
  pages={1193--1200},
  year={1997},
  publisher={LWW}
}

@article{stevens2005practice,
  title={Practice guidelines for the diagnosis and management of skin and soft-tissue infections},
  author={Stevens, Dennis L and Bisno, Alan L and Chambers, Henry F and Everett, E Dale and Dellinger, Patchen and Goldstein, Ellie JC and Gorbach, Sherwood L and Hirschmann, Jan V and Kaplan, Edward L and Montoya, Jose G and others},
  journal={Clinical Infectious Diseases},
  volume={41},
  number={10},
  pages={1373--1406},
  year={2005},
  publisher={Oxford University Press}
}

@article{backhed2005host,
  title={Host-bacterial mutualism in the human intestine},
  author={B{\"a}ckhed, Fredrik and Ley, Ruth E and Sonnenburg, Justin L and Peterson, Daniel A and Gordon, Jeffrey I},
  journal={science},
  volume={307},
  number={5717},
  pages={1915--1920},
  year={2005},
  publisher={American Association for the Advancement of Science}
}

@article{QIQQA-CUNQG
,	author	= {Ruth E Ley}
,	title	= {}
,	year	= {2014}
,	publisher	= {}
}

@article{pmid:23287624,
  title={Sense and nonsense of high-dose cytarabine for acute myeloid leukemia.},
  author={Löwenberg, Bob},
  journal={Blood},
  journal-iso={Blood},
  volume={121},
  number={1},
  year={2013},
  month={Jan},
  pages={26--8},
  doi={10.1182/blood-2012-07-444851},
  pmid={23287624},
  abstract={High-dose cytarabine applied during remission induction or as consolidation after attainment of a complete remission has become an established element in the treatment of adults with acute myeloid leukemia. Recent evidence has challenged the need for these exceptionally high-dose levels of cytarabine. In this review, we present a reappraisal of the usefulness of high-dose cytarabine for acute myeloid leukemia treatment.}
}


% BEGIN:Original PubMed XML
%  <PubmedArticle>
%    <MedlineCitation Owner="NLM" Status="MEDLINE">
%      <PMID Version="1">23287624</PMID>
%      <DateCreated>
%        <Year>2013</Year>
%        <Month>01</Month>
%        <Day>04</Day>
%      </DateCreated>
%      <DateCompleted>
%        <Year>2013</Year>
%        <Month>02</Month>
%        <Day>25</Day>
%      </DateCompleted>
%      <Article PubModel="Print">
%        <Journal>
%          <ISSN IssnType="Electronic">1528-0020</ISSN>
%          <JournalIssue CitedMedium="Internet">
%            <Volume>121</Volume>
%            <Issue>1</Issue>
%            <PubDate>
%              <Year>2013</Year>
%              <Month>Jan</Month>
%              <Day>3</Day>
%            </PubDate>
%          </JournalIssue>
%          <Title>Blood</Title>
%          <ISOAbbreviation>Blood</ISOAbbreviation>
%        </Journal>
%        <ArticleTitle>Sense and nonsense of high-dose cytarabine for acute myeloid leukemia.</ArticleTitle>
%        <Pagination>
%          <MedlinePgn>26-8</MedlinePgn>
%        </Pagination>
%        <ELocationID EIdType="doi" ValidYN="Y">10.1182/blood-2012-07-444851</ELocationID>
%        <Abstract>
%          <AbstractText>High-dose cytarabine applied during remission induction or as consolidation after attainment of a complete remission has become an established element in the treatment of adults with acute myeloid leukemia. Recent evidence has challenged the need for these exceptionally high-dose levels of cytarabine. In this review, we present a reappraisal of the usefulness of high-dose cytarabine for acute myeloid leukemia treatment.</AbstractText>
%        </Abstract>
%        <Affiliation>Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands. b.lowenberg@erasmusmc.nl</Affiliation>
%        <AuthorList CompleteYN="Y">
%          <Author ValidYN="Y">
%            <LastName>Löwenberg</LastName>
%            <ForeName>Bob</ForeName>
%            <Initials>B</Initials>
%          </Author>
%        </AuthorList>
%        <Language>eng</Language>
%        <PublicationTypeList>
%          <PublicationType>Journal Article</PublicationType>
%          <PublicationType>Review</PublicationType>
%        </PublicationTypeList>
%      </Article>
%      <MedlineJournalInfo>
%        <Country>United States</Country>
%        <MedlineTA>Blood</MedlineTA>
%        <NlmUniqueID>7603509</NlmUniqueID>
%        <ISSNLinking>0006-4971</ISSNLinking>
%      </MedlineJournalInfo>
%      <ChemicalList>
%        <Chemical>
%          <RegistryNumber>0</RegistryNumber>
%          <NameOfSubstance>Antimetabolites, Antineoplastic</NameOfSubstance>
%        </Chemical>
%        <Chemical>
%          <RegistryNumber>147-94-4</RegistryNumber>
%          <NameOfSubstance>Cytarabine</NameOfSubstance>
%        </Chemical>
%      </ChemicalList>
%      <CitationSubset>AIM</CitationSubset>
%      <CitationSubset>IM</CitationSubset>
%      <MeshHeadingList>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Adult</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Antimetabolites, Antineoplastic</DescriptorName>
%          <QualifierName MajorTopicYN="Y">administration &amp; dosage</QualifierName>
%          <QualifierName MajorTopicYN="N">adverse effects</QualifierName>
%          <QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
%          <QualifierName MajorTopicYN="N">adverse effects</QualifierName>
%          <QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
%          <QualifierName MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Consolidation Chemotherapy</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Cytarabine</DescriptorName>
%          <QualifierName MajorTopicYN="Y">administration &amp; dosage</QualifierName>
%          <QualifierName MajorTopicYN="N">adverse effects</QualifierName>
%          <QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Drug Administration Schedule</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Humans</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Induction Chemotherapy</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Infusions, Intravenous</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Leukemia, Myeloid, Acute</DescriptorName>
%          <QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
%          <QualifierName MajorTopicYN="N">pathology</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName>
%          <QualifierName MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Patient Selection</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
%          <QualifierName MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Retrospective Studies</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Risk</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Treatment Outcome</DescriptorName>
%        </MeshHeading>
%      </MeshHeadingList>
%    </MedlineCitation>
%    <PubmedData>
%      <History>
%        <PubMedPubDate PubStatus="entrez">
%          <Year>2013</Year>
%          <Month>1</Month>
%          <Day>5</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="pubmed">
%          <Year>2013</Year>
%          <Month>1</Month>
%          <Day>5</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="medline">
%          <Year>2013</Year>
%          <Month>2</Month>
%          <Day>26</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%      </History>
%      <PublicationStatus>ppublish</PublicationStatus>
%      <ArticleIdList>
%        <ArticleId IdType="pii">blood-2012-07-444851</ArticleId>
%        <ArticleId IdType="doi">10.1182/blood-2012-07-444851</ArticleId>
%        <ArticleId IdType="pubmed">23287624</ArticleId>
%      </ArticleIdList>
%    </PubmedData>
%  </PubmedArticle>
% END:Original PubMed XML


@article{dohner2010diagnosis,
  title={Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet},
  author={D{\"o}hner, Hartmut and Estey, Elihu H and Amadori, Sergio and Appelbaum, Frederick R and B{\"u}chner, Thomas and Burnett, Alan K and Dombret, Herv{\'e} and Fenaux, Pierre and Grimwade, David and Larson, Richard A and others},
  journal={Blood},
  volume={115},
  number={3},
  pages={453--474},
  year={2010},
  publisher={American Society of Hematology}
}

@article{segata2012composition,
  title={Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples},
  author={Segata, Nicola and Haake, Susan Kinder and Mannon, Peter and Lemon, Katherine P and Waldron, Levi and Gevers, Dirk and Huttenhower, Curtis and Izard, Jacques and others},
  journal={Genome Biol},
  volume={13},
  number={6},
  pages={R42},
  year={2012}
}

@article{gafter2005antibiotic,
  title={Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy},
  author={Gafter-Gvili, A and Fraser, A and Paul, M and Van De Wetering, M and Kremer, L and Leibovici, L},
  journal={Cochrane Database Syst Rev},
  volume={4},
  year={2005},
  publisher={Wiley Online Library}
}

@article{castro2008transplantation,
  title={Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings},
  author={Castro-Malaspina, Hugo and Jabubowski, Ann A and Papadopoulos, Esperanza B and Boulad, Farid and Young, James W and Kernan, Nancy A and Perales, Miguel A and Small, Trudy N and Hsu, Katharine and Chiu, Michelle and others},
  journal={Biology of Blood and Marrow Transplantation},
  volume={14},
  number={4},
  pages={458--468},
  year={2008},
  publisher={Elsevier}
}

@article{kim1981isolation,
  title={Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis},
  author={Kim, K-H and Fekety, R and Batts, DH and Brown, D and Cudmore, M and Silva, J and Waters, D},
  journal={Journal of infectious diseases},
  volume={143},
  number={1},
  pages={42--50},
  year={1981},
  publisher={Oxford University Press}
}

@article{giel2010metabolism,
  title={Metabolism of bile salts in mice influences spore germination in Clostridium difficile},
  author={Giel, Jennifer L and Sorg, Joseph A and Sonenshein, Abraham L and Zhu, Jun},
  journal={PloS one},
  volume={5},
  number={1},
  pages={e8740},
  year={2010},
  publisher={Public Library of Science}
}

@article{chang2008decreased
,	author	= {Chang, Ju Young and Antonopoulos, Dionysios A and Kalra, Apoorv and Tonelli, Adriano and Khalife, Walid T and Schmidt, Thomas M and Young, Vincent B}
,	title	= {Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.}
,	journal	= {The Journal of infectious diseases}
,	year	= {2008}
,	volume	= {197}
,	number	= {3}
,	pages	= {435--8}
,	month	= {Feb}
,	journal-iso	= {J. Infect. Dis.}
,	doi	= {10.1086/525047}
,	pmid	= {18199029}
,	abstract	= {Antibiotic-associated diarrhea due to Clostridium difficile (CDAD) is thought to reflect colonization of a disrupted microbial community by the pathogen. We profiled the fecal microbiota of patients with CDAD (both initial and recurrent episodes) by culture-independent phylogenetic analysis of 16S rRNA-encoding gene sequences. Compared with those from control subjects and patients with an initial episode, the fecal communities in patients with recurrent CDAD were highly variable in bacterial composition and were characterized by markedly decreased diversity. Preservation and restoration of the microbial diversity could represent novel strategies for prevention and treatment of recurrent CDAD, which is often recalcitrant to existing therapies.}
}

@article{walker2012characterisation,
  title={Characterisation of Clostridium difficile Hospital Ward--Based Transmission Using Extensive Epidemiological Data and Molecular Typing},
  author={Walker, A Sarah and Eyre, David W and Wyllie, David H and Dingle, Kate E and Harding, Rosalind M and O'Connor, Lily and Griffiths, David and Vaughan, Ali and Finney, John and Wilcox, Mark H and others},
  journal={PLoS medicine},
  volume={9},
  number={2},
  pages={e1001172},
  year={2012},
  publisher={Public Library of Science}
}

@article{sorg2010inhibiting,
  title={Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid},
  author={Sorg, Joseph A and Sonenshein, Abraham L},
  journal={Journal of bacteriology},
  volume={192},
  number={19},
  pages={4983--4990},
  year={2010},
  publisher={Am Soc Microbiol}
}

@article{sorg2009chenodeoxycholate,
  title={Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination},
  author={Sorg, Joseph A and Sonenshein, Abraham L},
  journal={Journal of bacteriology},
  volume={191},
  number={3},
  pages={1115--1117},
  year={2009},
  publisher={Am Soc Microbiol}
}

@article{rousseau2012clostridium,
  title={Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains},
  author={Rousseau, Clotilde and Poilane, Isabelle and De Pontual, Loic and Maherault, Anne-Claire and Le Monnier, Alban and Collignon, Anne},
  journal={Clinical infectious diseases},
  volume={55},
  number={9},
  pages={1209--1215},
  year={2012},
  publisher={Oxford University Press}
}

@article{rousseau2011clostridium,
  title={Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition},
  author={Rousseau, Clotilde and Levenez, Florence and Fouqueray, Charlene and Dor{\'e}, Jo{\"e}l and Collignon, Anne and Lepage, Patricia},
  journal={Journal of clinical microbiology},
  volume={49},
  number={3},
  pages={858--865},
  year={2011},
  publisher={Am Soc Microbiol}
}

@article{wang2006role,
  title={The role of bifidobacteria in gut barrier function after thermal injury in rats},
  author={Wang, Zhongtang and Xiao, Guangxia and Yao, Yongming and Guo, Shuzhong and Lu, Kaihua and Sheng, Zhiyong},
  journal={The Journal of Trauma and Acute Care Surgery},
  volume={61},
  number={3},
  pages={650--657},
  year={2006},
  publisher={LWW}
}

@article{louie2009opt,
  title={OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection},
  author={Louie, Thomas J and Emery, Judy and Krulicki, Walter and Byrne, Brendan and Mah, Manuel},
  journal={Antimicrobial agents and chemotherapy},
  volume={53},
  number={1},
  pages={261--263},
  year={2009},
  publisher={Am Soc Microbiol}
}

@article{jaffe2004prevention,
  title={Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study},
  author={Jaffe, Dana and Jakubowski, Ann and Sepkowitz, Kent and Sebti, R and Kiehn, Timothy E and Pamer, Eric and Papanicolaou, Genovefa A},
  journal={Clinical infectious diseases},
  volume={39},
  number={11},
  pages={1625--1632},
  year={2004},
  publisher={Oxford University Press}
}

@article{chakrabarti2002adenovirus,
  title={Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery},
  author={Chakrabarti, Suparno and Mautner, Vivien and Osman, Husam and Collingham, Kathryn E and Fegan, Chris D and Klapper, Paul E and Moss, Paul AH and Milligan, Donald W},
  journal={Blood},
  volume={100},
  number={5},
  pages={1619--1627},
  year={2002},
  publisher={American Society of Hematology}
}

@article{dethlefsen2008pervasive,
  title={The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing},
  author={Dethlefsen, Les and Huse, Sue and Sogin, Mitchell L and Relman, David A},
  journal={PLoS biology},
  volume={6},
  number={11},
  pages={e280},
  year={2008},
  publisher={Public Library of Science}
}

@article{dethlefsen2011incomplete,
  title={Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation},
  author={Dethlefsen, Les and Relman, David A},
  journal={Proceedings of the National Academy of Sciences},
  volume={108},
  number={Supplement 1},
  pages={4554--4561},
  year={2011},
  publisher={National Acad Sciences}
}

@article{qunfeng2012evaluation,
  title={Evaluation of the RDP classifier accuracy using 16S rRNA gene variable regions},
  author={Qunfeng, Dong and Claudia, Vilo and others},
  journal={Metagenomics},
  volume={2012},
  year={2012},
  publisher={Ashdin Publishing}
}

@article{hazlewood2010vancomycin,
  title={Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?},
  author={Hazlewood, Kathleen A and Brouse, Sara D and Pitcher, William D and Hall, Ronald G},
  journal={The American journal of medicine},
  volume={123},
  number={2},
  pages={182--e1},
  year={2010},
  publisher={Elsevier}
}

@article{sorror2013assess,
  title={How I assess comorbidities before hematopoietic cell transplantation},
  author={Sorror, Mohamed L},
  journal={Blood},
  volume={121},
  number={15},
  pages={2854--2863},
  year={2013},
  publisher={American Society of Hematology}
}

@article{pmid:1244564,
  title={Prediction of creatinine clearance from serum creatinine.},
  author={Cockcroft, D W and Gault, M H},
  journal={Nephron},
  journal-iso={Nephron},
  volume={16},
  number={1},
  year={1976},
  pages={31--41},
  pmid={1244564},
  abstract={A formula has been developed to predict creatinine clearance (Ccr) from serum creatinine (Scr) in adult males: (see article)(15% less in females). Derivation included the relationship found between age and 24-hour creatinine excretion/kg in 249 patients aged 18-92. Values for Ccr were predicted by this formula and four other methods and the results compared with the means of two 24-hour Ccr's measured in 236 patients. The above formula gave a correlation coefficient between predicted and mean measured Ccr's of 0.83; on average, the difference predicted and mean measured values was no greater than that between paired clearances. Factors for age and body weight must be included for reasonable prediction.}
}


% BEGIN:Original PubMed XML
%  <PubmedArticle>
%    <MedlineCitation Owner="NLM" Status="MEDLINE">
%      <PMID Version="1">1244564</PMID>
%      <DateCreated>
%        <Year>1976</Year>
%        <Month>02</Month>
%        <Day>13</Day>
%      </DateCreated>
%      <DateCompleted>
%        <Year>1976</Year>
%        <Month>02</Month>
%        <Day>13</Day>
%      </DateCompleted>
%      <DateRevised>
%        <Year>2013</Year>
%        <Month>11</Month>
%        <Day>21</Day>
%      </DateRevised>
%      <Article PubModel="Print">
%        <Journal>
%          <ISSN IssnType="Print">0028-2766</ISSN>
%          <JournalIssue CitedMedium="Print">
%            <Volume>16</Volume>
%            <Issue>1</Issue>
%            <PubDate>
%              <Year>1976</Year>
%            </PubDate>
%          </JournalIssue>
%          <Title>Nephron</Title>
%          <ISOAbbreviation>Nephron</ISOAbbreviation>
%        </Journal>
%        <ArticleTitle>Prediction of creatinine clearance from serum creatinine.</ArticleTitle>
%        <Pagination>
%          <MedlinePgn>31-41</MedlinePgn>
%        </Pagination>
%        <Abstract>
%          <AbstractText>A formula has been developed to predict creatinine clearance (Ccr) from serum creatinine (Scr) in adult males: (see article)(15% less in females). Derivation included the relationship found between age and 24-hour creatinine excretion/kg in 249 patients aged 18-92. Values for Ccr were predicted by this formula and four other methods and the results compared with the means of two 24-hour Ccr's measured in 236 patients. The above formula gave a correlation coefficient between predicted and mean measured Ccr's of 0.83; on average, the difference predicted and mean measured values was no greater than that between paired clearances. Factors for age and body weight must be included for reasonable prediction.</AbstractText>
%        </Abstract>
%        <AuthorList CompleteYN="Y">
%          <Author ValidYN="Y">
%            <LastName>Cockcroft</LastName>
%            <ForeName>D W</ForeName>
%            <Initials>DW</Initials>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Gault</LastName>
%            <ForeName>M H</ForeName>
%            <Initials>MH</Initials>
%          </Author>
%        </AuthorList>
%        <Language>eng</Language>
%        <PublicationTypeList>
%          <PublicationType>Journal Article</PublicationType>
%        </PublicationTypeList>
%      </Article>
%      <MedlineJournalInfo>
%        <Country>SWITZERLAND</Country>
%        <MedlineTA>Nephron</MedlineTA>
%        <NlmUniqueID>0331777</NlmUniqueID>
%        <ISSNLinking>0028-2766</ISSNLinking>
%      </MedlineJournalInfo>
%      <ChemicalList>
%        <Chemical>
%          <RegistryNumber>AYI8EX34EU</RegistryNumber>
%          <NameOfSubstance>Creatinine</NameOfSubstance>
%        </Chemical>
%      </ChemicalList>
%      <CitationSubset>IM</CitationSubset>
%      <MeshHeadingList>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Adult</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Age Factors</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Aged</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Body Weight</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Creatinine</DescriptorName>
%          <QualifierName MajorTopicYN="Y">blood</QualifierName>
%          <QualifierName MajorTopicYN="N">urine</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Humans</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Kidney</DescriptorName>
%          <QualifierName MajorTopicYN="Y">physiology</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Male</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Mathematics</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Methods</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
%        </MeshHeading>
%      </MeshHeadingList>
%    </MedlineCitation>
%    <PubmedData>
%      <History>
%        <PubMedPubDate PubStatus="pubmed">
%          <Year>1976</Year>
%          <Month>1</Month>
%          <Day>1</Day>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="medline">
%          <Year>1976</Year>
%          <Month>1</Month>
%          <Day>1</Day>
%          <Hour>0</Hour>
%          <Minute>1</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="entrez">
%          <Year>1976</Year>
%          <Month>1</Month>
%          <Day>1</Day>
%          <Hour>0</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%      </History>
%      <PublicationStatus>ppublish</PublicationStatus>
%      <ArticleIdList>
%        <ArticleId IdType="pubmed">1244564</ArticleId>
%      </ArticleIdList>
%    </PubmedData>
%  </PubmedArticle>
% END:Original PubMed XML


@article{dubberke2007clostridium,
  title={Clostridium difficile—associated disease in a setting of endemicity: identification of novel risk factors},
  author={Dubberke, Erik R and Reske, Kimberly A and Yan, Yan and Olsen, Margaret A and McDonald, L Clifford and Fraser, Victoria J},
  journal={Clinical infectious diseases},
  volume={45},
  number={12},
  pages={1543--1549},
  year={2007},
  publisher={Oxford University Press}
}

@article{herrera2011cord,
  title={Cord colitis syndrome in cord-blood stem-cell transplantation},
  author={Herrera, Alex F and Soriano, Gabriela and Bellizzi, Andrew M and Hornick, Jason L and Ho, Vincent T and Ballen, Karen K and Baden, Lindsey R and Cutler, Corey S and Antin, Joseph H and Soiffer, Robert J and others},
  journal={New England Journal of Medicine},
  volume={365},
  number={9},
  pages={815--824},
  year={2011},
  publisher={Mass Medical Soc}
}

@article{morris2013increased,
  title={Increased Levels of Urinary PGE-M, a Biomarker of Inflammation, Occur in Association with Obesity, Aging, and Lung Metastases in Patients with Breast Cancer},
  author={Morris, Patrick G and Zhou, Xi Kathy and Milne, Ginger L and Goldstein, Daniel and Hawks, Laura C and Dang, Chau T and Modi, Shanu and Fornier, Monica N and Hudis, Clifford A and Dannenberg, Andrew J},
  journal={Cancer Prevention Research},
  volume={6},
  number={5},
  pages={428--436},
  year={2013},
  publisher={AACR}
}

@article{kostic2012genomic,
  title={Genomic analysis identifies association of Fusobacterium with colorectal carcinoma},
  author={Kostic, Aleksandar D and Gevers, Dirk and Pedamallu, Chandra Sekhar and Michaud, Monia and Duke, Fujiko and Earl, Ashlee M and Ojesina, Akinyemi I and Jung, Joonil and Bass, Adam J and Tabernero, Josep and others},
  journal={Genome research},
  volume={22},
  number={2},
  pages={292--298},
  year={2012},
  publisher={Cold Spring Harbor Lab}
}

@article{van1971colonization,
  title={Colonization resistance of the digestive tract in conventional and antibiotic-treated mice},
  author={Van der Waaij, D and Berghuis-de Vries, J\_M and Lekkerkerk-Van der Wees, JEC},
  journal={Journal of Hygiene},
  volume={69},
  number={03},
  pages={405--411},
  year={1971},
  publisher={Cambridge Univ Press}
}

@article{walk2012clostridium,
  title={Clostridium difficile ribotype does not predict severe infection},
  author={Walk, Seth T and Micic, Dejan and Jain, Ruchika and Lo, Eugene S and Trivedi, Itishree and Liu, Eugene W and Almassalha, Luay M and Ewing, Sarah A and Ring, Cathrin and Galecki, Andrzej T and others},
  journal={Clinical Infectious Diseases},
  year={2012},
  publisher={Oxford University Press}
}

@article{gooley2010reduced,
  title={Reduced mortality after allogeneic hematopoietic-cell transplantation},
  author={Gooley, Ted A and Chien, Jason W and Pergam, Steven A and Hingorani, Sangeeta and Sorror, Mohamed L and Boeckh, Michael and Martin, Paul J and Sandmaier, Brenda M and Marr, Kieren A and Appelbaum, Frederick R and others},
  journal={New England Journal of Medicine},
  volume={363},
  number={22},
  pages={2091--2101},
  year={2010},
  publisher={Mass Medical Soc}
}

@article{vollaard1994colonization,
  title={Colonization resistance.},
  author={Vollaard, EJ and Clasener, HA},
  journal={Antimicrobial agents and chemotherapy},
  volume={38},
  number={3},
  pages={409},
  year={1994},
  publisher={American Society for Microbiology (ASM)}
}

@article{wingard2011long,
  title={Long-term survival and late deaths after allogeneic hematopoietic cell transplantation},
  author={Wingard, John R and Majhail, Navneet S and Brazauskas, Ruta and Wang, Zhiwei and Sobocinski, Kathleen A and Jacobsohn, David and Sorror, Mohamed L and Horowitz, Mary M and Bolwell, Brian and Rizzo, J Douglas and others},
  journal={Journal of Clinical Oncology},
  volume={29},
  number={16},
  pages={2230--2239},
  year={2011},
  publisher={American Society of Clinical Oncology}
}

@article{cullen2005antibacterial,
  title={Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas},
  author={Cullen, Michael and Steven, Neil and Billingham, Lucinda and Gaunt, Claire and Hastings, Mark and Simmonds, Peter and Stuart, Nicholas and Rea, Daniel and Bower, Mark and Fernando, Indrajit and others},
  journal={New England Journal of Medicine},
  volume={353},
  number={10},
  pages={988--998},
  year={2005},
  publisher={Mass Medical Soc}
}

@article{bucaneve2005levofloxacin,
  title={Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia},
  author={Bucaneve, Giampaolo and Micozzi, Alessandra and Menichetti, Francesco and Martino, Pietro and Dionisi, M Stella and Martinelli, Giovanni and Allione, Bernardino and D'Antonio, Domenico and Buelli, Maurizio and Nosari, A Maria and others},
  journal={New England Journal of Medicine},
  volume={353},
  number={10},
  pages={977--987},
  year={2005},
  publisher={Mass Medical Soc}
}

@article{laughlin2004outcomes,
  title={Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia},
  author={Laughlin, Mary J and Eapen, Mary and Rubinstein, Pablo and Wagner, John E and Zhang, Mei-Jei and Champlin, Richard E and Stevens, Cladd and Barker, Juliet N and Gale, Robert P and Lazarus, Hillard M and others},
  journal={New England Journal of Medicine},
  volume={351},
  number={22},
  pages={2265--2275},
  year={2004},
  publisher={Mass Medical Soc}
}

@article{eriguchi2012graft,
  title={Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of $\alpha$-defensins},
  author={Eriguchi, Y. and Takashima, S. and Oka, H. and Shimoji, S. and Nakamura, K. and Uryu, H. and Shimoda, S. and Iwasaki, H. and Shimono, N. and Ayabe, T. and others},
  journal={Blood},
  volume={120},
  number={1},
  pages={223--231},
  year={2012},
  publisher={American Society of Hematology}
}

@article{mielcarek2003graft,
  title={Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation},
  author={Mielcarek, Marco and Martin, Paul J and Leisenring, Wendy and Flowers, Mary ED and Maloney, David G and Sandmaier, Brenda M and Maris, Michael B and Storb, Rainer},
  journal={Blood},
  volume={102},
  number={2},
  pages={756--762},
  year={2003},
  publisher={American Society of Hematology}
}

@article{holler2006prognostic,
  title={Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination},
  author={Holler, Ernst and Rogler, Gerhard and Brenmoehl, Julia and Hahn, Joachim and Herfarth, Hans and Greinix, Hildegard and Dickinson, Anne M and Soci{\'e}, Gerard and Wolff, Daniel and Fischer, Gottfried and others},
  journal={Blood},
  volume={107},
  number={10},
  pages={4189--4193},
  year={2006},
  publisher={American Society of Hematology}
}

@article{barker2010successful,
  title={Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes},
  author={Barker, Juliet N and Doubrovina, Ekaterina and Sauter, Craig and Jaroscak, Jennifer J and Perales, Miguel A and Doubrovin, Mikhail and Prockop, Susan E and Koehne, Guenther and O'Reilly, Richard J},
  journal={Blood},
  volume={116},
  number={23},
  pages={5045--5049},
  year={2010},
  publisher={American Society of Hematology}
}

@article{hill2000primacy,
  title={The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation},
  author={Hill, Geoffrey R and Ferrara, James LM},
  journal={Blood},
  volume={95},
  number={9},
  pages={2754--2759},
  year={2000},
  publisher={American Society of Hematology}
}

@article{barker2010combined,
  title={Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies},
  author={Barker, Juliet N and Scaradavou, Andromachi and Stevens, Cladd E},
  journal={Blood},
  volume={115},
  number={9},
  pages={1843--1849},
  year={2010},
  publisher={American Society of Hematology}
}

@article{alpdogan2001administration,
  title={Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease},
  author={Alpdogan, Onder and Schmaltz, Cornelius and Muriglan, Stephanie J and Kappel, Barry J and Perales, Miguel-Angel and Rotolo, Jimmy A and Halm, Jens A and Rich, Benjamin E and van den Brink, Marcel RM},
  journal={Blood},
  volume={98},
  number={7},
  pages={2256--2265},
  year={2001},
  publisher={American Society of Hematology}
}

@article{khoruts2010changes
,	author	= {Khoruts, Alexander and Dicksved, Johan and Jansson, Janet K and Sadowsky, Michael J}
,	title	= {Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea.}
,	journal	= {Journal of clinical gastroenterology}
,	volume	= {44}
,	number	= {5}
,	pages	= {354--60}
,	journal-iso	= {J. Clin. Gastroenterol.}
,	doi	= {10.1097/MCG.0b013e3181c87e02}
,	pmid	= {20048681}
,	abstract	= {Clostridium difficile-associated disease (CDAD) is the major known cause of antibiotic-induced diarrhea and colitis, and the disease is thought to result from persistent disruption of commensal gut microbiota. Bacteriotherapy by way of fecal transplantation can be used to treat recurrent CDAD, which is thought to reestablish the normal colonic microflora. However, limitations of conventional microbiologic techniques have, until recently, precluded testing of this idea. In this study, we used terminal-restriction fragment length polymorphism and 16S rRNA gene sequencing approaches to characterize the bacterial composition of the colonic microflora in a patient suffering from recurrent CDAD before and after treatment by fecal transplantation from a healthy donor. Although the patient's residual colonic microbiota, prior to therapy was deficient in members of the bacterial divisions-Firmicutes and Bacteriodetes, transplantation had a dramatic impact on the composition of the patient's gut microbiota. By 14 days posttransplantation, the fecal bacterial composition of the recipient was highly similar to that of the donor and was dominated by Bacteroides spp. strains and an uncharacterized butyrate producing bacterium. The change in bacterial composition was accompanied by resolution of the patient's symptoms. The striking similarity of the recipient's and donor's intestinal microbiota following after bacteriotherapy suggests that the donor's bacteria quickly occupied their requisite niches resulting in restoration of both the structure and function of the microbial communities present.}
}

@article{van2013duodenal
, author = {van Nood, Els and Vrieze, Anne and Nieuwdorp, Max and Fuentes, Susana and Zoetendal, Erwin G and de Vos, Willem M and Visser, Caroline E and Kuijper, Ed J and Bartelsman, Joep F W M and Tijssen, Jan G P and Speelman, Peter and Dijkgraaf, Marcel G W and Keller, Josbert J}
, title = {Duodenal infusion of donor feces for recurrent Clostridium difficile.}
, journal = {The New England journal of medicine}
, year = {2013}
, volume = {368}
, number = {5}
, pages = {407--15}
, month = {Jan}
, journal-iso = {N. Engl. J. Med.}
, doi = {10.1056/NEJMoa1205037}
, pmid = {23323867}
, abstract = {Recurrent Clostridium difficile infection is difficult to treat, and failure rates for antibiotic therapy are high. We studied the effect of duodenal infusion of donor feces in patients with recurrent C. difficile infection.We randomly assigned patients to receive one of three therapies: an initial vancomycin regimen (500 mg orally four times per day for 4 days), followed by bowel lavage and subsequent infusion of a solution of donor feces through a nasoduodenal tube; a standard vancomycin regimen (500 mg orally four times per day for 14 days); or a standard vancomycin regimen with bowel lavage. The primary end point was the resolution of diarrhea associated with C. difficile infection without relapse after 10 weeks.The study was stopped after an interim analysis. Of 16 patients in the infusion group, 13 (81%) had resolution of C. difficile-associated diarrhea after the first infusion. The 3 remaining patients received a second infusion with feces from a different donor, with resolution in 2 patients. Resolution of C. difficile infection occurred in 4 of 13 patients (31%) receiving vancomycin alone and in 3 of 13 patients (23%) receiving vancomycin with bowel lavage (P<0.001 for both comparisons with the infusion group). No significant differences in adverse events among the three study groups were observed except for mild diarrhea and abdominal cramping in the infusion group on the infusion day. After donor-feces infusion, patients showed increased fecal bacterial diversity, similar to that in healthy donors, with an increase in Bacteroidetes species and clostridium clusters IV and XIVa and a decrease in Proteobacteria species.The infusion of donor feces was significantly more effective for the treatment of recurrent C. difficile infection than the use of vancomycin. (Funded by the Netherlands Organization for Health Research and Development and the Netherlands Organization for Scientific Research; Netherlands Trial Register number, NTR1177.).}
}

@article{eiseman1958fecal,
  title={Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis.},
  author={Eiseman, B and Silen, W and Bascom, GS and Kauvar, AJ and others},
  journal={Surgery},
  volume={44},
  number={5},
  pages={854},
  year={1958}
}

@article{you2008successful,
  title={Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy.},
  author={You, David M and Franzos, M Alaric and Holman, Robert P and others},
  journal={Annals of internal medicine},
  volume={148},
  number={8},
  pages={632},
  year={2008}
}

@article{mellow2011colonoscopic,
  title={Colonoscopic fecal bacteriotherapy in the treatment of recurrent Clostridium difficile infection--results and follow-up.},
  author={Mellow, Mark H and Kanatzar, Amy},
  journal={The Journal of the Oklahoma State Medical Association},
  volume={104},
  number={3},
  pages={89},
  year={2011}
}

@article{bakken2009fecal,
  title={Fecal bacteriotherapy for recurrent Clostridium difficile infection.},
  author={Bakken, Johan S and Johnson, S and Gerding, DN and others},
  journal={Anaerobe},
  volume={15},
  number={6},
  pages={285--289},
  year={2009},
  publisher={Elsevier Ltd}
}

@article{kelly2013fecal,
  title={Fecal Microbiota Transplantation—An Old Therapy Comes of Age},
  author={Kelly, Ciar{\'a}n P},
  journal={New England Journal of Medicine},
  year={2013},
  publisher={Mass Medical Soc}
}

@article{borody2004bacteriotherapy,
  title={Bacteriotherapy using fecal flora: toying with human motions},
  author={Borody, Thomas J and Warren, Eloise F and Leis, Sharyn M and Surace, Rosa and Ashman, Ori and Siarakas, Steven},
  journal={Journal of clinical gastroenterology},
  volume={38},
  number={6},
  pages={475--483},
  year={2004},
  publisher={LWW}
}

@article{baron2006factors,
  title={Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation},
  author={Baron, Fr{\'e}d{\'e}ric and Storb, Rainer and Storer, Barry E and Maris, Michael B and Niederwieser, Dietger and Shizuru, Judith A and Chauncey, Thomas R and Bruno, Benedetto and Forman, Stephen J and McSweeney, Peter A and others},
  journal={Journal of clinical oncology},
  volume={24},
  number={25},
  pages={4150--4157},
  year={2006},
  publisher={American Society of Clinical Oncology}
}

@article{armand2012disease,
  title={A disease risk index for patients undergoing allogeneic stem cell transplantation},
  author={Armand, Philippe and Gibson, Christopher J and Cutler, Corey and Ho, Vincent T and Koreth, John and Alyea, Edwin P and Ritz, Jerome and Sorror, Mohamed L and Lee, Stephanie J and Deeg, H Joachim and others},
  journal={Blood},
  volume={120},
  number={4},
  pages={905--913},
  year={2012},
  publisher={American Society of Hematology}
}

@article{kahl2007relapse,
  title={Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning},
  author={Kahl, Christoph and Storer, Barry E and Sandmaier, Brenda M and Mielcarek, Marco and Maris, Michael B and Blume, Karl G and Niederwieser, Dietger and Chauncey, Thomas R and Forman, Stephen J and Agura, Edward and others},
  journal={Blood},
  volume={110},
  number={7},
  pages={2744--2748},
  year={2007},
  publisher={American Society of Hematology}
}

@article{ruutu2014improved,
  title={Improved Survival with Ursodeoxycholic Acid Prophylaxis in Allogeneic Stem Cell Transplantation: Long-Term Follow-Up of a Randomized Study},
  author={Ruutu, Tapani and Juvonen, Eeva and Remberger, Mats and Remes, Kari and Volin, Liisa and Mattsson, Jonas and Nihtinen, Anne and H{\"a}gglund, Hans and Ringd{\'e}n, Olle},
  journal={Biology of Blood and Marrow Transplantation},
  volume={20},
  number={1},
  pages={135--138},
  year={2014},
  publisher={Elsevier}
}

@article{mikulska2012mortality,
  title={Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients},
  author={Mikulska, M and Del Bono, V and Bruzzi, P and Raiola, AM and Gualandi, F and Van Lint, MT and Bacigalupo, A and Viscoli, C},
  journal={Infection},
  pages={1--8},
  year={2012},
  publisher={Springer}
}

@article{vydra2012enterococcal,
  title={Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation},
  author={Vydra, Jan and Shanley, Ryan M and George, Ige and Ustun, Celalettin and Smith, Angela R and Weisdorf, Daniel J and Young, Jo-Anne H},
  journal={Clinical Infectious Diseases},
  volume={55},
  number={6},
  pages={764--770},
  year={2012},
  publisher={Oxford University Press}
}

@article{brunstein2007umbilical,
  title={Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease},
  author={Brunstein, Claudio G and Barker, Juliet N and Weisdorf, Daniel J and DeFor, Todd E and Miller, Jeffrey S and Blazar, Bruce R and McGlave, Philip B and Wagner, John E},
  journal={Blood},
  volume={110},
  number={8},
  pages={3064--3070},
  year={2007},
  publisher={American Society of Hematology}
}

@article{sorror2007comorbidity,
  title={Comorbidity and disease status--based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation},
  author={Sorror, Mohamed L and Sandmaier, Brenda M and Storer, Barry E and Maris, Michael B and Baron, Fr{\'e}d{\'e}ric and Maloney, David G and Scott, Bart L and Deeg, H Joachim and Appelbaum, Frederick R and Storb, Rainer},
  journal={Journal of Clinical Oncology},
  volume={25},
  number={27},
  pages={4246--4254},
  year={2007},
  publisher={American Society of Clinical Oncology}
}

@article{de2005clinical,
  title={Is this clinical trial fully registered?—A statement from the International Committee of Medical Journal Editors},
  author={De Angelis, Catherine D and Drazen, Jeffrey M and Frizelle, Frank A and Haug, Charlotte and Hoey, John and Horton, Richard and Kotzin, Sheldon and Laine, Christine and Marusic, Ana and Overbeke, A John PM and others},
  journal={New England Journal of Medicine},
  volume={352},
  number={23},
  pages={2436--2438},
  year={2005},
  publisher={Mass Medical Soc}
}

@article{kelly2012fecal,
  title={Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results},
  author={Kelly, Colleen R and de Leon, Lauren and Jasutkar, Niren},
  journal={Journal of clinical gastroenterology},
  volume={46},
  number={2},
  pages={145--149},
  year={2012},
  publisher={LWW}
}

@article{brandt2011endoscopic,
  title={Endoscopic Fecal Microbiota Transplantation:“First-Line” Treatment for Severe Clostridium difficile Infection?},
  author={Brandt, Lawrence J and Borody, Thomas Julius and Campbell, Jordana},
  journal={Journal of clinical gastroenterology},
  volume={45},
  number={8},
  pages={655--657},
  year={2011},
  publisher={LWW}
}

@article{brandt2011fecal,
  title={Fecal microbiota transplantation for recurrent Clostridium difficile infection},
  author={Brandt, Lawrence J and Reddy, Sheela S},
  journal={Journal of clinical gastroenterology},
  volume={45},
  pages={S159},
  year={2011}
}

@article{dubberke2010clostridium,
  title={Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes},
  author={Dubberke, Erik R and Reske, Kimberlay A and Srivastava, Anand and Sadhu, Justin and Gatti, Robert and Young, Rebecca M and Rakes, Lauren C and Dieckgraefe, Brian and DiPersio, John and Fraser, Victoria J},
  journal={Clinical transplantation},
  volume={24},
  number={2},
  pages={192--198},
  year={2010},
  publisher={Wiley Online Library}
}

@article{persky2000treatment,
  title={Treatment of recurrent Clostridium difficile--associated diarrhea by administration of donated stool directly through a colonoscope},
  author={Persky, Seth E and Brandt, Lawrence J},
  journal={The American journal of gastroenterology},
  volume={95},
  number={11},
  pages={3283--3285},
  year={2000},
  publisher={Nature Publishing Group}
}

@article{willems2012clostridium
,	author	= {Willems, Lise and Porcher, Rapha\"el and Lafaurie, Matthieu and Casin, Isabelle and Robin, Marie and Xhaard, Ali\'enor and Andreoli, Anna Lisa and Rodriguez-Otero, Paula and Dhedin, Nathalie and Soci\'e, G\'erard and Ribaud, Patricia and Peffault de Latour, R\'egis}
,	title	= {Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.}
,	journal	= {Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation}
,	year	= {2012}
,	volume	= {18}
,	number	= {8}
,	pages	= {1295--301}
,	month	= {Aug}
,	journal-iso	= {Biol. Blood Marrow Transplant.}
,	doi	= {10.1016/j.bbmt.2012.02.010}
,	pmid	= {22387347}
,	abstract	= {Clostridium difficile (C. difficile) infection was observed in 13% of recipients after hematopoietic stem cell transplantation (HSCT), mainly in the first month posttransplantation. Risk factors were cord blood as the source of stem cells, acute graft-versus-host disease (GVHD), and total body irradiation (TBI). No association was found with an increased risk of mortality. The purpose of this study was to evaluate the incidence, risk factors, and outcome of C. difficile infection (CDI) after HSCT. We conducted a single-center, retrospective, cohort study on all patients who received an allogeneic HSCT from January 2004 to December 2007. All patients with diarrhea in the first year after HSCT were tested for the presence of C. difficile in stools. Among the 407 assessable patients, 53 presented at least 1 CDI in the first year post-HSCT. The total incidence rate was 5.6 cases of CDI per 10,000 patient-days. Fifty percent of cases were diagnosed in the first month after HSCT, and 95% occurred during the first 6 months. Fewer than 5% of patients with CDI had severe diarrhea and severe complications were never observed. TBI in the conditioning regimen, cord blood as the source of stem cells, and acute graft-versus-host disease (aGVHD) were independently associated with CDI. Six patients (11%) had a recurrence of CDI. Four patients required second-line treatment with vancomycin. With a median follow-up of 22 months, the 2-year overall survival rates were similar between patients who presented a CDI and those who did not. CDI was observed in approximately 13% of recipients after HSCT, mainly in the first month posttransplantation and was associated with CB, aGVHD, and TBI. CDI was not associated either with severe complications or with an increased risk of mortality in this large cohort of patients.Copyright © 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.}
}

@article{silverman2010success
,	author	= {Silverman, Michael S and Davis, Ian and Pillai, Dylan R}
,	title	= {Success of Self-Administered Home Fecal Transplantation for Chronic Clostridium difficile Infection}
,	journal	= {Clinical Gastroenterology and Hepatology}
,	year	= {2010}
,	volume	= {8}
,	number	= {5}
,	pages	= {471--473}
,	publisher	= {Elsevier}
}

@article{brandt2012long,
  title={Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection},
  author={Brandt, Lawrence J and Aroniadis, Olga C and Mellow, Mark and Kanatzar, Amy and Kelly, Colleen and Park, Tina and Stollman, Neil and Rohlke, Faith and Surawicz, Christina},
  journal={The American journal of gastroenterology},
  year={2012},
  publisher={Nature Publishing Group}
}

@article{emanuelsson2013faecal,
  title={Faecal microbiota transplantation and bacteriotherapy for recurrent Clostridium difficile infection: A retrospective evaluation of 31 patients},
  author={Emanuelsson, Frida and Claesson, Berndt EB and Ljungstr{\"o}m, Lars and Tvede, Michael and Ung, Kjell-Arne},
  journal={Scandinavian Journal of Infectious Diseases},
  number={0},
  pages={1--9},
  year={2013},
  publisher={Informa Healthcare Stockholm}
}

@article{gooley2010reduced,
  title={Reduced mortality after allogeneic hematopoietic-cell transplantation},
  author={Gooley, Ted A and Chien, Jason W and Pergam, Steven A and Hingorani, Sangeeta and Sorror, Mohamed L and Boeckh, Michael and Martin, Paul J and Sandmaier, Brenda M and Marr, Kieren A and Appelbaum, Frederick R and others},
  journal={New England Journal of Medicine},
  volume={363},
  number={22},
  pages={2091--2101},
  year={2010},
  publisher={Mass Medical Soc}
}

@article{gough2011systematic,
  title={Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection},
  author={Gough, Ethan and Shaikh, Henna and Manges, Amee R},
  journal={Clinical infectious diseases},
  volume={53},
  number={10},
  pages={994--1002},
  year={2011},
  publisher={Oxford University Press}
}

@article{lawley2012targeted
,	author	= {Lawley, Trevor D and Clare, Simon and Walker, Alan W and Stares, Mark D and Connor, Thomas R and Raisen, Claire and Goulding, David and Rad, Roland and Schreiber, Fernanda and Brandt, Cordelia and Deakin, Laura J and Pickard, Derek J and Duncan, Sylvia H and Flint, Harry J and Clark, Taane G and Parkhill, Julian and Dougan, Gordon}
,	title	= {Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice.}
,	journal	= {PLoS pathogens}
,	year	= {2012}
,	volume	= {8}
,	number	= {10}
,	pages	= {e1002995}
,	journal-iso	= {PLoS Pathog.}
,	doi	= {10.1371/journal.ppat.1002995}
,	pmid	= {23133377}
,	abstract	= {Relapsing C. difficile disease in humans is linked to a pathological imbalance within the intestinal microbiota, termed dysbiosis, which remains poorly understood. We show that mice infected with epidemic C. difficile (genotype 027/BI) develop highly contagious, chronic intestinal disease and persistent dysbiosis characterized by a distinct, simplified microbiota containing opportunistic pathogens and altered metabolite production. Chronic C. difficile 027/BI infection was refractory to vancomycin treatment leading to relapsing disease. In contrast, treatment of C. difficile 027/BI infected mice with feces from healthy mice rapidly restored a diverse, healthy microbiota and resolved C. difficile disease and contagiousness. We used this model to identify a simple mixture of six phylogenetically diverse intestinal bacteria, including novel species, which can re-establish a health-associated microbiota and clear C. difficile 027/BI infection from mice. Thus, targeting a dysbiotic microbiota with a defined mixture of phylogenetically diverse bacteria can trigger major shifts in the microbial community structure that displaces C. difficile and, as a result, resolves disease and contagiousness. Further, we demonstrate a rational approach to harness the therapeutic potential of health-associated microbial communities to treat C. difficile disease and potentially other forms of intestinal dysbiosis.}
}

@article{nicolle2001urinary,
  title={Urinary tract pathogens in complicated infection and in elderly individuals},
  author={Nicolle, Lindsay E},
  journal={Journal of infectious diseases},
  volume={183},
  number={Supplement 1},
  pages={S5--S8},
  year={2001},
  publisher={Oxford University Press}
}

@article{hooton1997diagnosis,
  title={Diagnosis and treatment of uncomplicated urinary tract infection.},
  author={Hooton, Thomas M and Stamm, Walter E and others},
  journal={Infectious disease clinics of North America},
  volume={11},
  number={3},
  pages={551},
  year={1997}
}

